Contact Lenses and Tear Film Lipids. by Walther, Hendrik










presented to the University of Waterloo 
in fulfillment of the 
thesis requirement for the degree of 






Waterloo, Ontario, Canada, 2017 
 




Examining Committee Membership 
The following served on the Examining Committee for this thesis. The decision of the 
Examining Committee is by majority vote. 
 
External Examiner    Claude Giasson 
      Professor, University of Montreal 
 
Supervisor(s)    Lyndon Jones 
      Professor 
      Lakshman Subbaraman 
      Research Associate Professor 
 
Internal Member(s)    Nima Khadem Mohtaram 
      Lecturer 
      Luigina Sorbara 
      Associate Professor 
 
Internal-external Member   Marc Aucoin 





I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, 
including any required final revisions, as accepted by my examiners. 
 




Statement of Contributions 
I would like to acknowledge the names of my co-authors who contributed to this thesis: 
 Dr. Lyndon Jones (Chapters 3 – 7) 
 Dr. Lakshman Subbaraman (Chapters 3 – 7) 






Lipids are essential tear components that aid the stability of the tear film (TF) to protect it 
from excess evaporation. The composition, conformation, and function of TF lipids are 
jeopardized by external factors such as contact lens (CL) wear and environmental elements 
(i.e. UV radiation, oxidation). Specifically, silicone hydrogel (SiHy) CLs exhibit relatively 
high deposition of TF lipids that may be associated with visual disturbances and discomfort. 
Additionally, lipids are degraded by oxidation and may cause alterations of the TF lipid layer, 
which in turn might be a source for dry eye symptoms.  
The overall goal of this thesis was to evaluate the quantity and location of lipid deposition 
on various CL materials over time and also to assess the impact lipid contamination may have 
on various care products and TF quality measurements. 
 
The specific aims of each chapter of this thesis were as follows: 
 
• Chapter 3: To determine the efficacy of multi-purpose solutions (MPS) on the removal 
of cholesterol deposits from SiHy lens materials. 
• Chapter 4: To analyze the uptake of cholesterol on SiHy and conventional hydrogel 




• Chapter 5: To evaluate the differences in lipid uptake and penetration in DD CL using 
the conventional “in-vial” method compared to a novel in vitro eye model. 
• Chapter 6: To develop a novel in vitro model to determine pre-lens non-invasive break-
up times (NIBUT) and to subsequently compare the break-up times over five 
contemporary DD lens materials. 
• Chapter 7: To optimize and develop a method to determine and quantify lipid 
peroxidation by-products that indicates oxidative stress in tears. 
Materials and Methods 
• Chapter 3: Five contemporary SiHy lens materials were incubated for 7 days using a 
radiochemical experiment. Additionally, lenses were stored and cleaned in different 
MPSs using a rub and rinse technique. Lipids were then extracted from lenses with 2:1 
chloroform:methanol, analyzed in a beta-particle radiation counter and µg/lens of 
cholesterol was determined. 
• Chapter 4: Seven different commercially available DD CLs were incubated for 16 
hours to determine the impact of material composition on cholesterol deposition. 
Subsequent to the incubation, lenses were extracted using 2:1 chloroform:methanol and 
the extracts were analyzed in a beta-particle radiation counter and (ng/lens) 
extrapolated from standard curves. 
• Chapter 5: Seven DD CLs were incubated for 4 and 12 hours in an artificial tear solution 
(ATS) containing fluorescently-labelled cholesterol (7-nitrobenz-2-oxa-1,3-diazol-4-
yl-cholesterol, or NBD-cholesterol). Additionally, CLs were incubated in an “in-vial” 
 
vii 
condition and compared to a novel in vitro eye platform, designed to simulate 
physiological tear flow, tear volume, and ‘simulated’ blinking. After the incubation 
period, the CLs were analyzed using a laser scanning confocal microscope (LSCM), 
and quantitative analyses for penetration depth and relative fluorescence intensity 
values were carried out. 
• Chapter 6: Five DD lens materials were incubated in an artificial tear solution using a 
model blink cell that mimics intermittent air exposure. CLs were incubated by 
repeatedly being submerged and exposed to air for up to 16 hours. A corneal 
topographer (Topcon CA-100) was used to illuminate the lens surfaces with placido 
rings, which were captured with a digital video camera and from which NIBUTs of the 
CL materials were determined. 
• Chapter 7: Tear samples were collected using calibrated disposable capillary tubes and 
various assays that quantify lipid peroxidation by-products were compared against each 
other: thiobarbituric acid reactive substances (TBARS) assay, malondialdehyde 
(MDA), 4-hydroxynonenal (4-HNE), and oxidized low-density-lipoproteins (OxLDL) 
enzyme-linked immunosorbent assays (ELISAs). Pooled and individual tear samples 
were diluted in a wide range to determine the lowest volume of tears that could be used. 
Subsequently, the fluorescence was measured with a fluorescence spectrophotometer 






• Chapter 3: For all lens materials, only one of the multipurpose solutions removed more 
cholesterol than any other test solution; however, the amount of cholesterol removed 
from the individual CLs was statistically significant only for the two lens materials that 
deposited the most: balafilcon A (0.93±0.02µg/lens) and senofilcon A 
(0.95±0.01µg/lens). All of the other solutions evaluated showed no significant effect 
on lipid removal. 
• Chapter 4: Cholesterol deposited significantly more on SiHy lenses than CHs. The 
uptake of cholesterol ranged from 22.63 ± 2.98 ng/lens to 97.94 ± 4.18 ng/lens for all 
lens materials, with narafilcon A accumulating the largest quantity of cholesterol. The 
accumulation of cholesterol was shown to be continuous throughout the 16 hours of 
incubation without reaching a plateau. 
• Chapter 5: The depth of penetration of NBD-cholesterol varied between the vial and 
the eye-blink platform. In general, SiHy lenses showed higher intensities of NBD-
cholesterol than CH materials and the fluorescence intensities also varied between the 
incubation methods as well as the lens materials. 
• Chapter 6: Overall, NIBUTs ranged from 26.19 ± 5.79 s to 1.23 ± 0.13 s. After the 
initial (T0) break-up times were determined, CH CLs revealed significantly longer 
NIBUTs than SiHy CLs. After 16 hours of incubation, the SiHy lens material delefilcon 
A had the longest break-up time. Significant changes of NIBUTs within the lens 
 
ix 
materials varied between the examined time points. After 16 hours, all CLs showed 
significant reductions in NIBUTs in comparison to T0. 
• Chapter 7: After tear samples were pooled and concentrated, 0.056±0.004 µM of MDA 
could be measured using the TBARS assay. After optimizing various ELISAs, OxLDL 
in individual tear samples (2.5µL) ranged between 45.59 ± 2.95 ng/mL and 28.24 ± 
4.66 ng/mL. All measurements using the MDA- and 4-HNE ELISA were below the 
assays limit of detection. 
Conclusions 
• Chapter 3: Lipid-removal efficacy varies depending on the combination of lens material 
and solution. Only one MPS showed a significant reduction of lipids for any of the 
tested lens materials. 
• Chapter 4: For the periods of time that DD lens materials are worn, cholesterol deposits 
significantly more onto SiHy lenses than CHs. This could have implications for wearers 
who have higher levels of lipid in their tears that are fitted with SiHy DD materials. 
• Chapter 5: This study provides a novel in vitro approach to evaluate deposition and 
penetration of lipids on CLs. We show that the traditional “in-vial” incubation method 
exposes the CLs to an excessively high amount of ATS, which results in an 
overestimation for cholesterol deposition. The novel eye-platform, provides a more 
natural environment for in vitro lens incubation studies which will consequently better 
elucidate the interactions between CLs and TF components. 
 
x 
• Chapter 6: NIBUT values reduced gradually over time and varying levels of deposition 
on different CLs may impact the measured pre-lens NIBUT of various lens materials. 
While NIBUT of CH materials are longer than that obtained with SiHy materials 
immediately out of the blister pack, it appears that after TF exposure, the NIBUTs 
determined between CH and SiHy DD materials are very similar. 
• Chapter 7: Assays for oxidative stress were optimized and showed that oxidative stress 
is detectible in small quantities of tears (2.5 µL). These techniques could be employed 
to determine oxidative stress in TF lipids, which could potentially help to identify 
patients with dry eye and CL discomfort. 
 
This thesis has provided previously unavailable information on lipid deposition on CLs and 
its effect on clinically relevant TF quality measurements. The results showed that current CL 
cleaning solutions fail to efficiently remove lipid contaminations and that DD SiHy lens 
materials provide options for clinicians to consider when patients experience complications 
and excess lipid uptake with daily wear lens materials. Furthermore, this thesis has presented 
novel in vitro methods that will be useful for other researchers and the CL industry to 





Pursuing a PhD was not on my list of goals when I began my path as an optician in Germany, 
however, it will forever be one of the most profound achievements of my career. I now realize 
that one does not accomplish this in isolation, but only with the support of colleagues, friends 
and family. I would like to acknowledge and thank these individuals who have supported me 
in the completion of this endeavor. 
First and foremost, thank you to my supervisors Drs. Lyndon Jones and Lakshman 
Subbaraman. Anyone who has ever had or will have the pleasure of being supervised by Dr. 
Lyndon Jones can truly consider themselves a lucky graduate student. No words can describe 
how grateful I am for your steadfast guidance and encouragement throughout this process, 
especially in times of struggle and doubt. Dr. Lakshman Subbaraman, thank you for sharing 
your tremendous knowledge while guiding me in the right directions, and for always being 
available and supportive of my PhD work. 
I would also like to sincerely thank my committee members Drs. Maud Gorbet and Luigina 
Sorbara for sharing your scientific and clinical expertise and for inspiring me to reach higher 
levels in my research. A special thank you to Dr. Debbie Jones, who was part of my initial 
committee, for sharing your knowledge with me and your encouragement. To my examining 
committee members Dr. Nima Khadem Mohtaram, Dr. Marc Aucoin, and Dr. Claude Giasson 
thank you for your wonderful feedback on my written work and  great suggestions and insights 
 
xii 
you gave me during my defense. Specifically, thank you Dr. Nima Khadem Mohtaram for 
agreeing to be part of my committee on such short notice. 
I am very grateful and lucky to have been able to learn from such a diverse group of scholars 
and mentors along the way. A special thank you to Dr. Holly Irene Lorentz and Miriam Heynen 
for teaching me everything I needed to know about lipids, chemistry, and working in a state of 
the art laboratory. Thank you to Drs. Elizabeth Drolle and Kevin van Doorn for sharing your 
scientific expertise, proof reading my thesis drafts, and for being there for me if I needed to 
clear and refresh my mind from the writing process. 
Since I came to Canada, I have experienced a tremendous amount of support and met so 
many kind and wonderful people. The University of Waterloo School of Optometry and Vision 
Science, and especially the Centre for Contact Lens Research (CCLR) are perfect little 
paradigms of the exceptional support, kindness and diversity someone will encounter in 
Canada. I have to extend my thank you to the Graduates in Vision Science (GIVS), faculty, 
and staff at the school, but my special thank you goes to Stephanie Forsyth for doing a 
phenomenal job in assisting every graduate student to maneuver through the administrative 
maze to reach their goals of successfully finishing their degrees. 
I wouldn’t be in this position, without the encouragement and support of very special people 
in my life. My most sincere thanks to my former supervisor Prof. Wolfgang Sickenberger who 
first sparked my enthusiasm in contact lenses, who inspired me to conduct research to deepen 
our knowledge about them, and for creating the first connection to Dr. Lyndon Jones and the 
CCLR. A special thank you to Drs. Dörte Lünsmann and Marc Schulze who encouraged me to 
 
xiii 
conduct research for my masters in Canada and for introducing me to the love of my life, my 
wife Dr. Carolyn MacNeil. To my German and Canadian family, I will forever be grateful for 
your patience and support. 
Last, but not least, thank you to my three closest friends that have stood by my side for the 
past 15 years. Thank you to Thomas Harnisch, Dr. Alex Müntz, and PhD candidate Christian 




To my parents and my beloved wife Carolyn who have supported me throughout this 
journey. This is as much your work as it is mine. 
 
I love you! 
 
xv 
Table of Contents 
Examining Committee Membership ......................................................................................... ii 
Authors's Declaration ............................................................................................................... iii 
Statement of Contributions ...................................................................................................... iv 
Abstract ..................................................................................................................................... v 
Acknowledgements .................................................................................................................. xi 
Dedication .............................................................................................................................. xiv 
Table of Contents .................................................................................................................... xv 
List of Figures ....................................................................................................................... xxii 
List of Tables ....................................................................................................................... xxvi 
List of Abbreviations .......................................................................................................... xxvii 
Chapter 1 Literature Review ..................................................................................................... 1 
1.1 The Meibomian Glands .............................................................................................. 1 
1.1.1 Structure and Function ......................................................................................... 1 
1.1.2 Meibum Composition .......................................................................................... 3 
1.2 The Tear Film ............................................................................................................. 5 
1.2.1 Structure and Function ......................................................................................... 5 
1.2.2 Formation of the Lipid Layer ............................................................................... 7 
1.2.3 Tear Film Stability ............................................................................................... 9 
1.3 Contact Lens Materials ............................................................................................. 11 
1.3.1 Conventional Hydrogels .................................................................................... 12 
 
xvi 
1.3.2 Silicone Hydrogels ............................................................................................. 13 
1.3.3 Contact Lens Classifications .............................................................................. 15 
1.3.4 Contact Lens Distribution .................................................................................. 16 
1.4 Tear Film Lipid and Contact Lens Interactions ........................................................ 17 
1.4.1 Contact Lenses and Tear Film Stability ............................................................. 17 
1.4.2 Contact Lens Deposition .................................................................................... 18 
1.5 Lens Care Products ................................................................................................... 22 
1.5.1 Hydrogen Peroxide-Base Systems ..................................................................... 23 
1.5.2 Multipurpose Solutions ...................................................................................... 24 
1.5.3 Surfactants and Lipid Removal .......................................................................... 25 
1.5.4 Patient Compliance ............................................................................................ 26 
1.6 Methods to Detect and Analyse TF Lipids ............................................................... 27 
1.6.1 Lipid Collection Methods .................................................................................. 27 
1.6.2 Analytical Methods of Lipid Deposition ........................................................... 29 
Chapter 2 Objectives and Rationale ........................................................................................ 36 
Chapter 3 Efficacy of Contact Lens Care Solutions in Removing Cholesterol Deposits from 
Silicone Hydrogel Contact Lenses .......................................................................................... 41 
3.1 Outline ...................................................................................................................... 42 
3.1.1 Purpose ............................................................................................................... 42 
3.1.2 Materials & Methods ......................................................................................... 42 
3.1.3 Results ................................................................................................................ 42 
 
xvii 
3.1.4 Conclusion ......................................................................................................... 43 
3.1.5 Keywords ........................................................................................................... 43 
3.2 Introduction .............................................................................................................. 44 
3.3 Material & Methods ................................................................................................. 45 
3.3.1 Lens Materials .................................................................................................... 45 
3.3.2 Artificial Tear Solution ...................................................................................... 47 
3.3.3 Cholesterol and 14C Radioactivity ..................................................................... 47 
3.3.4 Vial pre-treatment .............................................................................................. 47 
3.3.5 Lens Incubation and Extraction ......................................................................... 47 
3.3.6 Statistical Analysis ............................................................................................. 49 
3.4 Results ...................................................................................................................... 50 
3.4.1 Total uptake of lipids onto lens materials .......................................................... 50 
3.4.2 Lens Care Product Performance on Lipid Removal .......................................... 52 
3.5 Discussion ................................................................................................................. 54 
3.6 Acknowledgement .................................................................................................... 57 
Chapter 4 In Vitro Cholesterol Deposition on Daily Disposable Contact Lens Materials ..... 59 
4.1 Outline ...................................................................................................................... 60 
4.1.1 Objective ............................................................................................................ 60 
4.1.2 Materials & Methods ......................................................................................... 60 
4.1.3 Results ................................................................................................................ 60 
4.1.4 Conclusion ......................................................................................................... 61 
 
xviii 
4.2 Introduction .............................................................................................................. 62 
4.3 Materials and Methods ............................................................................................. 63 
4.3.1 Lens Materials .................................................................................................... 63 
4.3.2 Contact Lens Incubation and Extraction ............................................................ 64 
4.3.3 Vial pre-treatment .............................................................................................. 64 
4.3.4 Lens incubation and extraction .......................................................................... 64 
4.3.5 Data Analysis ..................................................................................................... 65 
4.4 Results ...................................................................................................................... 65 
4.5 Discussion ................................................................................................................. 67 
4.6 Acknowledgment ...................................................................................................... 71 
Chapter 5 Differential Deposition of Fluorescently Tagged Cholesterol on Commercial 
Contact Lenses Using a Novel In Vitro Eye Model ................................................................ 73 
5.1 Outline ...................................................................................................................... 74 
5.1.1 Purpose ............................................................................................................... 74 
5.1.2 Methods ............................................................................................................. 74 
5.1.3 Results ................................................................................................................ 74 
5.1.4 Conclusions ........................................................................................................ 75 
5.1.5 Keywords ........................................................................................................... 75 
5.2 Introduction .............................................................................................................. 76 
5.3 Materials & Methods ................................................................................................ 78 
5.3.1 Contact lenses and pre-treatment ....................................................................... 78 
 
xix 
5.3.2 Artificial Tear Solution ...................................................................................... 80 
5.3.3 Fluorescently tagged cholesterol ....................................................................... 80 
5.3.4 Ocular flow model ............................................................................................. 81 
5.3.5 Experimental Outline ......................................................................................... 82 
5.3.6 Confocal Microscopy ......................................................................................... 83 
5.3.7 Statistical Analysis ............................................................................................. 84 
5.4 Results ...................................................................................................................... 84 
5.4.1 Impact of Contact Lens Material ....................................................................... 85 
5.4.2 Impact of Incubation Method ............................................................................ 87 
5.5 Discussion ................................................................................................................. 90 
5.6 Acknowledgment ...................................................................................................... 95 
Chapter 6 Novel In Vitro Method to Determine Pre-Lens Tear Break-up Time of Hydrogel and 
Silicone Hydrogel Contact Lenses .......................................................................................... 97 
6.1 Outline ...................................................................................................................... 98 
6.1.1 Purpose ............................................................................................................... 98 
6.1.2 Methods ............................................................................................................. 98 
6.1.3 Results ................................................................................................................ 98 
6.1.4 Conclusion ......................................................................................................... 99 
6.1.5 Keywords ........................................................................................................... 99 
6.2 Introduction ............................................................................................................ 100 
6.3 Material & Methods ............................................................................................... 102 
 
xx 
6.3.1 Contact lenses and pre-treatment ..................................................................... 102 
6.3.2 Artificial Tear Solution .................................................................................... 103 
6.3.3 Model Blink Cell ............................................................................................. 103 
6.3.4 Topographer ..................................................................................................... 104 
6.3.5 Experimental Outline ....................................................................................... 105 
6.3.6 Data Analysis ................................................................................................... 105 
6.4 Results .................................................................................................................... 106 
6.5 Discussion ............................................................................................................... 109 
Chapter 7 Development of a technique to quantify oxidative stress in tear film lipids ........ 115 
7.1 Outline .................................................................................................................... 116 
7.1.1 Purpose ............................................................................................................. 116 
7.1.2 Methods ........................................................................................................... 116 
7.1.3 Results .............................................................................................................. 117 
7.1.4 Conclusion ....................................................................................................... 117 
7.1.5 Keywords ......................................................................................................... 117 
7.2 Introduction ............................................................................................................ 118 
7.3 Materials and Methods ........................................................................................... 120 
7.3.1 Tear Samples & Collection .............................................................................. 120 
7.3.2 Test Assays ...................................................................................................... 120 
7.3.3 Analysis ........................................................................................................... 123 
7.4 Results and Discussion ........................................................................................... 124 
 
xxi 
7.4.1 Thiobarbituric Acid Reactive Substances Assay ............................................. 124 
7.4.2 ELISA Kits ...................................................................................................... 128 
7.5 Conclusion .............................................................................................................. 135 
7.6 Acknowledgment .................................................................................................... 136 
Chapter 8 Conclusions and Future Outlook .......................................................................... 137 
Letters of Copyright Permissions.......................................................................................... 144 
Republication License: Association for Research in Vision and Ophthalmology (Chapter 
1; Figure 1-4) ..................................................................................................................... 144 
Copyright: Optometry and Vision Science (Chapter 4) ............................................... 148 




List of Figures 
Figure 1-1. Tear producing structures and tear film structure of the eye. ................................ 1 
Figure 1-2. A MG functional unit with multiple acini units connected to a central duct. Meibum 
is produced at the acini units, which travels to the central duct, and eventually out of the 
MG orifice at the eyelid margin ........................................................................................ 2 
Figure 1-3. Chemical structure of cholesterol (386.65 g/mol).................................................. 4 
Figure 1-4. The structure of the tear film .................................................................................. 6 
Figure 1-5. Lipid peroxidation cycle ...................................................................................... 11 
Figure 1-6. Disruption of the tear film layer when a contact lens is placed onto the ocular 
surface ............................................................................................................................. 13 
Figure 1-7. Distribution of conventional vs. silicone hydrogel contact lenses in 2017, 
comparing between the world wide distribution vs. Canada vs. the USA.208 ................. 16 
Figure 1-8. MDA-TBA bond principle in the TBARS assay. ................................................ 35 
Figure 3-1. Study design. ........................................................................................................ 49 
Figure 3-2. The graph shows the Mean (± SD) total cholesterol uptake on the contact lens 
materials after 7 days of incubation in a complex tear solution containing radiolabeled 
14C-cholesterol. (*P < 0.05 for differences in uptake between CLs). ............................. 51 
Figure 3-3. Average reduction in cholesterol deposits (in μg/lens) when compared to uncleaned 
lenses by combining data for all the lens materials. (*P < 0.05 for differences in lipid 
reduction vs. uncleaned lenses)....................................................................................... 51 
 
xxiii 
Figure 3-4. The graph shows the Mean (± SD) total cholesterol uptake on various lens material 
when soaked and cleaned in saline and 5 different MPS after 7 days of incubation in a 
complex tear solution containing radiolabeled 14C-cholesterol. (*P < 0.05 for cleaned vs. 
uncleaned lenses). ........................................................................................................... 52 
Figure 4-1. Female patient aged 23 with significant oily contamination of the tear film was 
fitted with a silicone hydrogel daily disposable lens and complained of “smeary vision” 
after 3-4 hours of wear. The image shows significant deposition with what appears to be 
a lipid-like film after only 3 hours of wear. Refitting the patient with an FDA group IV 
hydrogel daily disposable resulted in no visible deposition and comfortable wear for 12 
hours. ............................................................................................................................... 63 
Figure 4-2. Mean (± SD) total cholesterol uptake on various daily disposable contact lens 
materials over 16 hours. Lipid quantities were measured using a radiolabel method in 
which cholesterol was labelled within an artificial tear solution containing a variety of 
proteins, lipids and mucin. .............................................................................................. 66 
Figure 5-1. Chemical structure of Cholesterol (386.65 g/mol) and NBD-cholesterol (494.63 
g/mol) 460 ......................................................................................................................... 80 
Figure 5-2. Lateral motion produces intermittent air exposure (A); Circular motion simulates 
rubbing action during blinking (B); tear fluid infusion into eyelid (C); OcuFlow platform 
(D). .................................................................................................................................. 82 
 
xxiv 
Figure 5-3. Confocal images showing a cross-section of etafilcon A, nelfilcon A, nesofilcon 
A, ocufilcon, delefilcon A, somofilcon A, narafilcon A after incubation with NBD-
cholesterol in the vial and OcuFlow model after 4h (A) and 12h (B) ............................ 88 
Figure 5-4. Histograms representing the different incubation methods: OcuFlow after 4h, 
OcuFlow after 12h, vial after 4h, and vial incubation after 12h; as well as depth of 
absorption of NBD-cholesterol of various contact lenses: etafilcon A (A), nelfilcon A (B), 
nesofilcon A (C), ocufilcon A (D), delefilcon A (E), somofilcon A (F), narafilcon A (G). 
The values plotted are the relative intensity fluorescence values (RIF). ........................ 89 
Figure 5-5. Drawbacks of using a simple vial model to evaluate contact lenses. ................... 90 
Figure 6-1. Teflon button for holding lenses (A) and Model Blink cell controlled environmental 
chamber (B). ................................................................................................................. 104 
Figure 6-2. Experimental set up of the topographer over the MBC. .................................... 104 
Figure 6-3. Placido ring image over a “fresh” contact lens (A) and a dried-up lens surface (B). 
The smooth rings in A compared with the irregular rings in B indicate the difference 
between a confluent and a broken tear layer. ................................................................ 105 
Figure 6-4. In vitro placido ring images retrieved from the experiment; T0 (A) and first break-
up (13 sec) over lens material (B) ................................................................................. 106 
Figure 6-5. Histogram representing the NIBUTs for the five daily disposable materials for up 
to 16 hours after incubation in a model blink cell. Statistically significant differences (*) 
are indicated for P ≤ 0.05. ............................................................................................. 109 
Figure 7-1. MDA-TBA bond principle in the TBARS assay. .............................................. 121 
 
xxv 
Figure 7-2. Generated calibration curve for TBARS assay and detected amount of MDA in 
diluted tear samples. Fluorescence was read at 530 nm (excitation) and 590 nm 
(emission). ..................................................................................................................... 125 
Figure 7-3. Generated calibration curve for TBARS assay and detected amount of MDA in 
concentrated tear pool and ATS. Fluorescence was read at 530 nm (excitation) and 590 
nm (emission)................................................................................................................ 125 
Figure 7-4. Generated calibration curve for OxLDL ELISA assay and detected amount of 
oxidation in pooled tear samples. Absorbance was read at 450 nm. ............................ 129 
Figure 7-5. Amount of OxLDL detected in 2.5 µL of individual tear samples. ................... 129 
Figure 7-6. Precipitation of tear samples after addition of lysozyme and ammonium sulfate: 
before (A) and after (B). ............................................................................................... 130 
Figure 7-7. Generated calibration curve for the MDA ELISA assay and detected amount of 
oxidation in symptomatic and asymptomatic tear samples. Absorbance was read at 450 
nm. ................................................................................................................................ 132 
Figure 7-8. Generated calibration curve for the 4-HNE ELISA assay and detected amount of 




List of Tables 
Table 1-1. The lipid composition of meibomian gland secretions 2, 45 ..................................... 3 
Table 1-2. Lipid concentration detected in human tears.92, 94, 97 ............................................... 8 
Table 1-3. FDA and ISO approved Contact Lens Classifications.207 ..................................... 16 
Table 3-1. Properties of contact lens materials evaluated in the study. .................................. 46 
Table 3-2. Saline and multi-purpose solution information. .................................................... 46 
Table 3-4. Percent Difference of cholesterol removal in comparison to uncleaned lens materials
......................................................................................................................................... 54 
Table 4-3. Repeated measures ANOVA statistical results for cholesterol uptake onto various 
DD contact lens materials. .............................................................................................. 67 
Table 5-1. Properties of conventional hydrogels (CH) used in the study ............................... 79 
Table 5-2. Properties of silicone hydrogels (SiHy) used in the study .................................... 79 
Table 5-3. Repeated measures ANOVA statistical results for cholesterol penetration 
comparing various incubation methods and contact lens materials ................................ 85 
Table 6-2. Repeated-measures analysis of variance statistical results for NIBUTs over various 
DD contact lens materials ............................................................................................. 107 
Table 6-3. NIBUT over contact lenses in seconds (mean ± SD) .......................................... 107 
Table 7-1. Linearity equations of calibration curves, LOD, LOQ, and coefficient of 
determination values of tested lipid oxidation assays. .................................................. 124 
Table 7-2. Amount of MDA (pmol/mg) measured in tears and on various contact lens 
materials. ....................................................................................................................... 133  
 
xxvii 
List of Abbreviations 
%   percent 
125I   iodine-125 
14C   carbon-14 
3H    tritium 
4-HNE  4-hydroxynonenal 
ADDE  aqueous deficient dry eyes 
ATS   artificial tear solution 
BA   balafilcon A 
CA   comfilcon A 
CH   conventional hydrogel 
CL   contact lens 
CLD   contact lens discomfort 
COD   coefficient of determination (R2) 
COETF  Canadian Optometric Education Trust Fund 
CSS   complex salt solution 
DD   daily disposable 
DE   dry eyes 
DED   dry eye disease 
DEWS  Dry Eye WorkShop 
Dk/t    oxygen transmissibility 
DMA  N,N-dimethylacrylamide 
 
xxviii 
DW   daily wear 
EDE   evaporative dry eye 
EDTA  ethylenediamine tetraacetic acid 
ELISA  enzyme-linked immunosorbent assay 
EOBO-41™  polyoxyethylene-polyoxybutylene 
et al.   et alii (“and others”)  
EW   extended wear 
FDA   Food and Drug Administration 
FMA   N-formylmethyl acrylamide 
GC   Gas Chromatography 
GLC   gas liquid chromatography 
H2O2   hydrogen peroxide 
HCl   hydrogen chloride 
HEMA  hydroxyethyl methacrylate 
HPLC  high pressure liquid chromatography 
i.e.   in essence (“in other words”)     
IR   infrared 
ISO   international organization of standardization 
LA   lotrafilcon A 
LB   lotrafilcon B 
LCD   liquid-crystal display 
LCMS  liquid chromatography mass-spectrometry 
 
xxix 
LOD   limit of detection 
LOQ   limit of quantification 
LSCM   laser scanning confocal microscope 
m/z    mass/charge ratios 
MA   methacrylic acid 
MAPD  myristamidopropyl dimethylamine 
MDA  malondialdehyde 
MG   meibomian glands 
mg   milligram 
mL   millilitre 
MPDMS  monofuncional polydimethylsiloxane 
MPS   multi-purpose cleaning solution 
MS   mass spectrometry 
NBD-cholesterol 7-nitrobenz-2-oxa-1,3-diazol-4-yl-cholesterol 
ng   nanogram 
NIBUT  non-invasive break-up times 
nm   nanometer 
NMR  Nuclear Magnetic Resonance Spectroscopy 
NVP   N-vinyl pyrrolidone 
OAHFA  (O-acyl)-ω-hydroxy fatty acids 
OxLDL  oxidized low-density-lipoproteins 
P    statistical significance 
 
xxx 
PAPB  polyaminopropyl biguanide 
PC   phosphatidylcholine 
PC-ABS  polycarbonate-acrylonitrile-butadiene-styrene 
PDMS  polydimethylsiloxane 
PE   phosphatidylethanomaline 
PEG   polyethylene glycol 
pHEMA   poly(hydroxyethyl methacrylate) 
PHMB  Polyhexamethylene biguanide 
PMMA  poly(methyl methacrylate) 
pmol   picomolar 
PTFE  polytetrafluoroethylene (Teflon™) 
PUFA  poly unsaturated fatty acids 
PVA   polyvinyl alcohol 
PVP    poly(vinylpyrollidone) 
RIF   relative intensity of fluorescence 
RM-ANOVA  repeated measures analysis of variance 
SA   senofilcon A 
SiHy   silicone hydrogel 
sPLA2  secretory phospholipase A2 
SPSS   Statistical Package for the Social Sciences 
SS   Sjögren’s Syndrome 
TBA   thiobarbituric acid 
 
xxxi 
TBARS  thiobarbituric acid reactive substances 
TBUT  Tear break-up time 
TEGDMA  tetraethyleneglycol dimethacrylate 
TF   tear film 
TLC   thin layer chromatography 
USAN  United States Adopted Names 
UV   ultra violet 
µg   microgram 
µL   microlitre 
µm   micrometer 








Chapter 1  
Literature Review 
1.1 The Meibomian Glands 
1.1.1 Structure and Function 
Meibomian glands (MG) are long, sebaceous, holocrine glands embedded within the tarsal plate 
of the eyelids that secrete lipids onto the ocular surface (Figure 1-1) and were first described in 
detail in the 17th century.1, 2 Positioned in vertical rows within the eyelids,2 their density varies, 
with approximately 20 to 30 individual glands in the lower lid and 25 to 40 glands in the upper 
lid.3 The location of MGs determines their individual lengths, which can range between 5.5 mm 








Figure 1-1. Tear producing 
structures and tear film structure 




Each gland is composed of a cluster of small acini that are connected to a central duct from 
which a mixture of various lipids (meibum) is secreted onto the tear meniscus through the orifices 
within the eyelid margins (Figure 1-2).2, 3 The production of meibum begins within the small acini 
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units (with approximate diameters of 150 to 200 µm) of each MG.2, 5, 6 The secretory cells within 
the acini (meibocytes) produce both polar and non-polar tear film (TF) lipids that are included in 
meibum.2, 5, 6 As these meibocytes mature, they migrate from the periphery to the center within the 
acinus where they subsequently disintegrate.2 The cell contents of the meibocytes are then released 
into the ductal system and are ultimately secreted as meibum through the main central duct (Figure 
1-2).2 
 
Figure 1-2. A MG functional unit with multiple acini units connected to a central duct. Meibum 
is produced at the acini units, which travels to the central duct, and eventually out of the MG orifice 
at the eyelid margin. Re-printed with the kind permission of Dr. William Ngo. 
 
The exact processes that control and regulate the secretion of meibomian glands are currently 
not well understood. Sullivan et al., however, have published a significant amount of research that 
suggests that the expressed lipid pattern is influenced by hormones, such as androgen, estrogen, 
and progesterone, which regulate the meibomian gland secretion.2, 3, 7-20 Other researchers have 
discussed neuronal control of the meibomian glands. 3 
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The excretion of the meibum relies on two mechanisms that occur simultaneously: 1) the 
continuous production of meibum within the MGs; and 2) the mechanical expression from the 
glands with every blink.3, 21 Once the lipids are secreted, they fulfill a variety of functions, 
including prevention of overflow of the tear meniscus by creating a hydrophobic barrier; formation 
of a seal between the eyelids during sleep; reduction of TF evaporation between blinks; lubrication 
during the blink; and potentially providing a protective layer against bacterial contamination of the 
ocular surface. 7, 22  
1.1.2 Meibum Composition 
A significant amount of research has been conducted to classify and quantify the exact lipid 
compositions within meibum.2, 21, 23-45 The application of different chromatography methods 
presented in these publications, however, makes it difficult to compare the results and be certain 
about the exact composition of lipids in meibum. Nevertheless, a variety of lipid categories have 
been identified and are listed in Table 1-1.2 Although all of these lipids are usually found in 
meibum, the lipid composition varies greatly between individuals.2, 45 Despite the inconsistency 
between subjects in terms of percentage present, the lipid types found in the meibomian glands 
remain fairly consistent in healthy eyes. 
Table 1-1. The lipid composition of meibomian gland secretions 2, 45 
Lipid 
% of Meibomian Gland 
Secretions Lipid 
% of Meibomian Gland 
Secretions 
Cholesterol 1 - 14 Phospholipids 1 – 15 
Cholesteryl 
Esters 
2 – 34 Free Fatty Acids 0 - 24 
Sterol Esters 27 - 39 Triacylglycerols 2 - 43 
Wax Esters 13 - 69 Polar Lipids 0 - 15 




Some of the common lipids found in meibum include cholesterol, cholesteryl oleate, cholesteryl 
linoleate, diacylglycerols, triolein, oleic acid methyl ester, oleic acid propyl ester, and 
triacylglycerols.2, 21, 23-45 Additionally, a mixture of polar lipids has been detected in meibum, 
especially phospholipids, where phosphatidylethanomaline (PE) and phosphatidylcholine (PC) are 
most common, as well as sphingolipids, and ω-hydroxy fatty acids. 2, 6, 16, 25, 28, 29, 31, 35, 38, 46-53 
Although the concentration of polar lipids in meibum is small, these amphiphilic lipids are thought 
to play a crucial role in the stability of the TF by functioning as mediators between their 
surrounding layers (see 1.2.2).2, 29, 35, 45  
1.1.2.1 Cholesterol 
Cholesterol and its esters are one of the major lipids found in meibum samples.5, 23, 26, 28, 35, 54, 55 
These non-polar lipids belong to the lipid group of isoprenoids, which are metabolically built up 
from five carbon units (isoprene). As shown in Figure 1-3, cholesterol is composed of 27 carbons 
that are arranged in four fused rings, a hydrocarbon division, two methyl groups, and a hydroxyl 
group. Based on its structure, it is an important component of cell membranes and aids their 
stability and rigidity.56, 57 However, cholesterol’s covalent bonds between its carbon and hydrogen 
atoms are of polar nature and, thus, render this lipid to be very hydrophobic and insoluble in water. 
Consequently, due to its hydrophobic characteristic, cholesterol is a common lipoidal contaminant 
on SiHy materials, 58-63 which is the reason why it was chosen to be the main lipid of interest for 










1.2 The Tear Film 
1.2.1 Structure and Function 
The TF is a complex layered structure that is historically believed to consist of three layers: the 
outermost lipid layer, accounting for approximately 1% to 1.5% of the total thickness of the TF 
ranging between < 60nm to 180nm; the middle aqueous layer, making up 98% (7 μm); and an 
inner mucin layer (0.5%; 0.02-0.05 μm) that lies closest to the ocular surface. 64-68 The outermost 
lipid layer mainly contains fatty secretions from the MGs (see section 1.1), which stabilizes the 
TF, aids lubrication and helps to avoid evaporation.67-71 The aqueous layer is produced by the 
lacrimal glands found in the superior orbital cavity.68 Among other components, it contains 
lysozyme, a protein that has antimicrobial properties.72-74 The thin mucin layer is produced by 
membrane-bound and secreted mucins that are produced by goblet cells, located in the 
conjunctiva.2, 75 It consists of fatty, glycosylated proteins that stay in direct contact with the cornea 
and penetrate the fine gaps between the corneal microvilli to create a smooth and even corneal 
surface, contribute to the stability of the TF, and provides lubricity for smooth blinks.68, 76-78 
Several decades after the first TF model was proposed, researchers suggested a more complex 
structure of the TF, including a more gel-like mucin layer and a lipid layer far more complex than 
previously reported.54, 79-81 Since then, researchers have investigated the TF intensively, resulting 
in further revisions and additional differentiation of the TF layers has been proposed.2, 30 These 
changes include a superficial non-polar lipid layer, an inner polar lipid layer with intercalated 
proteins, an aqueous layer incorporating “gel-like” mucins and a mucoid layer (glycocalyx) on top 
of the ocular surface.2, 30, 68 Figure 1-4 depicts a diagrammatic version of the three layer TF model, 
including the updated layers by Tiffany and McCulley et al.54, 79, 80 Furthermore, current research 
looking at the total TF thickness of all layers estimates a thickness of 2 to 5.5 µm.68, 82-90 
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The TF is described as having five main functions: 91 
• it protects the cornea from debris and foreign materials by forcing them away from the 
central cornea upon blinking; 
• it maintains the bulbar and palpebral conjunctival moisture and lubricates all surfaces which 
come into contact with air; 
• it allows for a smooth optical surface by alleviating any small imperfections in the corneal 
epithelium; 
• it contains various antibacterial and immunological agents to protect against ocular infection; 
• it provides oxygen and nutrition to the underlying corneal epithelium.91 
Figure 1-4. The structure of the tear film. Reprinted with permission from: Green-Church KB, Butovich I, 
Willcox M, Borchman D, Paulsen F, Barabino S, et al. The international workshop on meibomian gland 
dysfunction: report of the subcommittee on tear film lipids and lipid-protein interactions in health and 
disease. Invest Ophthalmol Vis Sci. 2011 Mar; 52(4):1979-93. © Association for Research in Vision and 
Ophthalmology 2017. 2 
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1.2.2 Formation of the Lipid Layer 
As mentioned in section 1.1, lipids originate from MGs and are found in several locations in 
the TF, including the base of the TF adjacent to the outermost corneal epithelium.51, 52 However, 
the exact role that MG lipids play in the TF is complicated and not entirely understood.51, 68 
After meibum is secreted, it mixes with tears on the ocular surface and the lipids form a thin 
sheet to stabilize and prevent evaporation of the TF.70 It is believed that lipid conformation and 
composition may change after the meibum has mixed with tears due to the change of environment 
and reactions with other TF components. Several studies comparing lipid composition have shown 
varying lipid profiles and lipoidal components between the TF and meibum.2, 24, 29, 31, 35, 53, 92 Many 
thousands of specific lipids are estimated to exist in meibum and tears and in spite of the 
differences in detected lipid profiles, the main types of lipids within meibum and the tears remain 
broadly the same: wax esters, cholesteryl esters, free fatty acids, fatty sterols, fatty alcohols, 
monoacylglycerols, diacylglycerols, and triglycerides. 2, 5, 9, 38, 43, 44, 93-96 
The TF lipid layer contains two different lipid phases: the outermost non-polar layer 
and an inner polar layer.2, 54 The characteristics of each TF lipid layer are unique and provide 
imperative functions.51 
1.2.2.1 Non-Polar Phase 
The outermost non-polar lipid phase contains a large amount of non-polar lipids, including 
cholesterol, wax esters, cholesterol esters, triglycerides, fatty acids, and hydrocarbons.54 The non-
polar phase is believed to be thicker than the polar phase (85-95%) 30, 32, 52 and, therefore, it is those 
lipids that are found in the greatest quantities.2, 29, 52, 54 The function of the non-polar phase is to 
regulate the transmission rate of water vapor, carbon dioxide, oxygen, and ions.28, 48, 54 
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Additionally, the non-polar layer is a storage unit for triglycerides, wax esters, other non-polar 
lipids, and surfactant proteins.2, 30, 54 
1.2.2.2 Polar Phase 
The polar phase of the TF lipid layer consists of a number of different types of polar lipids with 
the major ones being PE, PC, sphingomyelin, and ceramides, plus others.25, 46, 54 More recently, 
(O-acyl)-ω-hydroxy fatty acids (OAHFAs) have been detected in meibum and the polar lipid phase 
in higher concentrations.2, 33, 37, 42 Each of these polar lipids are thought to serve the purpose of 
acting as mediators between the hydrophobic non-polar layer and the aqueous layer to enhance the 
stabilization of the TF.2  
Specifically, the amphiphilic nature of polar lipids – containing both polar and non-polar 
segments – is believed to contribute significantly to the TF stability by positioning their 
hydrophilic head towards the aqueous TF layer and submersing their hydrophobic tails within the 
non-polar lipid phase.2 
1.2.2.3 Tear Film Lipid Concentration 
In contrast to the previously listed lipid concentration in human meibum (Table 1-1), the lipid 
concentration of human TF samples have been found to consist of a more complex lipid 
configuration where the majority of identified lipids were polar lipids, such as phospholipids and 
sphingomyelin (Table 1-2).92, 94, 97 These large quantities of polar lipids within the tear fluid 
emphasizes their important role as surfactants between the aqueous and lipid TF layer.  
Table 1-2. Lipid concentration detected in human tears.92, 94, 97 
Lipid % of Tear Film Sample Lipid % of Tear Film Sample 
Cholesterol esters 0 - 32 Phospholipids 45 – 70 
Diesters detected Free Fatty Acids 15 - 18 
Wax Esters detected Triacylglycerols 5.1 - 5.6 
OAHFAs detected Sphingomyelin 3 - 40 
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1.2.3 Tear Film Stability 
The stability of the TF is an important factor to fulfill its function in providing crisp vision and 
high comfort throughout the day.65, 68, 70, 91, 98 TF stability represents itself as the duration during 
which the TF remains fully spread and covers the ocular surface entirely.68, 98  
In healthy patients, research has shown that the TF may be stable for approximately 30 seconds 
between blinks until a break-up occurs and it has further been shown to be stable in the presence 
of disturbances within the TF itself (i.e. bubbles or particles).68, 69, 99, 100 Furthermore, a stable TF 
is an indicator of a fully functioning lipid layer and is directly connected to the integrity and 
composition of TF lipids, mucin layers, the intercalated proteins within the lipid layer, and the 
surface tension of the TF lipids at the air interface.68, 71, 98, 101-103 The TF stability, however, is very 
labile and can be affected by many factors such as age, medication, work environment, diet, ocular 
surface temperature, smoking, diurnal variations and contact lens (CL) wear.68, 79, 98, 104-118 
Additionally, various studies have shown increased TF evaporation rates and instability when the 
lipid layer is either absent, thinned, or has shown an unusual lipid arrangement within itself.68, 70, 
98, 119, 120  
The main causes of an unstable TF can be narrowed down to deficiencies in the quality and 
quantity of tears, which are directly correlated to the two types of dry eyes (DE): evaporative 
(EDE) and aqueous deficient (ADDE).121-124 While ADDE is caused by a deficiency of the lacrimal 
glands to produce sufficient quantities of tear volume, EDE can be triggered by various factors, 
such as ocular surface disorders, blink disorders, TF disorders, or meibomian gland dysfunction 
(MGD).124 As defined within the recently released DEWS II report, both EDE and ADDE coexist 
and may cause damage to the inter-palpebral ocular surface and are associated with symptoms of 
ocular discomfort.124  
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TF stability may further be affected by lipid degradation caused by oxidation or enzymatic 
lipolysis (through secretory phospholipase A2 [sPLA2]), which degrades lipids and may cause 
deterioration of the native lipid structure.125-131 Lipids that are highly amphiphilic, such as 
OAHFAs within the polar phase, may be affected by oxidative degradation, which can lead to loss 
of functionality that can subsequently cause tissue or cell damage due to the formation of toxic 
species, which in turn could result in an unstable TF.56, 97, 125, 126, 128, 129, 132-134 Phospholipase A2 is 
an enzyme that specifically degrades phospholipids such as PC and PE that are present in the TF 
(see section 1.2.2.2). By-products and biomarkers of both degradation processes have been 
associated with decreased comfort ratings in intolerant CL wearers.125 Some of the external stress 
factors that cause lipid oxidation are wind, extreme temperature, UV radiation, pollutants, irritants, 
and smoke.108, 132, 135-137 Lipid peroxidation is known to be influential in the development of 
Alzheimer’s disease, Parkinson’s,138, 139 and cancer,135 and in the eye specifically, lipid oxidation 
is associated with age-related macular degeneration,140, 141 DE,137, 142, 143 uveitis,144 cataract,145-148 
and keratitis.135, 149  
Lipid oxidation mostly affects unsaturated fatty acids that contain one or more carbon double 
bonds that are the main target.129, 150 Such lipids are prone to highly reactive oxygen free radicals 
that initiate an extraction of allylic hydrogen molecules to form lipid allylic radicals. Thereafter, 
the lipid radical reacts with oxygen to form peroxide radicals that are then able to form other lipid 
allylic radicals or degrade a lipid further to form highly reactive aldehydes.128-130, 150 Major lipid 
peroxidation by-products such as malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) are 




Figure 1-5. Lipid peroxidation cycle.150 Illustration is courtesy of 
https://en.wikipedia.org/wiki/File:Lipid_peroxidation.svg. 
 
1.3 Contact Lens Materials 
CLs have shown a steady increase since their introduction and remain a popular medical device 
for an estimated 140 million people worldwide to correct refractive errors.164-166 Their history dates 
back more than 500 years, when Leonardo da Vinci first showed the principle of altering the eyes 
refractive power by placing his head into a bowl of water.167, 168 The first recorded use of a CL, 
however, had to wait until late in the 19th century when the ophthalmologists Fick and Kalt fitted 
glass scleral lenses on rabbits, patients, and themselves to correct the optical power of eyes.168, 169 
However, the choice of glass as the first material for CLs failed to succeed as it is uncomfortable 
to wear and is impermeable to oxygen.168, 169 Another century passed until the very first 
biocompatible lens material was developed and rigid CLs were made out of 
polymethylmethacrylate (PMMA) that could be worn successfully.168, 169 Since then, the 
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development of CL materials has had an impressive journey, which led to the success they have 
today. The most prescribed lens materials to-date are soft hydrogels, that can be further categorized 
into conventional hydrogels (CH) and silicone hydrogels (SiHy).166, 168, 169 
1.3.1 Conventional Hydrogels  
In the 1960s, the Czech chemists Otto Wichterle and Drahoslav Lim developed the basis for the 
first soft CL materials that were made out of poly(hydroxyethyl methacrylate) (pHEMA).168-172 
The main benefits of the pHEMA lens material were its biocompatibility and its ability to absorb 
and retain water, which significantly increased their flexibility and comfort during lens wear. In 
the early 1970’s spin-casting technology for the mass production of pHEMA lenses was 
sufficiently developed to permit the commercialization of soft CLs as a device to correct refractive 
errors.168, 173 
Despite the supremacy of pHEMA-based CL materials over many years, these materials 
presented a shortcoming in providing sufficient amounts of oxygen to the eye.168, 172 The main 
source of oxygen to the eye is through its outermost TF layer that is in direct contact with the 
surrounding air interface and the circle of blood vessels within the limbus that circle the cornea. 
The placement of a CL onto the ocular surface introduces an additional obstacle (Figure 1-6) that 
limits the amount of oxygen reaching the cornea and leads to undernourishment of the cornea when 
pHEMA CLs are worn.168, 169, 174, 175 Extended wear of these lens materials eventually leads to 
increased hypoxic exposure, which limits the metabolic capabilities of the corneal endothelium to 
regulate the hydration of the cornea, and may subsequently manifest in edema within the cornea, 
increased inflammatory responses (i.e. infectious keratitis), neovascularisation, changes in 


















Figure 1-6. Disruption of the tear film layer when a contact lens is placed onto the ocular surface. 
Reprinted with permission from: Craig JP, Willcox MD, Argueso P, Maissa C, Stahl U, Tomlinson A, et 
al. The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions 
with the tear film subcommittee. Invest Ophthalmol Vis Sci. 2013;54(11):TFOS123-56. © Association for 
Research in Vision and Ophthalmology 2017.175 
 
1.3.2 Silicone Hydrogels 
To eliminate and/or reduce complications associated with hypoxia that were triggered by 
pHEMA based CL materials, manufacturers had to find a way to increase the amount of oxygen 
that was able to pass through a CL (also known as the oxygen transmissibility (Dk/t) of a CL). The 
water within CH lens materials is the dictating - and simultaneously limiting - factor in determining 
how much oxygen can flow through the lens materials.168, 174 A previous material known to have 
high oxygen transport capabilities were silicone-based. In fact, the first lenses with high oxygen 
transmissibility were made of silicone elastomer, used to treat infants after congenital cataract 
surgery.168, 179-183 However, silicone elastomers were not successful mainly due to their tendency 




Silicone-based soft lens materials became a commercial reality with the introduction of SiHy 
CLs in the late 1990s, when Bausch & Lomb and CIBA Vision presented the 1st generation SiHy 
lens materials, balafilcon A (Pure Vision) and lotrafilcon B (Focus Night & Day).168, 185 Combining 
both components provided CLs with the required oxygen transmissibility through the silicone 
backbone and the necessary ion and water permeation capabilities via the hydrogel that are crucial 
for lens movement and comfort.171, 185-187 However, including siloxy monomers into CL materials 
simultaneously led to an increase in hydrophobicity of SiHy CLs, which creates less wettable lens 
surfaces which may jeopardize CL comfort during lens wear.187 Both, oxygen transmissibility and 
hydrophobicity of SiHy lens materials is attributed to the silicon-oxygen bonds these CL are 
composed of 187 and to enhance the hydrophilicity of SiHy lens materials, manufacturers applied 
surface modifications. For the balafilcon A lens material, Bausch & Lomb applied a plasma 
oxidation process that created wettable silicate “islands” on the lens surfaces.171, 187-189 On the 
surface of the lotrafilcon B lens materials, CIBA Vision added a thin and continuous wettable non-
siloxy plasma coating (25nm) enclosing the entire CL.171, 187-189 The 2nd generation of SiHy lens 
materials was released by Johnson & Johnson, with the introduction of galyfilcon A (Acuvue 
Advance) and senofilcon A (Acuvue Oasys). Instead of applying an additional surface 
modification, Johnson & Johnson opted to incorporate the internal wetting agent 
poly(vinylpyrollidone) (PVP) to improve the hydrophilicity of these CLs.186, 187 The 3rd generation 
was introduced shortly after this through the release of CooperVision’s comfilcon A (Biofinity) 
lens material. In contrast to the previous two generations of SiHy CLs, comfilcon A lenses did not 
require any surface modification nor the incorporation of any internal wetting agents. Instead, 
CooperVision made use of incorporated inherently wettable moieties to improve comfort.168, 186, 
187 More recently, daily disposable (DD) lens materials were introduced to the portfolio of 
contemporary SiHy lenses. The newest members include Alcon’s delefilcon A (Dailies Total 1), 
 
15 
CooperVision’s somofilcon A (Clariti 1 Day), and Johnson & Johnson’s narafilcon B (1-Day 
Acuvue TruEye) lens materials. Whilst somofilcon A CLs do not include any surface modification 
or internal wetting agents,190 the internal wetting agent PVP is incorporated into narafilcon B 
CLs,191, 192 and Alcon developed a unique design strategy for its delefilcon A lens materials to 
enhance comfort.187 Delefilcon A CLs consist of a silicone core that is enclosed by a 5µm thick 
hydrogel layer. This design introduced a “water gradient” concept, where the CL surface has a 
very high water content (WC; >80%) material compared with the CL core SiHy material (33%).193-
196 Although SiHy lens materials have undergone extensive improvements to increase lens comfort 
and wettability, the main reason for patient “dropout” remains CL discomfort even with 
contemporary materials.197-201 
 
1.3.3 Contact Lens Classifications 
To initially differentiate the performance of a growing variety of contemporary CH lens 
materials and their interaction with TF proteins and various lens care products, researchers 202 
proposed a system to categorize these lenses into four groups based on the materials WC and ionic 
content, which was later adopted and implemented by the US Food and Drug Administration 
(FDA).203 Since then, the chemically more complex SiHy lens materials have been introduced to 
the market and showed different interaction patterns with TF components and lens care products, 
mainly due to their relatively hydrophobic lens material characteristics. To address these 
differences, researchers proposed the introduction of a fifth group 204-206 that is now implemented 




Table 1-3. FDA and ISO approved Contact Lens Classifications.207 
FDA 
Group Subgroup Water Content 
Ionic 
Charge Surface Treatment 
I - < 50% No - 
II - > 50% No - 
III - < 50% Yes - 
IV - > 50% Yes - 
V 




< 50% No 
No 
Contains a hydrophilic monomer 
& 
Semi-interpenetrating network 
C > 50% No - 
D No specification Yes - 
 
1.3.4 Contact Lens Distribution 
For almost two decades, an international consortium of clinicians, researchers, and industry 
partners has been conducting valuable information about the distribution of CLs in over 62 
different countries across the world.208 These annual reports highlight the steady increase in 
popularity of SiHy lens materials since their introduction to the CL market.166, 208-213 From the most 
recent market evaluation (Figure 1-7), it is apparent that within the Canadian market patients wear 
significantly more SiHy lens materials than CHs, which presents additional incentives for this 










Figure 1-7. Distribution of conventional vs. silicone hydrogel contact lenses in 2017, comparing 
between the world wide distribution vs. Canada vs. the USA.208 
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1.4 Tear Film Lipid and Contact Lens Interactions 
1.4.1 Contact Lenses and Tear Film Stability 
Inserting a CL onto the ocular surface disturbs and alters the general structure and integrity of 
the TF.91, 175 Figure 1-6 depicts how a CL separates the TF into post- and pre-lens films as it lies 
within the aqueous TF layer,175 which in turn creates a significantly thinner aqueous layer for TF 
lipids to adhere to. Furthermore, CLs present a hurdle that impacts the smoothness of a blink and 
the redistribution of a stable TF layer over their surfaces.175, 214, 215 For CLs to be worn comfortably 
until the end of the day and be considered biocompatible with the ocular surface, it is crucial to 
have a lens material that allows the TF to rebuild its intrinsic structure. 
CL wear has a notable impact on TF stability as TF lipids may be scarcely present over the CL 
surface or not at all. If they are present, TF lipids come into direct contact with the CLs that can 
lead to undesirable interactions with the lens materials. Lipid deposition may occur that could 
subsequently alter CL properties, impact the lens comfort during wear, cause symptoms of dryness, 
and affect visual acuity.216-219 The permeable characteristic of soft lenses allows lipids to both 
adsorb and absorb, which has a direct effect on the amount of detected lipid deposition.186 Protein 
deposition on CH lens materials and their impact on lens comfort and CL-related complications 
has been documented extensively over the past decades. They are mainly triggered by the attraction 
of TF proteins to the ionic charge of CHs; i.e. negatively charged CLs deposit higher amounts of 
positively charged proteins (i.e. lactoferrin or lysozyme) than positively or neutrally charged 
CHs.220-239 It was not until the appearance of silicone-based lens materials and the tendency of 
hydrophobic TF lipids to adhere to their hydrophobic sites that the topic of lipid deposition became 
an issue, leading to a shift of focus and increased interest by researchers and practitioners alike. 
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1.4.2 Contact Lens Deposition 
1.4.2.1 Lipid Deposition on Conventional Hydrogel Contact Lenses 
One of the earliest observations of the interaction of TF lipids with CHs was made by Hart et 
al.240, 241 who first detected “Jelly Bumps” that mainly consist of cholesteryl esters that are also 
found in meibum and tear samples.240, 241 The extended wear (EW) lens materials examined 
showed varying levels of lipid deposition, which led to the conclusion that the extent of lipid 
deposition on these CL is highly subject-dependent.240, 241 By using histochemical staining analysis 
and microscopy, Hart and colleagues were able to determine that the major component of these 
deposits were lipids, particularly cholesteryl esters, wax esters, and triglycerides.240, 241 
Furthermore, Hart et al. found that subjects with a lipid-rich TF, taking certain medications, and 
subjects with a diet rich in alcohol, fats, and proteins tended to be heavier TF lipid depositors.112, 
241 Moreover, the researchers found that once these lipids adhered to the CL surfaces, they could 
not be removed by cleaning regimens.241 
Later on, Bowers and Tighe et al. published further work on lipids, showing that “white surface 
films” are different than “elevated white spot deposits” 242, 243 and that these films mainly consist 
of cholesterol and their esters. Through the use of various microscopy technologies (i.e. scanning 
electron, light and dark-phase, phase contrast, and stereo microscopy), the researchers were able 
to determine that white spot deposits formed a three-layered structure, with unsaturated lipids 
forming the base layer and cholesterol and their esters creating the second and third layer.242, 243 
The morphology of these white spot deposits was consistent in spite of differences in CL wear 
routine and type of worn lens material; however, the rate of accumulation differed and was 
influenced by subject variability and CL material.242, 243 From these studies,242, 243 Bowers and 
Tighe concluded that the biocompatibility and the characteristics of CL surfaces was mainly 
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affected by the unsaturated lipids that form the base layer of white spots.242, 243 In contrast, “white 
surface films” on CL materials showed a different morphology than “elevated white spot deposits”, 
in that the amount of calcium that the CLs were exposed to determined how much lipid deposition 
was detected. The more calcium that was present, the lower the number of white spots found on 
these lens materials.244 
Further research by Tighe and colleagues found lipids in the matrix of CHs 245, 246 and showed 
that lipid deposition is influenced by lifestyle choices of the CL wearer, their TF composition, the 
surrounding environment, and that various cleaning regimens were only moderately efficient in 
removing lipid deposition from CH CLs.245, 247, 248 Of particular note was the finding that the 
effectiveness of surfactant-containing, traditional chlorine-, and peroxide-based cleaning solutions 
was highly influenced by the composition of the lipid deposition and lens material, making them 
only moderately helpful; disinfectants removed virtually no lipids at all.248 Usually, the benefits of 
these cleaners are to be observed only in the first few days of wear/use, as the lipid layer of the TF 
is constantly replenished.245 
Rapp and colleagues conducted extensive in vitro and ex vivo research to determine lipid 
deposition on various lens materials using a wide variety of techniques, including thin layer 
chromatography (TLC), high pressure liquid chromatography (HPLC) and gas liquid 
chromatography (GLC).224, 249-252 The researchers were able to show that certain TF lipids 
(cholesterol, cholesteryl esters and triglycerides) were not detectable on CLs, as opposed to fatty 
acids, alcohols, sterols, wax esters, and diglycerides. Moreover, Rapp et al. concluded that polar 
TF lipids deposit favourably on CH lens materials compared to non-polar lipids.249 Additionally, 
Bontempo and Rapp confirmed that the amount of lipid deposition found on CLs is highly material 
and lipid-type dependent.224, 250, 252 Specifically, the researchers were able to conclude that FDA 
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group II CLs deposit the most TF lipids and FDA group III lens materials the least, and showed 
that non-ionic CLs and those with a high WC deposit significantly more TF lipids.224, 250, 252  
More recent publications by Jones and Tighe et al. showed that lipid deposition was 
significantly higher on FDA II group lens materials and presented further proof that lipid uptake 
was primarily driven by the lens material characteristics and inter-subject differences.253, 254 FDA 
group II lens materials containing N-vinyl pyrrolidone (NVP) showed high quantities of lipid 
deposition.246, 255 Furthermore, Jones et al. were amongst the first to find that the amount of lipid 
deposition found on CLs strongly correlates with the replacement frequency, showing an increase 
of 44% more lipid uptake on lenses worn for three months compared to one month.255  
1.4.2.2 Lipid Deposition on Silicone Hydrogels 
With the introduction of SiHy lens materials, studying lipid deposition has become more 
important. Adding siloxane monomers has brought major improvements in eliminating hypoxic 
clinical findings, allowing patients to wear their CL for far longer than before.256 The downside, 
however, is the increased hydrophobicity of CLs due to the presence of the siloxane moieties, 
which has produced new areas for material research and development due to the fact that these 
materials deposit greater amounts of lipid than CHs.58, 62, 257 
The very first study examining the type and quantity of lipid deposition onto worn SiHy lens 
materials was that conducted by Jones et al.227 In this study, the researchers found significantly 
greater amounts of cholesterol, oleic acid methyl esters, and oleic acid deposits on SiHy lens 
materials compared to CH CLs.227 Since then, additional studies conducted by other researchers 
confirmed these findings and further determined cholesterol to be the highest depositing TF lipid 
on SiHy lens materials.58, 59, 258-261 
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Several other studies have looked at other factors that could impact lipid deposition and the 
impact lipids may have on CL wear. 60, 62, 63, 258, 260, 262-268 Lorentz et al., for example, examined the 
effect of TF lipids on CL surface wettability and unexpectedly found an initial improvement in 
wettability on surface treated SiHy CLs, which could explain higher comfort ratings experienced 
with such lens materials after the first few hours of wear.269 An in vitro study by Carney et al. 
examined the kinetic uptake of various TF lipids over 20 days and showed varying lipid uptake 
patterns between different contemporary SiHy lens materials and was the first to show deposition 
differences between polar and non-polar lipids.260 In total, Carney and colleagues detected ~20 
µg/lens of non-polar cholesterol and ~5 µg/lens of the polar PE.260 Iwata et al. reported similar 
trends of lipid deposition on SiHy lenses, however, they found slightly lower amounts of 
cholesterol (between 1 to 8 µg/lens) by using gas chromatography mass spectrometry (GC-MS).259 
Since then, other studies examining the kinetic uptake rates of TF lipids on various SiHy lens 
materials showed significant variations between different lens types and continuous lipid uptake 
between 1 to 28 days of simulated CL wear.58, 59, 63 Furthermore, proportional relationships were 
found between the quantity of lipid deposition, the lipid concentration within an artificial tear 
solution (ATS), and the renewal of the test solution.63 Bearing this in mind, more recent 
publications have been conducted that try to use more advanced in vitro models to simulate lipid 
contamination on various lens materials.266, 270 In particular, a study by Lorentz et al. showed the 
importance of a more advanced model when the researchers found increased lipid contamination 
on various SiHy lens materials by simulating intermittent air exposure between blinks.266  
Only a few studies to-date have investigated the impact of lens care products on lipid deposition 
on SiHy lens materials, showing that lens cleaning efficiency varied between different lens care 
products.60, 263, 265 Particularly, Polyquad/Aldox- and polyhexanide-based lens care products 
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performed significantly better than one-step hydrogen peroxide cleaning systems in reducing the 
amount of accumulated TF lipids.60, 263, 265 
Research relating the impact of cholesterol deposition on microbial contamination on SiHy lens 
materials was conducted by Omali et al.264 The researchers were able to show that the amount of 
extracted cholesterol from worn CLs did not affect the adhesion of the bacteria Staphylococcus 
aureus and Pseudomonas aeruginosa.264 
Thus far, the number of studies that have been conducted that examined the clinical impact of 
lipid contamination on SiHy are very few.261, 271, 272 In an in vivo study, Cheung et al. examined 
the effects of lipid deposition on comfort, visual acuity, and ocular integrity but found no 
detrimental correlation.261 In a later study by Zhao et al., cholesterol deposits only showed a small 
influence on CL-induced adverse events.271 A more recent study, however, was able to show 
increased levels of lipid contamination in tolerant CL wearers, which could be an indicator that 
lipid uptake may be associated with CL comfort.272 
Even though current research has helped tremendously to better our understanding of the ways 
TF lipids deposit on various lens materials, the factors affecting lipid contamination, and the 
impact lipid deposition may have on lens wear, further research is required that elucidates the 
effects that lipid deposits have on CL discomfort and the ocular environment. Specifically, future 
studies need to investigate the performance of new lens care products and CL materials to provide 
up to date knowledge to the CL industry, practitioners, and patients. 
1.5 Lens Care Products 
Lens care products are an essential part of a daily CL wear routine. Two of the main goals all 
lens care products should accomplish is to provide disinfection to prevent contamination and 
infection with any pathogenic micro-organisms and to remove accumulated TF deposits, prior to 
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re-insertion of a CL.273-275 Further requirements include enhancing CL comfort and that they are 
easy to use, convenient, affordable, provide relatively quick disinfection, and that they can be 
safely used by anyone and in combination with any contemporary CL material on the market.273  
The following sections will provide an overview of available lens care regimens and portray 
their efficacy in removing TF deposits to potentially enhance CL comfort. 
1.5.1 Hydrogen Peroxide-Base Systems 
The use of lens care products based on hydrogen peroxide (H2O2) has a long history and for 
many, is considered to be the most efficient cleaning regimen for CLs. However, the use of these 
lens care products requires good compliance by patients as H2O2 requires a minimum amount of 
time to be neutralized to be harmless to the ocular surface.273, 276-278 Traditionally, H2O2 lens care 
regimens are differentiated into two- and one-step systems. The main difference between these 
two systems is that when using a two-step cleaning regimen the H2O2 continuously disinfects the 
CL until the hydrogen peroxide reaction is neutralized by applying an appropriate method, usually 
after an overnight soak.273 In contrast, a one-step regimen combines the disinfection and 
neutralization step such that neutralisation occurs promptly, resulting in a system that is far more 
convenient and encourages compliance.273 One-step systems however present a greater risk of 
potential bacterial regrowth and infection if lenses are stored for longer periods of time after the 
H2O2 is neutralized as the lens is essentialy left sitting in saline.273 
In terms of lipid deposition removal, however, H2O2 lens care systems were not able to show 
significant reduction in lipid contamination nor were they able to enhance CL comfort for 
patients.265, 273, 275, 279-281  
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1.5.2 Multipurpose Solutions 
Multipurpose solutions (MPS) are the most commonly used lens care products 166, 282 and 
combine a wide range of components that allow CLs to be disinfected and stored at the same 
time.273 Therefore, all MPS products mainly contain a buffer, a preservative/biocide, and in many 
cases, additionally include lubrication-improving agents, chelating agents, and surfactants.273 
Disinfectants can be broadly categorized into two groups: the ones that damage (indicated by 
the term “-static”) or the ones that destroy (“-cidal”) microbial cells.273 The first disinfectants 
included in lens care products were chlorhexidine and thimerosal; however, these agents caused 
severe ocular reactions due to allergy and induced both corneal infiltrates and diffuse staining.273, 
283-286 Modern day MPS use a variety of preservatives that are far more effective and less toxic to 
the ocular surface, including polyhexamethylene biguanide (PHMB), polyquaternium-1 
(Polyquad), alexidine, and myristamidopropyl dimethylamine (MAPD). Other than in lens care 
products, PHMB is a common antimicrobial that is used as a disinfectant in hand wipes and 
swimming pool sanitizers. By binding to exposed phospholipids of microbial cell membranes, 
PHMB causes cell membrane disruption and destruction. The disinfecting strategy of 
polyquaternium-1 is the same as PHMB, in that it binds to microbial cell membranes. 
Polyquaternium-1 however, is a substantially higher molecular weight molecule than PHMB, 
which prevents it from being absorbed into CL materials, lowering solution induced toxic signs 
and symptoms after CL wear and providing higher efficacy.273, 287, 288 Alexidine has commonly 
been used in mouthwashes and is a fast acting antimicrobial and fungicidal agent that has a 
comparable structure to the first generation disinfectant chlorhexidine.289-291 However, the industry 
stopped using alexidine in lens care products for quite some time due to an association of a product 
containing alexidine with Fusarium keratitis, although they might have been more linked to non-
 
25 
compliance rather than the disinfectant itself.273, 292-296 Alexidine has recently been re-introduced 
in a contemporary solution (AMO RevitaLens OcuTec).  
Chelating agents are additives to MPSs that enhance the efficacy of a preservative and/or 
support the removal of deposited TF proteins. Commonly used chelating agents are 
ethylenediamine tetraacetic acid (EDTA), hydroxyalkylphosphonate (Hydranate™), and citrate.273 
While EDTA is synergistic with biocides and aids the destruction of microbial cells, Hydranate 
and citrate are sequestering agents that remove proteins by reacting with calcium and breaking the 
bonds between TF deposits on CL materials.273, 297  
Besides biocides and chelating agents, buffers are included to either stabilize the pH and 
osmolality of the MPSs or to enhance the efficacy and functionality of incorporated preservatives 
or chelating agents.273, 274 Common buffers in lens care products included to maintain and stabilize 
osmolality and pH may include tromethamine, taurine, citrate buffers, phosphate buffers, borate 
buffers, salts, and others.273, 274 Sorbitol and dexpanthenol however, are additives to some MPSs 
to enhance lubricity and wettability of CLs in combination with other ingredients. 273, 274 
1.5.3 Surfactants and Lipid Removal 
Surface active agents (surfactants) are important ingredients in MPS products, particularly in 
those used with SiHy lens materials. Similar to phospholipids, surfactants are amphiphilic, which 
allows them to interact at both the air-water interface and between the liquid-liquid interface of 
water and lipids.273, 274 Therefore, surfactants fulfill two main functions in lens care products: the 
binding and subsequent removal of loose deposits and debris, and the augmentation of surface 
wettability by decreasing the CL materials’ surface tension, which is especially important for SiHy 
lens materials.273, 274, 298 The two most common copolymers for surfactants used in MPS are 
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poloxamer (Pluronic) and poloxamine (Tetronic) that function as backbones for various surfactant 
derivatives.273, 274 
To remove loosely bound components from CL surfaces, surfactants create bonds with the 
targeted substances to form micelles that are then easier to remove when applying a rub and rinse 
to the lens material before CL disinfection.273, 274, 299-302 Furthermore, their amphiphilic structure 
provides surfactants with the ability to increase the wettability of a lens surface, especially of SiHy 
lens materials. The surfactant’s hydrophobic segment binds and occupies any hydrophobic silicone 
monomer of a CL, leaving its hydrophilic segment exposed, which in turn, increases the wettability 
and may simultaneously prevent or decrease lipid deposition.273, 274, 303-306 Based on these 
functions, surfactants were also added to H2O2 lens care products.273, 274, 298 
Various studies examining the efficacy of different lens care products have shown surfactants 
to successfully reduce surface deposition but have yet to proof their capabilities to reduce lipid 
contamination effectively. 60, 265, 279, 307-310 Because of the industry’s relentless approach to improve 
CL performances and the efficacy of lens care products to improve lens wear comfort, it is of great 
importance to consistently investigate the interaction between the newest lens material/care 
product combinations. 
1.5.4 Patient Compliance 
Patient compliance can play an important role in the success of lens care products.274, 311-313 
Many studies have examined patient compliance in the past and have shown that approximately 
50% of CL wearers fail to follow recommendations relating to cleaning procedures or appropriate 
hygiene.274, 313-320 Among the most common recommendations patients neglect are: allowing 
enough disinfection time; to apply a rub and rinse technique to aid with cleaning the lens; and to 
always use fresh lens care solution every time a CL is disinfected.311, 313, 321 
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1.6 Methods to Detect and Analyse TF Lipids 
Sufficient collection and subsequent analytical methods are required to study MG lipids, TF 
lipids, and lipid deposition on CLs. To analyse lipid deposition in various lens materials, CLs can 
either be incubated in an ATS or be extracted from CLs post-wear (ex vivo).45, 58, 60-63, 227, 249, 250, 
252, 253, 259, 263, 265, 266, 279, 322-325  
The following section outlines the main collection and analytical methods used to measure TF 
lipids. 
1.6.1 Lipid Collection Methods  
The collection of MG and TF lipid samples uses a variety of methods described below, which 
are categorized into soft and hard expressions of MGs, microcapillary collection, and Schirmer 
test strips.2, 23, 29-31, 39, 45, 53 For further analysis and to avoid sample contamination, MG and TF 
lipid samples require the same appropriate methods of handling and storage.2, 45 Ideally, it is 
recommended that lipid samples are stored in a dark place at -80°C, in an oxygen-free 
environment, and that they are handled and stored in containers free of silicone or plastic.2, 45 
1.6.1.1 Meibum Collection 
When applying “soft expression” for meibum collection, the eyelid is first cleansed using a 
sterile swap before applying gentle pressure only to the outer portion of the lid.2, 29, 31, 45, 326 To 
perform a “hard expression” meibum collection, the lid is compressed between a sterile lid 
conformer, while applying pressure to the lid using a finger or another device.2, 23, 28, 29, 31, 40, 43, 45, 
119, 326-328 After the MGs have been expressed, meibum can be collected from the lid margin with 
a curette or spatula.28, 29, 31, 40, 43, 45, 326-328 
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Meibum samples may also be collected directly from the MG orifices using microcapillary 
tubes, which are thin-walled glass tubes that use capillary forces to draw in fluid when a tube is 
placed in contact with the orifices.2, 31, 45 Despite being less invasive, the use of microcapillary 
tubes for meibum collection has limitations: they yield smaller sample quantities, meibum samples 
will solidify almost immediately within the tubes, and meibum samples might be contaminated 
with small tear volumes.2, 21, 30, 32, 39, 45 
1.6.1.2 Tear Collection 
Microcapillary tubes are the most commonly used tool to collect TF samples.2, 45, 71, 112, 125 To 
collect tears, the tubes are gently placed on the lower lid margin at the lateral canthus of the eye to 
collect tears from the lower tear meniscus.45, 71 Researchers typically prefer to collect basal tears 
(un-stimulated), but in certain circumstances researchers may also collect reflex tears 
(stimulated).71, 125, 329, 330 Once TF samples are collected, the fluid is removed using a thin wire or 
solvents and analyzed.2, 45 
The use of absorbent filter paper (Schirmer) strips is another way to collect tears, however, they 
are usually applied to confirm the presence of very dry eyes due to aqueous tear deficiency.24, 241 
To collect tears, the Schirmer strips are placed in the lower conjunctival sac of the eye where they 
absorb tear fluid.241 Using Schirmer strips is a non-specific method, in that all components of the 
TF are absorbed.30 Furthermore, this test is usually conducted without anesthetic and may be less 
comfortable than collecting tears with microcapillary tubes, resulting in tear stimulation and 
altering the composition of the TF collected from that which is usually present. After tear fluids 
are collected, the TF components can then be extracted from the filter strips and analysed further. 
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1.6.2 Analytical Methods of Lipid Deposition 
To remove TF lipids from CLs, researchers traditionally expose them to extraction solutions 
that commonly include the solvents chloroform and methanol. These lipids are then analyzed using 
a variety of methods.58, 61-63, 250, 259, 263, 265, 266, 279 Several techniques are highlighted below that have 
been used to study meibum and TF composition and provide valuable information on the 
composition and conformation of lipids. 
1.6.2.1 Radiochemical Experiments 
Radiochemical methods are used to analyze the uptake of TF lipids and proteins on CL materials 
in in vitro experiments.61-63, 229, 231, 234, 266, 323, 331-335 Trace amounts of radioactive elements of 
interest are incorporated into an ATS mixture or “doping solution”. In one of the first 
radiochemical lipid studies, Prager et al.323 added the radiolabelled lipids tritium (3H)-cholesteryl 
oleate and carbon-14 (14C)-dioleoyl-PC to a complex ATS. Various CL materials were then 
exposed to the ATS and the amount of radiolabelled lipid taken up was quantified using 
scintillation beta counting.323 In more recent studies, radiochemical experiments have been used 
to determine the impact of a variety of testing conditions on the deposition of lipid 61-63, 266, 279 and 
protein 229, 231, 234, 331-333 on SiHy and CH lens materials. The two main advantages of using 
radiolabeling for deposition detection relates to its degree of sensitivity and that the radioactive 
isotope tracers (i.e. iodine-125 (125I), 14C, or 3H) are very small and thus only modify the original 
size, structure, or functions of the molecules’ of interest by a small degree. 
1.6.2.2 Chromatography 
Initially, lipids could only be quantified as being  present or absent on CLs through histo-
chemical staining, in conjunction with the use of electron and light microscopy.322 In more recent 
years, various chromatography techniques have been applied to detect the components of the MGs 
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and the TF and to analyse individual lipid conformation. A range of the most commonly used 
chromatography techniques are highlighted below: thin-layer chromatography (TLC), gas 
chromatography (GC), and high-pressure liquid chromatography (HPLC).2, 45 
1.6.2.2.1 Thin-Layer Chromatography (TLC) 
TLC can be used to both analyse and separate different lipid types, which can then be further 
analysed using additional and more advanced technologies.2, 45, 336, 337 Samples are applied at the 
base of a stationary phase, which is applied on a solid plate (plastic, aluminum, or glass) that is 
coated with a thin layer of an absorbent silica gel. Further, samples are applied into a solvent 
(commonly chloroform), which is known as the mobile phase. Capillary forces then draw the lipids 
of interest dissolved in the mobile phase across the plate.2, 45, 336, 337 During this process, lipids will 
travel through the solid phase at different rates, separate and settle at different heights due to 
different affinities of the sample molecules to the solid and mobile phases, solubility, and polarity.2, 
45, 336, 337 After separation, the sample composition can be further identified visually (by UV light) 
or without additional equipment when charred.2, 45, 336, 337 
While TLC was often used for early deposition studies, it is not sensitive enough to detect 
differences between some major TF lipids and requires large sample quantities. Despite this, early 
studies used this method to detect and analyze lipids from various locations in the eye. 2, 43, 45, 241, 
336-338 
1.6.2.3 Gas Chromatography (GC) 
Similar to TLC, the separation of sample compounds via GC is performed through a mobile 
and stationary phase. When using GC, however, the samples are in a gaseous mobile phase that is 
sent through either a liquid (gas-liquid chromatography) or solid (gas-solid chromatography) 
stationary phase.2, 45, 337, 339 Through the use of a carrier gas (methane, nitrogen, or helium) and 
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heat vaporization, the samples are sent through the stationary phase within a chromatography 
column. Sample separation occurs based on the affinity of the individual compounds to the mobile 
and stationary phase. After the compound separation, detectors measure the different retention 
times to identify individual lipid types.2, 45, 337, 339 The separation capabilities of GC can be used in 
combination with a variety of detectors, including UV absorption, infrared, and mass 
spectrometers (MS).2, 45, 337, 339 However, the heating process involved with GC can induce high 
temperatures that could potentially change sample structures, which in turn may lead to false 
interpretation/readings of sample components. Despite this, GC has been used in various studies 
to determine meibum and TF composition.2, 30, 35, 36, 40, 45, 52, 326 
1.6.2.4 High-Pressure Liquid Chromatography (HPLC) 
Instead of a gaseous mobile phase, liquid chromatography (LC) uses a liquid mobile phase to 
separate sample mixtures into its components.2, 45, 336, 337 In HPLC, the liquid mobile phase is 
additionally pushed through a column with high pressure to enhance sample separation and once 
the sample component separation occurs the individual compounds can be analyzed with 
additional detectors.2, 45, 336, 337 A broad variety of usable solvents, reusable columns, and detectors 
make HPLC a very flexible and powerful method to use and it has thus been applied in several 
studies to analyze polar and non-polar lipids. 2, 23, 45, 109, 249, 265, 336, 337, 340  
1.6.2.5 Spectrophotometry 
Spectrophotometry (spectroscopy) includes sensitive analytical techniques to detect and 
determine any type of molecules within small sample mixtures.2, 45, 336, 337 The main principle of 
these methods entails the excitation of a sample with a specific wavelength and the detection of 




1.6.2.5.1 Mass Spectroscopy (MS) 
In mass spectroscopy (MS), an ion source “shoots” high-energy electrons at sample molecules 
to form ions with specific mass/charge ratios (m/z).2, 45, 341, 342 These ions are sent through a mass 
analyzer that induces an electronic or magnetic field to separate the ions based on their different 
m/z ratios.2, 45, 341 Once the ions are detected, software plots a mass spectrum of distinctive m/z 
ratio peaks of each ion of a sample as a function of the relative abundance.45, 341, 342 
Several different variations/combinations of MS have been used to analyse lipids extracted from 
CLs and within meibum samples, including GC-MS, LC-MS, matrix assisted-laser desorption 
ionization (MALDI), atmospheric pressure chemical ionization (APCI-MS), and electrospray 
ionization mass spectroscopy (ESI-MS).2, 16, 29, 32, 33, 35, 36, 43, 45, 54, 60, 95, 96, 249, 259, 343, 344 Although MS 
allows for the analysis of lipidomes of small sample quantities, it requires standards to efficiently 
identify and quantify lipids in meibum or TF samples, which can make exact lipid determination 
difficult to achieve. 
1.6.2.5.2 Nuclear Magnetic Resonance Spectroscopy (NMR) 
In nuclear magnetic resonance (NMR) spectroscopy the nucleus of a molecule is excited into a 
higher energy level through radiofrequency radiations that are induced by a magnetic field.45, 342, 
345 The molecules can then be characterized and identified based on re-emitted radiation that is 
detected at a unique frequency.45, 342, 345 
NMR is one of the most powerful analytical tools to analyse molecular structures because it is 
non-destructive and has been used in several studies to analyze lipids in meibum and TF samples.2, 
25, 45, 46, 345-349 NMR is considered to have a relatively low sensitivity that generally requires large 
volumes (mg) and pooling of samples.2, 45, 342 However, in a recent study researchers were able to 
show high sensitivities with small sample quantities (µg) when using a 600mHz NMR.350 
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1.6.2.5.3 Raman and Infrared Spectroscopy 
Raman and infrared spectroscopy (IR) both detect vibrational changes in molecules to 
determine conformational and compositional information, but use different energy wavenlengths.2, 
45 In Raman spectroscopy, a sample is excited with a monochromatic light/laser, the light scatters 
at varying frequencies, which are then detected as a Raman spectrum, which provides unique 
information about the molecules within a sample. In IR spectroscopy, infrared radiation is 
projected through a sample mixture to then measure its absorbance and transmittance and create 
an interferogram. When a sample is energized, the molecules absorb the radiation, which excites 
them into a vibrational and rotational state, which is detected by IR spectroscopy and provides 
information about the molecular characteristic.2, 45 Both methods have disadvantages which can, 
however, complement each other to create a broad knowledge of molecular structures, 2, 45, 351, 352 
e.g. water within a sample interferes with IR but not with Raman spectroscopy. Several researchers 
have successfully used both technologies to determine differences in meibum lipids.2, 24, 45, 52, 351-
356 
1.6.2.5.4 Colorimetric Assays 
Colorimetric assays are spectroscopic methods that have been used to detect lipid deposition on 
CLs.45, 58, 59, 126, 127, 233, 253-255, 260, 357-359 These methods make use of colorimetric changes of a sample 
mixture after a reagent has been added, measuring the absorbance or fluorescence with either 
spectrophotometers or confocal microscopes. However, most of these methods have low 
specificities and only allow for the detection of lipid classes. Various methods have been 
developed and used to analyse the quantities of total lipids,127, 253-255 phospholipids,126, 127 
cholesterol,58, 59 and differences in the amount of accumulated on CLs.358 
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A special colorimetric method employs fluorescently-labeled lipids 260 or proteins. 233, 357, 359, 
360 By using these fluorescently-labeled TF components, researchers have been able to analyze the 
penetration patterns of specific lipids or proteins of interest that provide further knowledge about 
the interaction between the TF and various CL materials.45, 233, 260, 357, 359, 360 To measure the 
penetration of TF deposits, fluorescently labeled molecules of interest are added to a test solution 
in which various CL are incubated over varying periods of time. Using this methodology, Carney 
et al.260 measured the absorbance of various CLs after 14 hours and 20 days of lens incubation and 
tracked the penetration of lipids. Luensmann et al. used a similar incubation method to determine 
the penetration pattern of different TF proteins (albumin and lysozyme) on various lens materials, 
but instead used LSCM for detection.233, 357, 359, 360 LSCM can be differentiated from traditional 
microscopic techniques in that it makes use of a spatial pinhole phenomenon that eliminates any 
light rays that are out-of-focus on the focal plane, allowing for high resolution images. 
Additionally, an adjustable focal plane allows for scanning the medium of interest at different 
depths to create 2D penetration profiles. 
Two additional colorimetric assays of interest for this thesis are thiobarbituric reactive 
substances (TBARS) and enzyme-linked immunosorbent assays (ELISA). Both assays are well 
established assays used to detect and monitor lipid peroxidation by-products in blood, serum, or 
TF samples.106, 128, 133, 142, 152, 153, 161, 163, 361-365 TBARS is solely used to detect the oxidation by-
product MDA, whereas ELISAs can be used to detect various by-products (e.g. MDA, 4-HNE, or 
oxidized low-density lipoproteins[ox-LDL]). To determine the amount of MDA in a sample, the 
TBARS assay forms an adduct between thiobarbituric acid (TBA) and MDA through heat and 
acidic conditions to subsequently measure the presence of the bond colorimetrically at specific 
wavelengths (Figure 1-7).133, 153, 366, 367 However, the efficacy and specificity of the TBARS assay 
is still questioned, as TBA is known to react with other components within samples.133, 366, 367 
 
35 
ELISAs use antibodies that are bound to micro-titre plates (e.g. polystyrene) that may react with a 
protein within a sample mixture that is of interest.368 Thereafter, protein quantities are detected 
through fluorescent or chemiluminescent reactions and wavelengths are measured using a 
spectrophotometer 368 and have traditionally been used to determine TF proteins on CLs.221, 236, 238, 
253, 369-371 
 




In summary, the analysis of MG, TF, and CLs lipids is a very complex research field. The 
outermost ocular surface layer is composed of a large variety of lipids that all have an important 
role in discomfort, the performance of CLs on the eye, DE, and CL discontinuation. Various 
analytical methods are available to determine the impact of these lipids, but no method can be 
singled out to be the single “correct” one to use. It is therefore necessary to further explore these 
and other methods to continue to narrow down the impact various lipids may have on the comfort 
of the eye, CL wear, and DE disease. 
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Chapter 2  
Objectives and Rationale 
The introduction of silicone hydrogel (SiHy) lens materials gained significant interest amongst 
practitioners, patients, and researchers alike. It was initially believed that these lens materials 
would resolve a number of issues that occurred with conventional hydrogel lenses, particularly 
those associated with hypoxia. While SiHy lenses did indeed live up to their potential in respect to 
the management of hypoxia, an unforeseen issue related to excessive lipid deposition in certain 
wearers appeared with these lens materials. 187, 227, 252, 257, 268, 372-374 
During my master thesis, the deposition of cholesterol onto daily wear (DW) lens materials 
over a period of 28 days was studied.63 This in vitro study addressed the effects of incubation time, 
contact lens (CL) material, lipid concentration, and tear film (TF) replenishment on the amount of 
cholesterol deposition.63 This work showed that cholesterol accumulates significantly more onto 
SiHy lens materials and continuously builds up on CLs over time, without reaching a plateau. It 
also showed that the quantity of cholesterol deposition was proportional to the lipid concentration 
in the doping solution and that replenishing the incubation solution led to an increase in deposition 
on all lens materials. Our results led us to theorize that wearers of reusable SiHy CL materials with 
excessive lipid in their tears might experience lens discomfort linked to an increase in lipid 
deposition. 
Lens materials that are worn on a DW basis and reused following daily removal require the 
use of a nightly solution routine to ensure that the lens is appropriately disinfected prior to 
reinsertion. Many different lens care products are available, and in addition to disinfection these 
solutions incorporate various components that are designed to remove TF deposits (mainly 
proteins and lipids) to attempt to optimise the performance of CLs during wear. Despite the 
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importance of this function, few studies to-date have reported on the efficacy of solutions at 
removing lipid deposition from lens materials.307, 308 To further our knowledge in this area, Chapter 
3 is an in vitro exploration of the efficacy of a variety of contemporary multi-purpose solutions 
(MPS) on the removal of a TF lipid from current DW lens materials. 
A different approach to reducing discomfort for patients that present increased rates of lipid 
uptake on CLs might be to recommend a switch into lenses with shorter wear modalities, such as 
daily disposables (DDs), which have gained a steady increase in popularity in recent years. 166 At 
the time of my previous work,63 DD SiHy lens materials were not available and to-date no 
published studies have determined the degree of lipid contamination on such materials. Chapter 4 
provides the results of an in vitro study to deepen our insight into the lipid deposition behaviour 
of contemporary DD lens materials. 
When undertaking in vitro deposition studies, the vast majority of previous studies have 
exposed the lens materials to the deposit type of interest by merely soaking the lens in a solution 
containing the protein or lipid being studied. However, recent work has shown that the static vial 
incubation method used in such studies is not optimal and has limitations when we want to compare 
the results to on-eye lens wear conditions.375-380 In vitro models that mimic blinking, air exposure, 
tear replenishment, and that decrease the amount of incubation solution that the CLs are exposed 
to appear far better at predicting on eye performance and show uptake results that are more similar 
to those found in ex vivo samples.62, 266, 270, 375-380 With this in mind, our laboratory developed a 
novel in vitro platform (OcuFlow) that simulates blinking, air exposure between blinks, and 
physiological tear volumes and flow rates.381 This advanced in vitro eye model has previously been 
used for studies to examine drug release 382, 383 and protein uptake,384 and has been shown to be a 
versatile method to provide new insights into CL material performance. After determining the 
quantities of lipid contamination on various lens materials and modalities, and in consideration of 
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the results from Chapter 3, the question of where lipid deposition is located within a CL material 
remained unanswered. By using our advanced eye model, Chapter 5 examines the penetration of 
a TF lipid on commercially available DD lens materials. 
A major interest persists in the clinical value of understanding the role of lipid deposition in 
contact lens discomfort (CLD) and the involvement of lipids in causing dry eye disease (DED). 
Increased lipid deposition on SiHy lens materials may increase discomfort.63, 257, 268 When 
deposited on CLs, lipids may exacerbate poor lens wettability by adding an additional hydrophobic 
layer over the lens surface, which may play a significant role in impacting on-eye performance 
and comfort ratings.372-374 Tear break-up time (TBUT) measurements are a method to determine 
and predict CL performance in vivo over a lens surface.338, 385-387 Although it appears that denatured 
proteins on CLs may impact lens comfort, a recent study has shown that protein deposition on lens 
materials does not influence TBUT measurements over the surface of lenses.238 To-date, no studies 
have been published that examine the impact lipid deposition on TBUT measurements. Thus, 
Chapter 6 investigates the potential use of TBUT technology and compares contemporary DD 
CLs, in vitro. 
Finally, lipid degradation through oxidation is thought to be influential in the development of 
DED and discomfort.106, 125, 160 Lipids can “break down”, losing their functionality, which may 
potentially destabilize the TF lipid layer and could ultimately cause tissue damage.56, 129, 132, 135 To 
our knowledge, only a few studies have been able to measure lipid degradation in tears or CLs.125, 
142, 156, 163, 365 However, there is no sensitive analytical method currently available to determine 
lipid oxidation in small volumes of individual tear samples. To help determine if lipid oxidation 
in tears might be a cause for CLD and DED, Chapter 7 investigates various contemporary lipid 
oxidation assays to develop a new sensitive test method to test for oxidative by-products in tears. 
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The concluding Chapter 8 provides a summary of the presented work and suggestions for future 


















In the following chapter, the uptake rate of tear film lipids on various commercial contact lenses 
will be measured over time using a radiochemical methodology, and the capabilities of various 
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To determine the efficacy of multi-purpose solutions (MPS) on the removal of cholesterol 
deposits from silicone hydrogel (SiHy) contact lens materials using an in vitro model. 
3.1.2 Materials & Methods 
Five SiHy lens materials: senofilcon A, comfilcon A, balafilcon A, lotrafilcon A and lotrafilcon 
B were removed from the blister pack (n=4 for each lens type), incubated for 7 days at 37°C in an 
artificial tear solution (ATS) containing 14C radiolabeled cholesterol. Thereafter, lenses were 
stored in a preserved saline solution control (Sensitive Eyes Saline Plus) or cleaned with one of 
five MPSs incorporating different preservatives (Polyquad®/Aldox®, polyquaternium-1/alexidine, 
polyquaternium-1/PHMB and 2 based on PHMB alone) using a rub and rinse technique, according 
to the manufacturer recommendations, and stored in the MPS for eight hours. Lenses were then 
extracted with 2:1 chloroform:methanol, analyzed in a beta counter and µg/lens of cholesterol was 
determined. 
3.1.3 Results 
Balafilcon A and senofilcon A showed the highest amounts of accumulated cholesterol 
(0.93±0.02µg/lens and 0.95±0.01µg/lens, respectively), while lotrafilcon A and lotrafilcon B 
deposited the lowest amounts (0.37±0.03; 0.47±0.12). For all lens materials, the MPS preserved 
with Polyquad®/Aldox® removed more cholesterol than any other test solution; however, the 
amount of cholesterol removed from the individual CLs was statistically significant only for 
balafilcon A and senofilcon A (P = 0.006 and P = 0.042, respectively). Sensitive Eyes and the 




Lipid-removal efficacy varies depending on the combination of lens material and solution. Only 
one MPS showed a significant reduction of lipids for any of the tested lens materials.  
3.1.5 Keywords 






Soft contact lenses (CL) interact with the ocular surface and rapidly sorb tear film (TF) 
components, particularly proteins 220, 221, 233, 239, 253, 268, 388-390 and lipids.58, 63, 224, 227, 246, 249, 252, 253, 
255, 257, 258, 265, 268 These deposits can influence the on-eye performance of lenses and potentially 
influence dryness and discomfort associated with lens wear.216, 238, 255 In severe cases, they can 
lead to inflammatory responses resulting in contact lens associated papillary conjunctivitis 226, 391, 
392 and may also increase bacterial adhesion to the lens materials.324, 393-395  
Today, the majority of contact lens wearers are fitted with silicone hydrogel (SiHy) lens 
materials, which are worn most commonly on a reusable basis, utilizing replacement periods of 
two or four weeks.396 Lens materials used as frequent replacement lenses require a suitable lens 
care solution system for overnight disinfection and to remove TF and extraneous deposits. The 
majority of patients use preserved multipurpose solutions (MPS) to care for their soft contact 
lenses.396 MPS combine many different ingredients, including biocides to disinfect the lenses, 
wetting agents to reduce the hydrophobicity of the lens surface and surfactants to remove TF 
deposits that have accumulated during wear.274, 397  
Silicone hydrogel lens materials accumulate greater amounts of lipid compared to conventional 
hydrogel (CH) lenses.58, 63, 227, 252, 258, 266, 268 One TF lipid that has been found to fairly consistently 
deposit on SiHy lens materials is the non-polar lipid cholesterol, and its esters.58-61, 63, 258, 260, 263, 265, 
325, 398-400 The efficacy of various MPS in removing deposits from lenses depends upon the 
composition of the MPS and the lens material properties. Previous in vitro 279, 333, 401 and ex vivo 
60, 228, 263, 265, 297, 402 studies demonstrated that cleaning solutions have varying abilities to remove 
TF deposits on SiHy lens materials.  
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The purpose of this study was to determine the efficacy of several contemporary MPS in 
removing cholesterol deposits from various SiHy CL materials, using an in vitro radiolabeling 
model.  
3.3 Material & Methods 
3.3.1 Lens Materials 
Five different SiHy lens materials were investigated; senofilcon A ([SA] Acuvue® Oasys™; 
Johnson & Johnson, Jacksonville, FL), balafilcon A ([BA] PureVision® 2; Bausch+Lomb, 
Rochester, NY), comfilcon A ([CA] Biofinity®; CooperVision, Pleasanton, CA), lotrafilcon A 
([LA] Air Optix® Night & Day® Aqua; Alcon, Fort Worth, TX) and lotrafilcon B ([LB] Air Optix® 
Aqua; Alcon, Fort Worth, TX). The lens care solutions that were evaluated included five 
contemporary MPS of varying compositions: polyquaternium-1/PHMB based system [Biotrue® 
MPS; Bausch+Lomb, Rochester, NY]; PHMB-1 based solution [renu® fresh™; Bausch+Lomb, 
Rochester, NY], polyquaternium-1/alexidine based system [Blink RevitaLens® MPS; Johnson & 
Johnson, Jacksonville, FL], Polyquad®/Aldox® based cleaning solution [OptiFree® PureMoist® 
MPS; Alcon Inc., Fort Worth, TX], PHMB-2 based system [Solo-Care Aqua® MPS; Menicon Ltd., 
Nagoya, Japan]); and a saline (Sensitive Eyes® Plus Saline, Bausch+Lomb, Rochester, NY) that 
was used as a control. Table 3-1 and Table 3-2 provide further information on the lenses and 





Table 3-1. Properties of contact lens materials evaluated in the study. 
USAN senofilcon A balafilcon A comfilcon A lotrafilcon A lotrafilcon B 
Lens Type SiHy SiHy SiHy SiHy SiHy 
Trade Name Acuvue
® OASYS™ with 
HYDRACLEAR™ Plus PureVision
® 2 HD Biofinity® Air Optix
® 
Night&Day® Aqua Air Optix
® Aqua 
Water Content 38% 36% 48% 24% 33% 
Oxygen permeability (Dk) 
(x 10-11) 147 91 116 175 138 
Surface Modification None. Internal wetting agent Plasma oxidation None Plasma surface treatment 
Plasma surface 
treatment 
Manufacturer Johnson & Johnson Bausch + Lomb Cooper Vision Alcon Alcon 
USAN: United States Adopted names, SiHy: silicone hydrogel, FDA: Food and Drug Administration 
 

























sodium borate, sodium chloride 
Sodium chloride, 













Disodium edetate, Poloxamine 


















Manufacturer Bausch+Lomb Bausch+Lomb Bausch+Lomb Johnson&Johnson Alcon Menicon America 




3.3.2 Artificial Tear Solution 
In an effort to mimic the complexity of human tears, our laboratory has developed an artificial 
tear solution (ATS) that has been utilized for the in vitro incubation of various lens materials in 
several previous studies.62, 63, 237, 266, 279, 325, 331 The full composition of the ATS has been previously 
published. 61  
3.3.3 Cholesterol and 14C Radioactivity 
To quantify the deposited cholesterol, a trace amount of radioactive 14C labeled cholesterol 
(Perkin Elmer, Waltham, MA) was added to the ATS. The concentration of 14C-cholesterol was 
3% of the total non-radioactive concentration of cholesterol, as previously described.61-63, 279, 325 
3.3.4 Vial pre-treatment 
The porosity of the borosilicate vials (6 ml) interferes with the degree of lipid uptake onto 
contact lens materials, as the lipid adheres to the inner walls (unpublished internal data). To 
overcome this issue the vials were pre-treated with 3.5 ml of non-radioactive ATS to saturate the 
inner surface of the vial with lipid and protein to minimize the uptake of lipids onto the inner vial 
surface, prior to radioactive incubation. Subsequently, the vials were emptied of the pre-treatment 
solution, rinsed with a complex salt solution (CSS) 61 and refilled with the same quantity of ATS 
that contains the 14C-cholesterol.  
3.3.5 Lens Incubation and Extraction 
The lens materials tested (n=4 for each lens–solution combination, in addition to uncleaned 
control lenses) were soaked in a CSS for 24 hours on a shaker to remove any residual blister pack 
solution. Thereafter, the lenses were rinsed twice in CSS, gently blotted on a lens paper, and placed 
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in a vial containing fresh radioactive ATS. The vials were capped, sealed with Parafilm®, and 
incubated at 37°C with shaking for 1 week. At the end of the one-week incubation period, each 
lens was rinsed twice in CSS and blotted on a lens paper. Thereafter, each test lens was rubbed 
and/or rinsed with the appropriate MPS as per the manufacturer’s instructions and then stored in 
the MPS or saline for eight hours. Subsequently, lenses were placed in 20 mL glass scintillation 
vials with 2 mL of 2:1 chloroform:methanol extraction solution and shaken at 1600 rpm for 30 
minutes at room temperature. Each lens was extracted in this manner at two separate times and 
both extracts were pooled in the same vial. The extract vials were dried down completely using air 
or nitrogen in a water bath at 35° ± 5°C. All vials were re-suspended in 1 mL of chloroform, then 
sonicated for one minute, and 10 mL of Ultima Gold™ F (Perkin Elmer, Waltham, MA) 
scintillation fluor was added. The vials were subjected to liquid scintillation beta counting using a 
L6500 Beckman Coulter Beta Counter (Beckmann Coulter Inc., Brea, CA, U.S.). Standard 
radioactive counts were prepared and counted to determine the total radioactive counts in the 
system. The uncleaned control lenses were subjected to radioactive counting (as detailed 
previously) and did not undergo the cleaning procedure. The efficacy of a given MPS for different 
lens materials was determined by calculating the difference in deposition between “uncleaned” 
and “cleaned” lenses. Figure 3-1 provides a schematic of the study design.  
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Figure 3-1. Study design. 
 
3.3.6 Statistical Analysis 
Statistical analysis was performed using repeated measures analysis of variance (RM-ANOVA) 
and Tukey post-hoc analysis was performed when required. Analysis was performed using SPSS 






Figure 3-2 and Figure 3-3 and Table 3-3 detail the results. Overall, we found that both variables 
(lens care solution and CL material) were statistically significant (P ≤ 0.001), as well as the 
interaction between both (P = 0.001). 
Table 3-3. Repeated measures ANOVA statistical results for cholesterol uptake. 




Square F P value 
Lens Care Solution 0.133 5 0.027 11.958 <0.001 
Contact Lens Material 4.512 4 1.128 1334.35 <0.001 
Lens Care Solution * 
Contact Lens Material 0.134 20 0.007 3.022 0.001 
Error 0.111 50 0.002   
3.4.1 Total uptake of lipids onto lens materials 
Figure 3-2 illustrates cholesterol deposition on all the control (uncleaned) lenses. Balafilcon A 
and senofilcon A lens materials deposited the most cholesterol (0.93±0.02µg/lens; 
0.95±0.01µg/lens respectively), lotrafilcon B and lotrafilcon A the least amount of cholesterol 
(0.47±0.12µg/lens; 0.37±0.03µg/lens, respectively). Post-hoc analysis revealed that comfilcon A 
lenses (0.76±0.06µg/lens) deposited significantly less cholesterol than senofilcon A and balafilcon 
A (P < 0.05), but significantly more than the lotrafilcon lens materials (P < 0.05). No significant 
differences were found between senofilcon A and balafilcon A (P = 0.97) or between lotrafilcon 
A and lotrafilcon B (P = 0.131). 
Figure 3-3 depicts the average cholesterol reduction post-cleaning for the saline solution and 
each MPS product compared to uncleaned lenses. The average reduction of cholesterol varies 
greatly between the test solutions, where Polyquad®/Aldox® (0.086 µg/lens; P ≤ 0.001) and 
PHMB-1 (0/054 µg/lens; P = 0.035) removed the most. None of the other MPS or the saline 





Figure 3-2. The graph shows the Mean (± SD) total cholesterol uptake on the contact lens materials 
after 7 days of incubation in a complex tear solution containing radiolabeled 14C-cholesterol. (*P < 0.05 for 
differences in uptake between CLs). 
 
 
Figure 3-3. Average reduction in cholesterol deposits (in μg/lens) when compared to uncleaned lenses 




3.4.2 Lens Care Product Performance on Lipid Removal  
Figure 3-4 shows the comparison of cholesterol remaining on each CL material, after storing 
them in saline and cleaning with each test MPS. In addition, Table 3-4 provides a comparison chart 





Figure 3-4. The graph shows the Mean (± SD) total cholesterol uptake on various lens material when 
soaked and cleaned in saline and 5 different MPS after 7 days of incubation in a complex tear solution 
containing radiolabeled 14C-cholesterol. (*P < 0.05 for cleaned vs. uncleaned lenses). 
 
For the senofilcon A lens material, Polyquad®/Aldox® removed the most cholesterol when 
compared to the control lenses (25% reduction, p=0.042 vs. uncleaned lenses). No significant lipid 
reduction (P > 0,05) was found when the lenses were cleaned with the PHMB-1 solution (11% 
reduction), the polyquaternium-1/alexidine-based MPS (7% reduction), PHMB-2 (4% reduction), 
and with saline and the polyquaternium-1/PHMB solution (0% reduction). 
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For balafilcon A, the Polyquad®/Aldox® based MPS (P=0.006) was the only solution to show 
a significant amount of cholesterol removal, with 8% removal compared to the control, 
respectively. The percentage removal of cholesterol by saline was 6% and by the other MPS 
products were 3% (polyquaternium-1/alexidine and PHMB-2), and 2% (polyquaternium-1/PHMB, 
PHMB-1), which were all statistically irrelevant (Tukey HSD, P > 0.05). 
Although Figure 3-4 shows the highest reduction of cholesterol on comfilcon A lenses after 
they were cleaned with the Polyquad®/Aldox® solution (24% reduction), post-hoc analysis did 
not reveal a significant reduction for any of the tested lens care products (Tukey HSD, P > 0.05). 
The products PHMB-2, PHMB-1, polyquaternium-1/alexidine, saline, and polyquaternium-
1/PHMB reduced the amount of lipid by 16%, 13%, 10%, 6%, and 0% respectively. 
Figure 3-4 shows a reduction of cholesterol on the lotrafilcon B lens material when cleaned 
with Polyquad®/Aldox®, polyquaternium-1/PHMB-based, PHMB-2 solution to be 24%, 21%, and 
20%, respectively. These results were not statistically significant (P ≥ 0.330). The reduction of 
cholesterol using saline and PHMB-1 were 12% and 10% respectively, and polyquaternium-
1/alexidine showed minimal reduction (1%) in comparison to the control lenses. None of these 
were significant (P > 0.05). 
For the lotrafilcon A lens material, none of the tested MPS solutions removed the low levels of 
cholesterol from the lens material (0%). A post-hoc analysis revealed no significant differences 




Table 3-4. Percent difference of cholesterol removal in comparison to uncleaned lens materials. 











Comfilcon A 6% 0% 13% 10% 24% 16% 
Senofilcon A 0% 0% 11% 7% 25% 4% 
Lotrafilcon A 2% 0% 0% 0% 0% 0% 
Balafilcon A 6% 2% 2% 3% 8% 2% 
Lotrafilcon B 9% 2% 4% 6% 11% 6% 






Wetting Agent  poloxamine Tetronic
® 904 poloxamine 1107 Tetronic
® 1304 poloxamer 407 
  
3.5 Discussion 
These results showed that among the SiHy materials evaluated, after 7 days of incubation in an 
artificial tear solution, that senofilcon A and balafilcon A deposited the highest amounts of 
cholesterol, whereas the lotrafilcon A and B lenses accumulated the least. The quantity of 
deposited cholesterol determined from this study is in broad agreement with previously measured 
quantities, determined after the same time span 62, 63, 260 and ex vivo studies.60, 263, 265 Furthermore, 
we found that the Polyquad®/Aldox® based MPS removed more cholesterol than the other MPS 
systems evaluated, with the results for balafilcon A and senofilcon A being statistically significant. 
In comparison, all the other MPSs tested were not efficient in removing cholesterol from any of 
the CL materials.  
The commercialization of SiHy materials in the late 1990’s produced materials with 
significantly improved oxygen transmissibility 185, 403 and these materials now account for some 
70-80% of all new fits.396 However, the relatively hydrophobic nature of silicone results in the 
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materials being more likely to deposit lipids from the TF 58, 60, 62, 63, 260, 265, 268, 325, 399 and the 
materials to be less wettable.187, 404-406 
To create a hydrophilic and more wettable surface, some manufacturers modify their SiHy 
materials, using a wide variety of methods. A plasma oxidation procedure is applied to balafilcon 
A lens materials, creating silicate islands that spread discontinuously over the lens.185, 189, 407 The 
comfilcon A and senofilcon A materials are not surface modified, relying on internal wetting 
agents or monomer characteristics to augment wettability.407-411 A 25nm thick permanent plasma 
surface treatment surrounds the lotrafilcon A and B lens materials and conceals the hydrophobic 
moieties, to provide a hydrophilic outer layer.185, 189, 407 In previous studies using similar 
procedures to those reported in this study we also found balafilcon A materials to be one of the 
highest depositors of cholesterol.61, 63 The distribution of the silicate islands and a relatively porous 
internal structure 412 allow more lipids to penetrate into and onto the lens material, thus, showing 
higher uptake rates than most other lens materials. In comparison, the plasma surface treatment of 
the lotrafilcon A and B lens materials prevents lipid uptake more effectively, which is evident by 
the low levels of cholesterol sorption demonstrated in this study.  
Contact lens care systems play a major role in disinfecting, removing, and preventing the 
accumulation of TF components on lens materials. MPS consist of a wide variety of components, 
to ensure adequate disinfection, cleaning and to aid wettability.274, 397 Removal of deposited TF 
components is undertaken through the incorporation of amphiphilic surfactants (1.5.3), such as 
poloxamer and poloxamine (Tetronic). These surface-active agents consist of hydrophobic tails 
and hydrophilic heads that have the capability to chemically adhere and remove lipids, proteins 
and other debris.413 Furthermore, wetting agents that are incorporated in MPS also have surfactant 
properties and, thus, may have a supportive effect on the removal of TF components on CLs. Table 
3-2 provides a list of the various surfactants and wetting agents that are included in the MPS 
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evaluated in this study. Our results show that the combination of components found in the 
Polyquad®/Aldox® solution was the most efficacious in reducing the amount of cholesterol. When 
examining the comparison chart Table 3-4, it is apparent that the type of surfactant that is being 
used in a care regimen may be a driving factor for higher cleaning efficiency of a MPS, with 
Tetronic® 1304 performing better in removing cholesterol deposition than using “simple” 
poloxamine as in the polyquaternium-1/PHMB cleaning solution. In addition, the lipid-cleaning 
efficacy of the MPSs varied between the lens materials, which shows that the cleaning performance 
is highly dependent on the combination of lens material and lens care product. Of note, is that the 
highest amounts of lipid were removed from the higher depositing CL materials. 
This is the first study to evaluate the cleaning efficacy of different MPSs in removing 
cholesterol deposits from SiHy contact lens materials using an in vitro radiolabeling technique. 
The results from this study are in agreement with previously published work from our laboratory,27, 
37, 46 demonstrating that radiolabeling is a reproducible and reliable technique to quantify 
cholesterol deposition on and into silicone hydrogel contact lenses.  
“To rub or not to rub”, has been a common question relating to contact lens care. Manufacturers 
introduced solutions with “no rub” instructions to improve patient convenience and such an 
approach was well received by patients. However, various research groups have reported that MPS 
products were more effective at removing microorganisms, TF constituents and make-up 
components when a “rub and rinse” step was applied 414-419 and such data has resulted in calls for 
all such products to be used with a rub step included.420 While previous work has been equivocal 
regarding the removal of TF deposits, with some reports suggesting that protein removal was not 
different when comparing “rub and rinse” with “no-rub”, 333 we believe that a gentle rub and rinse 
step should increase the efficacy of lipid removal. This is borne out by studies by Tam et al, 307, 308 
who determined lipid sorption before and after pre-soaking test lenses in one of two MPSs,307 and 
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applying a “rub and soak” or “soak” only test procedure. 308 Tam and co-workers found significant 
removal of lipids only when the MPS was used in a gentle rub and rinse regimen.308 This further 
shows that incorporating a rubbing step into the cleaning procedure increases the efficiency of 
MPS to remove sorbed lipids from CLs. However, despite these findings, many CL patients still 
fail to apply a rubbing step to their cleaning routine,314, 321 obviating any benefit that rubbing may 
provide in removing lipids.  
In conclusion, this experiment shows that the efficiency of MPS to remove lipids from SiHy 
lens materials is highly dependent on the lens material/solution combination. Herein, we found 
that the Polyquad/Aldox based solution demonstrated the best performance in removing 
cholesterol from the tested lens materials; however, this was statistically significant only for 
balafilcon A and senofilcon A lens materials. It is also worth noting that this study only evaluated 
lipid deposition over 7 days, and most SiHy lenses are replaced after one month.396 Lipid 
deposition is cumulative over time 58, 63, 227, 255, 260, 325 and so another management option to manage 
lipid deposition would be to replace lenses after shorter periods of wear. These results would 
suggest that if lipid deposition is an issue for patients wearing SiHy materials on a reusable basis 
that trying differing MPS products would only marginally enhance lipid removal. In such cases 
where lipid deposition is an issue, switching to another SiHy material, switching to CH materials 
or increasing the frequency of replacement of the SiHy material would also be appropriate clinical 
management options.  
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In the next chapter, the degree of lipid uptake on commercially available DD CLs using a 
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The goal of this study was to analyze how various incubation times affect the uptake of 
cholesterol on silicone hydrogel (SiHy) and conventional hydrogel (CH) daily disposable (DD) 
contact lens materials using an in vitro radiochemical detection method.  
4.1.2 Materials & Methods 
Three SiHy (somofilcon A, delefilcon A, and narafilcon A) and four CH (etafilcon A, nesofilcon 
A, ocufilcon A, and nelfilcon A) contact lenses were incubated in an artificial tear solution (ATS) 
that contained major TF components, and a portion of radioactive 14C-cholesterol. Lenses (n=4) 
were incubated for four incubation times (2, 6, 12 or 16 hours) to assess the effects on cholesterol 
deposition. Subsequent to the incubation, the lenses were extracted using 2:1 chloroform: methanol 
and the extracts were analyzed in a beta counter and (ng/lens) extrapolated from standard curves. 
4.1.3 Results 
In general, cholesterol deposited statistically significantly more on SiHy lenses than CHs (P ≤ 
0.033), with the exception of somofilcon A and nesolfilcon A materials (P = 0.067). Within the 
SiHy materials, narafilcon A accumulated the largest quantity of cholesterol (P < 0.05) and 
somofilcon A the lowest (P < 0.05). The uptake of cholesterol ranged from 22.63 ± 2.98 ng/lens 
to 97.94 ± 4.18 ng/lens for all lens materials. The accumulation of cholesterol was shown to be 




For the periods of time that DD lens materials are worn, cholesterol deposits significantly more 
onto SiHy contact lenses than CHs. This could have implications for wearers who have higher 




The introduction of frequent replacement daily wear soft lenses in the late 1980’s resulted in a 
significant reduction in complications that were due to lens deposition and ageing and resulted in 
increased patient satisfaction with lens wear. 421-423 The ultimate option for daily wear frequent 
replacement lenses, daily disposable (DD) soft lenses that are worn once and then discarded, 
became a commercial reality in 1995.424, 425 These lenses provide the ultimate in convenience for 
wearers, have high levels of compliance with replacement frequency 426, 427 and many studies have 
shown their benefits in terms of clinical performance and reduction in complications. 428-438   
Over the past decade, silicone hydrogel (SiHy) contact lenses have become the predominant 
material of choice for practitioners and lens wearers, 211 primarily due to their high oxygen 
transmissibility. 177, 439, 440 Until recently, practitioners were unable to offer DD lenses 
manufactured from SiHy materials, with the majority of DD lenses being manufactured from 
conventional hydrogel (CH) materials. While SiHy materials will increase oxygen transport, the 
presence of siloxane groups within these materials results in relatively hydrophobic surfaces that 
may impact wettability. 404, 405, 441 The hydrophobicity may also result in increased deposition of 
certain lipid species, 58, 227, 257, 260, 266 which might enhance the prevalence of lens-induced dryness 
70, 373, 374, 442 and discomfort 443 during lens wear if the inappropriate type or quantity of lipids were 
deposited. 
To-date, no studies have examined the degree to which DD lens materials may deposit lipid, in 
particular cholesterol, which is a common lipoidal contaminant on SiHy materials. 58-63 Patients 
who have an oily TF may notice rapid deposition of lipid onto SiHy materials (Figure 4-1). The 
purpose of this study was to quantify the amount of cholesterol contamination on hydrogel and 







Figure 4-1. Female patient aged 23 with significant oily 
contamination of the tear film was fitted with a silicone 
hydrogel daily disposable lens and complained of “smeary 
vision” after 3-4 hours of wear. The image shows significant 
deposition with what appears to be a lipid-like film after 
only 3 hours of wear. Refitting the patient with an FDA 
group IV hydrogel daily disposable resulted in no visible 
deposition and comfortable wear for 12 hours. 
4.3 Materials and Methods 
4.3.1 Lens Materials 
The study included seven commercially available, unworn DD lens materials (n=4 per type), 
including three SiHy materials (delefilcon A [Alcon, Ft Worth, TX]; somofilcon A [CooperVision, 
Pleasanton, CA]; narafilcon A [Johnson & Johnson, Jacksonville, FL]), and four CH lens materials 
(ocufilcon B and nesofilcon A [CooperVision, Pleasanton, CA]; nelfilcon A [Alcon, Ft Worth, 
TX]; etafilcon A [Johnson & Johnson, Jacksonville, FL]). The properties of these lens materials 
are listed in Table 4-1 and all lenses had an optical power of -3.00 diopters.  
Table 4-1. Contact lens material information 
USAN Trade Name Water Content FDA Group 
Oxygen 
Permeability 
(Dk) (x 10-11) 
Lens 
Type 
Delefilcon A DAILIES TOTAL1 33% V 156 SiHy 
Somofilcon A clariti 1day 56% V 86 SiHy 
Narafilcon A 1-Day ACUVUE TrueEye 46% V 118 SiHy 
Etafilcon A 1-Day ACUVUE MOIST 58% IV 25.5 CH 
Ocufilcon B Biomedics 1Day 52% IV 24 CH 
Nelfilcon A DAILIES AquaComfort Plus 69% II 26 CH 
Nesofilcon A Biotrue ONEday 78% II 42 CH 




4.3.2 Contact Lens Incubation and Extraction 
The methods used to expose the lenses to lipid and to extract the lipid post-doping are similar 
to those previously published by our laboratory.61-63 
4.3.3 Vial pre-treatment 
Initial in-house studies showed that the vials used to store the lenses during the incubation 
process adsorbed some of the cholesterol and impacted the deposition data. To avoid this, every 
vial was initially pre-treated with a previously characterised artificial tear solution (ATS) at 37°C 
for seven days prior to the experiment.61 This was demonstrated to minimize lipid uptake from the 
incubation solution and negate this issue, as previously reported.63 
4.3.4 Lens incubation and extraction 
To quantify the deposited cholesterol, a trace amount of radioactive 14C labeled cholesterol 
(Perkin Elmer, Waltham, MA) was added to the ATS, as previously described. 63 This ATS 
included six lipids commonly found in the tears, at physiologically relevant concentrations. 61 The 
concentration of 14C-cholesterol was 3% of the total non-radioactive concentration of cholesterol. 
Following the addition of radioactivity, the solution was sonicated for 5 minutes and the ATS was 
ready to use as the incubation solution. The lens materials were taken directly out of their blister 
packages, rinsed in phosphate buffer saline (PBS), and blotted dry on lens paper before placing 
them into the incubation vials. Following vial pre-treatment, the vials were filled with 3.5mL of 
the prepared radioactive ATS and the pre-soaked lenses were placed in the vials. All vials were 
sealed with Parafilm® and incubated at 37°C while shaking at 60 RPM for their specified 
incubation periods.  
The study design involved four different incubation times that simulate different wearing times 
that are typical for DD lenses, ranging from very short periods of wear (to simulate that often seen 
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for use for sports activities), through to an entire day. Lenses were incubated in the doping solution 
for 2, 6, 12 and 16 hours. 
Following incubation, each lens was removed from the vial and rinsed twice in PBS to remove 
excess incubating ATS. The contact lenses were then transferred to 20 ml glass scintillation vials 
and extracted twice with 2mL of 2:1 chloroform: methanol for three hours. During extraction, the 
vials were incubated at 37°C with orbital shaking. Once extraction was complete the extraction 
solution was dried completely using nitrogen gas and the dried samples were re-suspended with 1 
ml of chloroform. Each vial was then sonicated, filled with 10 ml of Ultima Gold F (Perkin Elmer, 
Waltham, MA) scintillation fluid and counted using the L6500 Beckman Coulter Beta Counter 
(Beckmann Coulter Inc., Brea, CA). The radioactive counts per minute were then converted to 
masses of cholesterol (µg) using standard lipid calibration curves.  
4.3.5 Data Analysis 
Repeated measures ANOVA, univariate and Tukey post-hoc analysis were performed when 
required. The factors analysed were lens material and incubation time. The statistical program was 
IBM SPSS Statistics 20 (IBM Corporation, Armonk, NY, U.S.). Statistical significance was 
considered at a P value of < 0.05. 
4.4 Results 
Table 4-2 and Figure 4-2 report the amount of cholesterol accumulated by the lens materials 
over the times investigated. Table 4-3 shows that cholesterol deposition was dependent on both 
the contact lens type and length of incubation (P < 0.001), as was the interaction between them (P 
< 0.001). Increasing time of incubation resulted in increased cholesterol deposition, regardless of 





Figure 4-2. Mean (± SD) total cholesterol uptake on various daily disposable contact lens materials over 
16 hours. Lipid quantities were measured using a radiolabel method in which cholesterol was labelled 





Table 4-2. Cholesterol deposition on lenses in ng/lens (Mean ± SD) 
USAN 2 hours 6 hours 12 hours 16 hours 
Delefilcon A 39.91 ± 2.06 53.76 ± 3.76 73.25 ± 2.35 96.97 ± 11.66 
Somofilcon A 38.23 ± 0.82 50.62 ± 5.01 75.79 ± 4.99 95.52 ± 6.51 
Narafilcon A 42.86 ± 2.44 62.30 ± 12.40 87.21 ± 5.10 97.94 ± 13.18 
Ocufilcon B 25.34 ± 14.77 49.03 ± 12.09 51.12 ± 3.26 59.52 ± 8.22 
Nelfilcon A 22.63 ± 1.94 23.51 ± 2.96 33.79 ± 4.28 33.98 ± 7.43 
Etafilcon A 27.95 ± 3.31 31.51 ± 3.46 36.54 ± 1.34 39.13 ± 2.01 
Nesofilcon A 35.76 ± 2.21 47.73 ± 2.15 61.76 ± 6.13 80.11 ± 3.35 
USAN: United States Adopted Names, CH: conventional hydrogel, SiHy: silicone hydrogel, FDA: Food and Drug 
Administration 
  
SiHy CLs CH CLs 
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Table 4-3. Repeated measures ANOVA statistical results for cholesterol uptake onto various DD contact 
lens materials. 
Repeated Measures ANOVA statistical results for cholesterol uptake over time 
Variable Sum of Squares 
Degrees of 
Freedom Mean Square F P  value 
Length of Incubation 23819.11 3 7939.71 211.29 < 0.001 
Lens Material 27565.38 6 4594.23 73.28 < 0.001 
Length of Incubation 
* Lens Material 6536.26 18 363.13 9.66 < 0.001 
Error 2367.42 63 37.58   
 
Within the SiHy materials, there was no significant difference in the amount of cholesterol 
deposited (P ≥ 0.149). Within the CH materials, a difference did exist. In terms of order of 
cholesterol deposited, nesofilcon A deposited the most, followed by ocufilcon B (P = 0.024), and 
then etafilcon A and nelfilcon A deposited the least (these latter two were not statistically different; 
P = 0.504). Ocufilcon B deposited more cholesterol than both etafilcon A (P = 0.004) and nelfilcon 
A (P < 0.001). 
Overall, SiHy lens materials deposited significantly more cholesterol than CH materials (P ≤ 
0.033). The exception to this was that there was no statistically significant difference (P = 0.067) 
between the lowest depositing SiHy material (somofilcon A) and the highest depositing CH 
(nesofilcon A).  
4.5 Discussion 
Daily disposable lenses have many advantages over reusable lenses, including convenience and 
high levels of wearer satisfaction,429 in addition to providing a more cost-effective option for the 
occasional wearer. In comparison to re-usable hydrogel frequent replacement modalities, DD 
lenses provide improved comfort and vision,429, 436, 444 better visual acuity,444 reduced lens 
deposition430 and a low rate of complications.445, 446 As a result of these benefits, practitioners have 
continued to adopt the use of this modality and some markets now see almost 50% of new fits with 
DD lenses.211, 447  
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Recently, manufacturers have started to introduce DD materials manufactured in SiHy 
materials. Several previous studies have shown that cholesterol deposits significantly more onto 
silicone-based lens materials than CHs. 58, 62, 63, 227, 258, 260, 263 However, these studies were 
conducted on reusable lens materials and this in vitro study is the first to investigate the sorption 
of a TF lipid (cholesterol) onto different DD lens materials, using an established radiolabeling 
method. Previous studies examined the accumulation of lipids over timespans of days or weeks, 
whereas, the DD materials in this study were only incubated for a maximum time of 16 hours. As 
shown in Figure 4-2, regardless of the time that the lens materials were exposed to the lipid-
containing solution, the SiHy materials deposited more cholesterol than the CH materials.  
In contrast to several DW SiHy contact lenses, SiHy DDs are not surface treated. Narafilcon A 
is a silicone hydrogel in which an internal wetting agent poly(vinyl-pyrrolidone) (PVP) is 
incorporated into the material, 191, 192 to lower lens dehydration, decrease friction, and to prevent 
deposits on the lens materials. Somofilcon A-based lenses do not feature an internal wetting agent 
or a surface treatment. 190 The latest DD SiHy material, delefilcon A, features a ‘water-gradient’ 
design, with a silicone core that is surrounded by a hydrogel layer that is approximately 5µm thick. 
193-196 This strategy provides a higher amount of water (>80%) on the lens surface, whereas, the 
bulk material has a water content of 33%. Despite these obvious differences in approach to the 
development of SiHy DD lenses, there were minimal differences in cholesterol uptake after 16-
hours of incubation, suggesting that these differences in material composition have a relatively 
minimal impact on overall cholesterol accumulated by the SiHy DD materials examined, over the 
period of time that they were tested. However, it should be borne in mind that we did not examine 
the uptake of other lipids by these materials or indeed whether these lipids were oxidised or not, 
which may have clinical relevance 132 and warrants further evaluation.  
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In a recent study using similar methods to this report, 63 we examined uptake rates of cholesterol 
on reusable SiHy materials, with accumulations of ≥0.21µg/lens (210ng/lens) after one day of 
incubation. The SiHy DDs examined in this study accumulated far less cholesterol after 16 hours 
of incubation than their DW counterparts, depositing approximately 96 ng/lens, which is less than 
half the amount of cholesterol uptake found on DW lenses, suggesting that SiHy DD lenses may 
be a good option for patients who tend to have deposition problems with reusable SiHy lenses.  
Conventional hydrogel DD materials do not include any siloxane moieties and thus require no 
surface modification. Figure 4-2 demonstrates that the CH material with the highest water content 
(nesofilcon A; 78%) deposited the highest amount of cholesterol, followed by the material with 
the lowest water content (ocufilcon B; 52%). This demonstrates that water content is clearly not a 
driver for cholesterol deposition within CH materials. Nesofilcon is a co-polymer of polyHEMA 
and N-vinylpyrrolidone (NVP) and a number of previous studies have shown that NVP has a 
tendency to increase lipid deposition, 132, 246, 253, 254 which is further confirmed by the data from 
this current study, even for NVP-containing materials that are exposed to lipid for short periods of 
time. This known tendency for pyrrolidone-derivatives to selectively adsorb lipids is one of the 
reasons it has been used as a transdermal penetration enhancer. 448 Ocufilcon B and etafilcon A 
are both FDA group IV (high water content, ionic charge) copolymers of polyHEMA and 
methacrylic acid. Examination of Figure 4-2 shows that etafilcon A deposited less cholesterol than 
ocufilcon B at all points in time, and the reason for this difference is not obvious from their 
composition.  
The nelfilcon A material is an FDA group II (high water content, neutral charge) material that 
is composed of polyvinyl alcohol (PVA) and exhibited similarly low levels of cholesterol uptake 
to that seen with etafilcon A. For patients who wish to use DD lenses and have a relatively heavy 
contamination of lipid within their tears, potentially due to the presence of meibomian gland 
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dysfunction, these latter two CH materials may be excellent choices. In wearers who require higher 
levels of oxygen transport but who exhibit oily tears, switching them into a SiHy DD lens may 
potentially result in some surface wetting issues (see Figure 4-1) and this is worthy of 
consideration, particularly if long wearing periods are required, as this cholesterol uptake is 
cumulative with time of wear, as clearly shown in Figure 4-2. This variability in lipid deposition 
between individuals being greater than that seen with protein deposition (which is far more 
mediated by lens material composition) has been shown in a number of previous studies. 246, 254, 
255, 449, 450  
To our knowledge, this is the only study to-date that elucidates the uptake rate of TF lipids on 
commercially available SiHy and CH DD lens materials, albeit using an in vitro model. A recent 
ex vivo study by Maissa et al. 449 determined the accumulation of various TF lipids onto SiHy 
(balafilcon A) and CH (etafilcon A) materials, in which the lenses were worn on a daily disposable 
basis for 10 hrs and an overnight basis for 7 consecutive days. Maissa and co-workers confirmed 
that SiHy materials deposit more lipid than CH materials and also determined that lipid uptake was 
cumulative, which supports previous studies 62, 63, 254, 255 investigating kinetic uptake of lipid and 
also the results from this current study. After 10 hours of lens wear, Maissa and colleagues 
measured 0.03 µg/lens (30 ng/lens) of cholesterol on the etafilcon A material, which is very similar 
to the values we report in this manuscript for the same material. This suggests that the technique 
utilized in this experiment is a sensitive in vitro method to determine lipid uptake on CL materials 
and that the data reported should be relatively reflective of that seen in vivo. However, one issue 
that is worthy of discussion is that this current study was conducted in a static vial format, 
preventing the TF rupture that often occurs during the inter-blink period. Our group has previously 
shown that incorporating such a break in the surrounding fluid does tend to increase lipid 
deposition, due to the increased hydrophobicity that can occur. 266 Thus, it is plausible that the 
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values reported in this manuscript may be slightly lower than that seen with lenses collected from 
an in vivo study, particularly for more hydrophobic materials in which dehydration and surface 
drying may be more relevant than in more hydrophilic materials such as etafilcon A.  
It is possible that this higher lipid uptake may cause some surface wetting issues and may result 
in in-eye de-wetting and potential reduced comfort. However, results to date have shown that DD 
SiHy materials appear to be well received by the majority of wearers and provide excellent in-eye 
comfort. 451-453 
In conclusion, the SiHy DD lens materials demonstrated significantly higher rates of cholesterol 
deposition than the CH DD materials and this information is valuable for practitioners to consider 
when considering using such materials in patients with TFs that may contain excess lipid. This in 
vitro study is the first to investigate lipid uptake onto various DD lens materials and provides 
hitherto unavailable information to practitioners, patients, and contact lens manufacturers. Further 
studies are required to determine if these levels of lipid may prove deleterious during wear and 
follow-up clinical studies are warranted, particularly in patients with meibomian gland 
dysfunction.  
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In the following chapter, it will be determined where lipids are located after depositing on 
contemporary DD CL materials by using fluorescently labeled cholesterol and detecting its 
position with a confocal microscope. Comparisons of the lipid penetration will be made 
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Current in vitro models to evaluate tear film (TF) deposition on various contact lenses (CLs) 
do not adequately simulate physiological ocular conditions. The aim of this study was to 
evaluate the differences in lipid uptake and penetration in daily disposable (DD) CLs using the 
conventional “in-vial” method compared to a novel in vitro eye model. 
5.1.2 Methods 
The penetration of NBD-cholesterol (7-nitrobenz-2-oxa-1,3-diazol-4-yl-cholesterol) on 
three silicone hydrogel (SiHy) (delefilcon A, somofilcon A, narafilcon A) and four 
conventional hydrogel (CH) (etafilcon A, ocufilcon B, nesofilcon A, nelfilcon A) DD CLs 
were investigated. The CLs were incubated for 4 and 12 hours (h) in an artificial tear solution 
(ATS) containing fluorescently labelled NBD-cholesterol at room temperature (21oC). For the 
vial condition, the CLs were incubated in a vial containing 3.5 mL of ATS. In the in vitro eye 
model, the CLs were mounted on our eye-blink platform designed to simulate physiological 
tear flow (2 mL/24 h), tear volume and ‘simulated’ blinking. After the incubation period, the 
CLs were analyzed using laser scanning confocal microscopy (LSCM). Quantitative analysis 
for penetration depth and relative fluorescence intensity values was determined using ImageJ. 
5.1.3 Results 
The depth of penetration of NBD-cholesterol varied between the vial and the eye-blink 
platform. Using the traditional vial incubation method, NBD-cholesterol uptake occurred 
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equally on both sides of all lens materials. However, employing our eye-blink model, 
cholesterol penetration was observed primarily on the anterior surface of the CLs. In general, 
SiHy lenses showed higher intensities of NBD-cholesterol than CH materials. Fluorescence 
intensities also varied between the incubation methods as well as the lens materials.  
5.1.4 Conclusions 
This study provides a novel in vitro approach to evaluating deposition and penetration of 
lipids on CLs. We show that the traditional “in-vial” incubation method exposes the CLs to an 
excessively high amount of ATS on both the front and back surface of the lens, which results 
in an overestimation for cholesterol deposition. Our model, which incorporates important 
ocular factors such as intermittent air exposure, small tear volume, and physiological tear flow 
between blinks, provides a more natural environment for in vitro lens incubation. 
Consequently, this will better elucidate the interactions between CLs and TF components. 
5.1.5 Keywords 
cholesterol, lipid, contact lens, daily disposable, eye model, deposition, laser scanning 





Contact lens (CL) dropout remains a pressing concern for the CL industry, with discomfort 
being a primary factor.197, 198, 454 Consequently, there is an increasing demand on manufacturers 
to continually produce safer and more comfortable CLs.171, 185, 186 The first generation of soft 
CLs, consisting of poly(2-hydroxyethyl methacrylate) (pHEMA) and its derivatives, were 
relatively comfortable, but unfortunately did not permit adequate oxygen transmission for the 
cornea to function optimally.176, 455 This problem was addressed in the late 1990s with the 
introduction of silicone hydrogel (SiHy) CL 177, 439, 440 materials that provided relatively high 
oxygen transmissibility. 177, 439, 440 However, due to the hydrophobic siloxane moieties within 
SiHy CLs, these materials suffered from reduced surface wettability,404, 405, 441 and increased 
lipid deposition.58, 62, 257, 260, 267, 456 As a result, these lenses were not as comfortable as initially 
expected.  
Despite extensive research over the past five decades, the paradigm for CL discomfort 
remains unclear, likely due to the multifactorial nature of comfort. One potential hypothesis 
suggests that discomfort manifests from the deposition of tear components, such as lipids, on 
the lens over time, which leads to changes within and on the surface of the lens.63, 257, 268 One 
strategy to overcome the complications associated with long-term lipid deposition is to switch 
to daily disposable (DD) lens wear. Even then, lipid deposition from short term or daily wear 
modality could still lead to end of day discomfort.325 
To investigate this phenomenon, studies have historically systematically investigated 
factors which can influence lipid deposition on CLs.61-63, 325 Important elements to consider are 
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TF lipid concentration, exposure time, properties of the lens material, and interactions between 
various TF components with the lens.62, 63, 224, 259, 260, 263 Previously, we have also shown that 
intermittent air exposure from a simulated blinking motion is also a crucial factor in 
influencing the degree of lipid deposition.266  
The challenge in elucidating the mechanisms of TF deposition in vivo is to adequately model 
a similar scenario in vitro. In the past, for CL deposition studies, researchers employed 
simplistic models by immersing lenses in a vial containing 3.5 mL of simulated tear fluid 
containing the component of interest.62, 63, 325 However, on the ocular surface, the tear volume 
is estimated to be only 7 ± 2 µL,457 with a tear exchange rate of 0.95-1.55μL/min.458 Thus, it 
is apparent that the previous models are too rudimentary, lacking not only the tear flow 
component, but the incubation volume also far exceeds physiological levels. Thus, to further 
our understanding of TF deposition, a better in vitro model is necessary.  
Studies evaluating lipid deposition on CLs traditionally have focused on quantifying the 
amount of lipids deposited on the lens.58, 61, 62, 257, 260, 266 In order to gain further insights on tear 
deposition, it is also of interest to evaluate the patterns of lipid deposition and penetration 
through the lens over time. The use of laser scanning confocal microscopy (LSCM) has been 
used previously to map protein penetration on the surface and matrix of CLs using 
fluorescently labeled proteins.233, 357 The ability to visualize lipid penetration in different CL 
materials may help explain the variations in comfort experienced between different CLs. The 
aim of this study was to characterize the penetration of fluorescently-tagged cholesterol on 
 
78 
commercially available DD CLs using a novel ocular model 459 which simulates tear volume, 
tear flow, and blinking and to compare the results to the standard vial incubation method.  
 
5.3 Materials & Methods 
5.3.1 Contact lenses and pre-treatment 
Four commercially available conventional hydrogel (CH) DD CLs [etafilcon A (Johnson & 
Johnson), ocufilcon B (CooperVision), nesofilcon A (Bausch+Lomb), nelfilcon A (Alcon)] 
and three SiHy lenses [delefilcon A (Alcon), somofilcon A (CooperVision), narafilcon A 
(Johnson & Johnson)] were evaluated in the study. All lenses had a dioptric power of -3.00 
and base curve of 8.5 or 8.6 mm, obtained from the manufacturer in the original packaging. 
Table 5-1 and Table 5-2 detail the properties of the CH and SiHy CLs respectively. Prior to all 
incubation studies, all CLs were removed from their packaging solutions and soaked in 5mL 
of PBS for 24 hours (h) while shaking at 30 RPM to remove excess packaging solution. After 
the 24h soaking, the CLs were removed from the pre-treatment solution and were blotted on 
lens paper to remove any excess liquid.  
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Table 5-1. Properties of conventional hydrogels (CH) used in the study 
 1-DAY ACUVUE MOIST BioMedics 1Day Biotrue 1Day 
DAILIES AquaComfort 
Plus 
United States adopted name (USAN) etafilcon A ocufilcon B nesolfilcon A nelfilcon A 
Manufacturer Johnson & Johnson CooperVision Bausch+Lomb Alcon 
Water content (%) 58% 52% 78% 69% 
FDA group IV IV II II 
Centre thickness (mm) 0.08 0.07 0.05 0.10 
Oxygen transmissibility (x10-9) 25.5 24 24 26 
Principal monomers HEMA, MA HEMA, PVP, MA HEMA, NVP FMA, PVA, PEG 
FMA, N-formylmethyl acrylamide; HEMA, hydroxyethyl methacrylate; MA, methacrylic acid; PEG, polyethylene glycol; PVA, polyvinyl alcohol; PVP, polyvinyl 
pyrrolidone; NVP, N-vinylpyrrolidone  
 
Table 5-2. Properties of silicone hydrogels (SiHy) used in the study 
 DAILIES TOTAL1® clariti™ 1day 1-DAY ACUVUE® TruEye® 
United States adopted name (USAN) delefilcon A somofilcon A narafilcon A 
Manufacturer Alcon CooperVision Johnson & Johnson 
Water content (%) 33% (surface >80%) 56% 46% 
FDA group V V V 
Centre thickness (mm) 0.09 0.07 0.09 
Oxygen transmissibility (x10-9) 156.0 86 118.0 
Principal monomers Not disclosed Not disclosed MPDMS, DMA, HEMA, siloxane macromer, TEGDMA, PVP 
DMA, N,N-dimethylacrylamide; HEMA, hydroxyethyl methacrylate; MPDMS, monofunctional polydimethylsiloxane; PVP, polyvinyl pyrrolidone; TEGDMA, 
tetraethyleneglycol dimethacrylate
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5.3.2 Artificial Tear Solution  
The composition of the artificial tear solution (ATS) has been previously reported by our 
group.61 Briefly, it contains various mucins, urea, salts, glucose, proteins (lysozyme and 
albumin), and various lipids (oleic acid methyl ester, cholesterol, triolein, phosphatidylcholine, 
cholesteryl oleate, and oleic acid).61  
5.3.3 Fluorescently tagged cholesterol 
Cholesterol and its derivatives are one of the primary lipid deposits found on CLs, and thus 
it was chosen as the representative lipid for this study.58, 60, 258, 263, 265 Fluorescently-tagged 
NBD-cholesterol [22-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-23,24-bisnor-5-cholen-
3ß-ol-cholesterol) (Figure 5-1), obtained from Avanti Polar Lipids Inc. (Alabama), was used 
to visualize the deposition and penetration of cholesterol into CLs. For this study, NBD-
cholesterol was dissolved at a physiological concentration of 1.9 mg/mL in a cholesterol-free 
solution of ATS.  
 
 












5.3.4 Ocular flow model 
Our in vitro model (OcuFlow) consists of a two-piece model that includes a 
“corneal/scleral” piece and an “eyelid” component, spaced 250 µm apart. The templates for 
the eye models were designed using a computer aided drawing software (Solid Works 2013), 
and printed using 3-D printing technology.459 The resulting 3-D printed molds (PC-ABS, 
polycarbonate-acrylonitrile-butadiene-styrene) were filled with polydimethylsiloxane (PDMS) 
and cured at 75°C for 1 h. The corneal and the eyelid pieces were then mounted on a special 
clip, which attaches to our blink platform.  
The platform consists of two mechanical actuators. The first motor moves the eyelid 
laterally to simulate the closing of the eye, spread of the TF, and intermittent air exposure 
(Figure 5-2A). The second motor rotates the corneal piece circularly when the two eye pieces 
come together to simulate the rubbing action produced during blinking (Figure 5-2B). The 
system is connected to a microfluidic syringe pump (PHD UltraTM, Harvard Apparatus), 
which injects ATS into the eye models at a physiological flow rate at 1.3 µL/min (Figure 5-2C). 




Figure 5-2. Lateral motion produces intermittent air exposure (A); Circular motion simulates rubbing 
action during blinking (B); tear fluid infusion into eyelid (C); OcuFlow platform (D). 
5.3.5 Experimental Outline 
For the vial incubation condition (1), six lenses of each type were immersed in a vial 
containing 3.5 mL of ATS with NBD-cholesterol for 12h at room temperature with shaking. 
For the eye model condition (2), six lenses of each type were placed on the OcuFlow model 
and allowed to run for 12h at room temperature with a flow rate at 1.3µL/min (2 mL/24h).  
At 4h and 12h, three lenses of each type were removed from each experimental condition, 
blot dried on lens paper, and prepared for imaging. These time intervals were chosen to 
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correspond to typical short wearing times found in part-time wearers of DD lenses and an all-
day daily CL wear time period. Using a hole-punch, 5 mm diameter discs were punched out 
from the centre of the CLs. The lens discs were then carefully mounted onto a piece of 22 x 40 
x 1 mm Fisherbrand® microscope glass cover slip (Fisher Scientific, Pittsburgh, PA). 40 µL of 
PBS was then carefully pipetted onto the lens disc, and a second glass cover slip was carefully 
placed on top. To secure the cover slip onto the microscope slide, a small amount of clear nail 
polish was applied to the sides of the cover glass using a pipette tip. 
5.3.6 Confocal Microscopy 
To image the slides, a Zeiss LSM 510 Meta LSCM (ZEISS Inc., Toronto, Canada) was used 
to both excite the NBD-cholesterol with an argon laser at 488 nm and to capture the emitted 
fluorescence at its peak wavelength of 528 nm by using a band pass filter of 505nm-530nm. 
The LSCM captured a series of consecutive images spaced 0.5 µm apart. The resulting images 
were rendered into a two-dimensional cross section using the ZEN 2009 light software (Zeiss). 
The fluorescence was recorded for every fourth image per sample using ImageJ (National 
Institute of Health, United States) and the subsequent data were averaged and corrected for the 
auto-fluorescence from the control lenses soaked in PBS and plotted on a histogram. Based on 
this plot, the depth of cholesterol penetration into the CL material over time was determined. 
By sustaining the identical laser settings for all CLs, a direct relationship can be drawn between 




5.3.7 Statistical Analysis 
IBM SPSS Statistics 23 for Macintosh (IBM Corp., Armonk, NY) software was used to 
conduct repeated measures analysis of variance (RM-ANOVA) and post-hoc Tukey’s multiple 
comparisons to test the impact of the incubation methods, CL materials, and incubation times 
on the lipid penetration. Statistical differences were considered significant for a P value of < 
0.05. The graphs were plotted using GraphPad Prism version 6.0h for Macintosh (GraphPad 
Software, La Jolla, CA).  
 
5.4 Results 
The RIF of accumulated NBD-cholesterol varied greatly between the tested lens materials 
and the tested incubation methods. A collage of the penetration patterns and a graphical 
illustration of the results are shown in Figure 5-3 and Figure 5-4, respectively. The results of 
the performed RM-ANOVA are shown in Table 5-3 and reveal that all three test variables were 




Table 5-3. Repeated measures ANOVA statistical results for cholesterol penetration comparing various 
incubation methods and contact lens materials 
Repeated Measures ANOVA statistical results for cholesterol penetration 




Square F P 
Incubation Methods 1094750.82 1 1094750.82 615.43 < 0.001 
Contact Lens Materials 2287925.12 6 381320.85 90.33 < 0.001 
Incubation Times 200928.78 1 200928.78 47.60 < 0.001 
Incubation Methods 
* Contact Lens Materials 475027.12 6 79171.19 44.507 < 0.001 
Contact Lens Materials 
* Incubation Times 193438.91 6 32239.82 7.64 < 0.001 
Incubation Methods 
* Incubation Times 7148.49 1 7148.49 4.02 0.045 
Incubation Methods 
* Contact Lens Materials 
* Incubation Times 
295658.03 6 49276.34 27.701 < 0.001 
Error (Incubation Methods) 2844359.78 1599 1778.84   
 
5.4.1 Impact of Contact Lens Material 
Overall, SiHy lens materials accumulated significantly more (P ≤ 0.001) of the 
fluorescently-labeled lipid than CHs, with the exception of nesofilcon A CLs (P ≥ 0.209), 
which showed similar amounts of accumulated NBD-cholesterol as the somofilcon A and 
narafilcon A lens materials. The general pattern found, after pooling all data points for each 
CL material and statistically comparing between them, was: delefilcon A > somofilcon A ≥ 
nesofilcon A ≥ narafilcon A > etafilcon A > ocufilcon B > nelfilcon A, with no statistically 
significant differences between the SiHy lenses (P ≥ 0.117). Within the CH materials, however, 
the differences of accumulated cholesterol were statistically significant (P ≤ 0.003), except 
between etafilcon A and ocufilcon B (P = 0.992). 
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After the 4 h vial incubation, the deposition sequence was the same as the previously listed 
general pattern, however, these differences were not statistically significant between all SiHy 
lenses (P ≥ 0.582), the SiHy lenses and nesofilcon A (P ≥ 0.721), as well as between etafilcon 
A and narafilcon A (P = 0.130), nesofilcon A (P = 0.141), and ocufilcon B (P = 1.000). The 
pattern after the 12 h vial incubation varied slightly and was: delefilcon A > narafilcon A > 
somofilcon A > nesofilcon A > etafilcon A > ocufilcon B > nelfilcon A. All those differences 
were statistically significant (P ≤ 0.012), except between delefilcon A and narafilcon A (P = 
1.000), somofilcon A and nesofilcon A (P = 0.989), and ocufilcon B and nelfilcon A (P = 
0.092). 
For the OcuFlow incubation method and after 4 h, the pattern was: delefilcon A > narafilcon 
A > somofilcon A > nesofilcon A > ocufilcon B > etafilcon A > nelfilcon A. All of the 
differences were significant (P ≤ 0.001), except between somofilcon A and narafilcon A (P = 
0.342) and etafilcon A (P = 1.000), narafilcon A and nesofilcon A (P = 0.451), etafilcon A and 
ocufilcon B (P = 1.000) and nelfilcon A (P = 0.978), and between ocufilcon B and nelfilcon A 
(P = 0.855). After 12 h of incubation, the pattern varied: nesofilcon A > somofilcon A > 
delefilcon A > etafilcon A > narafilcon A > ocufilcon B > nelfilcon A. All differences were 
statistically significant, except between nesofilcon A, somofilcon A (P = 0.973) and delefilcon 
A (P = 0.475), between delefilcon A, somofilcon (P = 0.827) and etafilcon A (P = 0.064), 
between narafilcon A and etafilcon A (P = 1.000), and between ocufilcon B, narafilcon A (P 
= 1.000), etafilcon A (P = 0.957), and nelfilcon A (P = 0.328). 
 
87 
Interestingly, the NBD-labeled cholesterol permeated through the entire thickness of the 
SiHy lens materials; the sole exception was in somofilcon A lenses, where the lipid only 
accumulated on the anterior and posterior margins (Figure 5-3A and Figure 5-3B). 
Unexpectedly, the CH lens material nesofilcon A revealed the same pattern of cholesterol 
penetration using both of the in vitro methods. Also, etafilcon A and ocufilcon A showed 
noteworthy penetration patterns after 4 h incubation with the vial method, where the NBD-
cholesterol was found to deposit in the front section of those lens materials. These penetration 
patterns however subsided after 12 h and lipid penetrated through the entire lens material 
thickness (Figure 5-3B) for both incubation methods. 
5.4.2 Impact of Incubation Method 
Based on the RIF and subsequent to both incubation times (4h and 12h), the uptake of the 
lipid was elevated considerably after 12h compared to the 4h exposure time for most lens 
materials. Figure 5-3 and Figure 5-4 depict substantial differences of NBD-cholesterol between 
our OcuFlow model and the common vial incubation method, with a superior amount of uptake 
and penetration using the latter in vitro procedure (P < 0.001). In particular, the general pattern 
of NBD-cholesterol accumulation for the incubation methods was ‘vial 12h’ > ‘vial 4h’ > 
‘OcuFlow 12h’ > ‘OcuFlow 4h’. All differences were statistically significant (P ≤ 0.007), 
except between the incubation times of the vial method (P = 0.109).  
Comparing the differences between the incubation methods within each CL material, the 
order of the general pattern changed slightly, nevertheless, the traditional vial method always 
showed greater amounts of accumulated NBD-cholesterol over the OcuFlow platform. 
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Interestingly, somofilcon A, delefilcon A, nesofilcon A, and ocufilcon B showed higher rates 
of accumulated NBD-cholesterol after 4h of vial incubation compared to 12h. This, however, 
was only statistically significant for delefilcon A and ocufilcon B CLs (P ≤ 0.001). Most of the 
CLs accumulated the lowest amount of lipid after the 4h incubation using the in vitro platform, 
except for narafilcon A, that showed the least overall amount of NBD-cholesterol after 12h 
incubation with the OcuFlow, which however was not statistically significant (P = 0.833) 













Figure 5-3. Confocal images showing a cross-section of etafilcon A, nelfilcon A, nesofilcon A, 
ocufilcon, delefilcon A, somofilcon A, narafilcon A after incubation with NBD-cholesterol in the vial 

































Figure 5-4. Histograms representing the 
different incubation methods: OcuFlow after 
4h (∎), OcuFlow after 12h (∎), vial after 4h 
(∎), and vial incubation after 12h (∎); as well 
as depth of absorption of NBD-cholesterol of 
various contact lenses: etafilcon A (A), 
nelfilcon A (B), nesofilcon A (C), ocufilcon A 
(D), delefilcon A (E), somofilcon A (F), 
narafilcon A (G). The values plotted are the 








5.5 Discussion  
In recent years, researchers have recognized the various limitations 375-379, 461 of using a vial 
as an in vitro method for evaluating their interactions with tear-film components (Figure 5-5). 
Subsequently, to better simulate the ocular environment, several unique in vitro eye models 
have been developed such as the inclusion of a microfluidic tear replenishment component,375-
379, 461 intermittent air exposure,266 and/or a mechanism of in vivo fouling of soft contact 
lenses.270 Not surprisingly, the results generated from these experiments are very different than 
those obtained with the conventional vial model and might more closely resemble in vivo 
data.266, 270, 375-379, 461 Our unique eye model incorporates multiple key elements of the ocular 
environment, including tear flow, tear volume, air exposure, and mechanical rubbing, to 





Figure 5-5. Drawbacks of using a simple vial 
model to evaluate contact lenses. 
 
Being able to correctly visualize the localization of lipid deposits on CLs provides a better 
understanding on how the deposition of certain tear elements could progressively lead to 
discomfort. Previous research has been limited to quantifying lipid deposits on CLs, which 
provided useful data for comparing the relative performance of different CLs.58, 61, 62, 257, 260, 266, 
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325 However, to fully understand the mechanism leading to discomfort, it is also important to 
characterize how lipids penetrate the lens material over time.  
Conventional methods of evaluating tear fluid (TF) deposition on CL have been performed 
in vials. As shown in Figure 5-5, there are several drawbacks when CLs are evaluated in this 
manner, which may significantly skew the results of lipid deposition on CLs. In particular, the 
high incubation volume and the incorrect horizontal orientation of the CL will facilitate lipid 
deposition on the CL, leading to an overestimation of lipid deposits. Not surprisingly, the 
penetration and fluorescence intensity of NBD-cholesterol for all materials were considerably 
higher in the vial than the eye model, especially after 4h of incubation time. Furthermore, we 
also observed uncharacteristic deposition patterns for two CH, etafilcon A and ocufilcon B in 
the vial, but not in the eye model. Typically, CH hydrogels are hydrophilic and therefore do 
not absorb a high quantity of lipids.58, 61, 62, 257, 260, 266 However, as seen in Figure 5-3, more 
cholesterol penetration was seen in etafilcon A and ocufilcon B within their lens matrix when 
incubated using a vial at 4h. After 12h of incubation time, the uncharacteristic deposition 
pattern for these two CHs subsided and the fluorescence intensity of NBD-cholesterol 
decreased. We speculate that this effect could be due to the diffusion of the lipid through the 
lens materials over time. Most likely, there was no further accumulation of cholesterol within 
the 4h and 12h time-points but instead more of a “spreading” (i.e. balancing out) of the lipid 
within the CL materials. Therefore, the total amount of lipid deposited may be similar between 
the time-points; however, the fluorescence intensity appears vastly different because the NBD-
cholesterol is distributed more uniformly after 12h than 4h. This inconsistency also highlights 
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the drawback of using a vial in which the CL is positioned horizontally. In this orientation, the 
deposition of TF on the CL is partially facilitated by gravity, rather than the material properties 
of the CL. In contrast, these artifacts were not observed in the OcuFlow, which can be 
attributed to the unique vertical orientation of the CL on the model. 
For most part, there was still a strong agreement between the vial and the model in regards 
to the overall pattern of lipid penetration and deposition on the materials. For instance, both 
conditions showed that there was no lipid penetration in the matrix of the lens for nesofilcon 
A (CH) and somofilcon A (SiHy) at either the 4h or 12h time-point. With the exception of 
nelfilcon A, cholesterol deposition and penetration increased between 4h and 12h for all lens 
types in both the vial and the OcuFlow model. Similar and consistent patterns in lipid 
penetration was also observed for nelfilcon A, delefilcon A, and narafilcon A. The penetration 
and fluorescence intensity was higher in SiHy than CH CLs in both models. Therefore, results 
from the vial experiments could still be considered relevant for evaluating the relative 
performance of CLs in regards to lipid deposition.325  
For commercially available CH and SiHy lenses, the effective pore sizes are approximately 
150 nm.205 The molecular size of cholesterol is estimated to be 1.6 nm across its length.462 
Since none of the DD CLs used in this study were surface coated, we expected that NBD-
cholesterol would be able to penetrate throughout the lens material.462 Interestingly, for some 
lens materials, such as nesofilcon A (CH) and somofilcon A (SiHy), cholesterol was localized 
mostly on the surface of the lens but not within the polymer matrix, even after 12h. The reasons 
for this lipid localization is unclear. We propose that it could be due to a structural arrangement 
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of the polymers within these lenses, which favors binding to NBD-cholesterol at the surface. 
Furthermore, this interaction is likely not solely due to hydrophobic interactions, but rather the 
result of side chains between the polymer and the lipid. Other lenses, such as delefilcon A and 
narafilcon A, also exhibited a similar deposition pattern after 12h for the OcuFlow system. 
Interestingly, nelfilcon A showed almost no sign of cholesterol penetration even after 12h. 
An important property that cannot be simulated in a vial incubation is the formation of the 
pre- and post-lens TF, created when the CL sits on the cornea in vivo. While the pre-lens TF is 
continually replenished, there is very little tear exchange occurring behind the post-lens TF.463-
465 Consequently, we initially expected that there would be minimal lipid deposition occurring 
on the posterior side of the lens. To date, there are few studies that have investigated the 
differential deposition of TF on CLs, but this observation has been noted previously with the 
deposition of vitronectin.466 However, even using the OcuFlow model, we were unable to 
observe a significant difference between the front and back surface deposition for NBD-
cholesterol. This suggests that there is enough CL distortion and movement to allow for 
sufficient tear fluid to deposit on the back surface of the lens.467 One of the problems with our 
current model is that the eyepiece is synthesized from polydimethylsiloxane (PDMS), a highly 
hydrophobic material. As such, the post-lens seal created between the eyepiece and the contact 
lens in our model may be less tight and, thus, may not yet achieve the perfect fit that an in vivo 
lens does on the eye. As a result, as the eyelid piece presses on the corneal piece, there is 
enough pressure to force fluid beneath the lens. We predict that using a more hydrophilic 
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material for the eye-piece will generate a different penetration profile for the back surface of 
the CL and this warrants further experimentation.  
LSCM can provide useful insights on how tear components are absorbed within a lens 
material.233, 357 However, one of the main drawbacks in using fluorescently-labelled probes, 
such as NBD-cholesterol, is the assumption that the labelled compound will behave similarly 
as its native counterpart. In the case of NBD-cholesterol, the fluorophore contains functional 
groups not found on the native lipid, which may interact differently with the lens materials. In 
addition, the fluorescently tagged lipid mass (494.63 g/mol) is significantly higher than the 
mass of the native cholesterol (386.65 g/mol). To our knowledge, there are no studies that 
compare the sorption of cholesterol and NBD-cholesterol on CLs. However, a study evaluating 
sorption of fluorescently-labeled proteins on hydrogels has shown that CLs adsorb labelled 
proteins much higher than native proteins, and the effect is significantly pronounced for 
silicone hydrogels.468 Consequently, quantitative determinations of lipid deposition based on 
fluorescently-tagged lipids may be unreliable. However, for visualizing deposition patterns on 
CLs, we do not expect major significant differences between NBD-cholesterol and cholesterol, 
as both molecules are relatively small and hydrophobic. 
In conclusion, the OcuFlow system presented in this study can be used as a model to 
evaluate lipid deposition on CLs. The platform mimics key ocular parameters and can replace 
conventional vial-based studies to provide better insights on the performance of CLs on the 
eye. The localization of lipid deposits and penetration on a CL, in tandem with the amount 
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deposited, may play a significant role in determining CL discomfort. The current system 
described here can also be extended to evaluate deposition of other tear components. 
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In this next chapter, a novel in vitro method will be presented to determine tear break-up times 
over CLs and comparisons of NIBUTs over different commercially available DD lens 
materials using this method, will be made.  
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To develop a novel, in vitro model to determine pre-lens non-invasive break-up time 
(NIBUT) and to subsequently use this method to compare the NIBUT over five contemporary 
daily disposable (DD) contact lenses (CL). 
6.1.2 Methods 
Three silicone hydrogel (SiHy) and two conventional hydrogel (CH) DD lens materials 
were incubated in an artificial tear solution (ATS) containing a variety of proteins and lipids. 
A device designed to model the drying effect that occurs on lens surfaces during the inter-blink 
interval (a model blink cell; MBC) was utilized to mimic intermittent air exposure. CLs were 
incubated by repeatedly being submerged for 3 seconds (s) and exposed to air for 10 s over 
periods of 2, 6, 12, and 16 hours (h). NIBUTs over the CL materials (n=4) were determined 
out of the blister pack (T0) and at the end of the incubation period. To measure NIBUTs, a 
corneal topographer (CA-100, Topcon Canada) was used to illuminate the lens surfaces and 
the reflected placido ring images on the lens surfaces were captured with a digital video camera 
(Canon-XA10). 
6.1.3 Results 
Overall, NIBUTs ranged from 26.19 ± 5.79 s to 1.23 ± 0.13 s, with nesofilcon A showing 
the longest NIBUT (P <0.001). At T0, CH CLs revealed significantly longer NIBUT (P ≤0.001) 
than SiHy CLs. After 2 h, nesofilcon A showed the longest NIBUT, however, this was only 
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statistically significant compared with delefilcon A (P ≤ 0.001). After 6 h, nesofilcon A NIBUT 
was significantly longer than all other CLs (P ≤ 0.001). Etafilcon A showed a significantly 
superior NIBUT (P ≤ 0.001) over all other CLs after 12 h and delefilcon A had the longest 
break-up time (P ≤ 0.001) after 16 h of incubation. Statistically significant (P ≤ 0.05) changes 
of NIBUT within the lens materials varied between the examined time points. NIBUT 
decreased significantly (P ≤ 0.002) between T0 and 2 h for all CLs, except for somofilcon A 
(P = 0.728). After 16 h, all CLs showed significant reductions in NIBUTs (P ≤ 0.001) in 
comparison to T0. 
6.1.4 Conclusion 
NIBUT values reduced gradually over time and varying levels of deposition on different 
CLs impacted the measured pre-lens NIBUT of various lens materials. While NIBUT of CH 
materials are longer than that obtained with SiHy materials immediately out of the blister pack, 
it appears that after TF exposure, the NIBUTs obtained between CH and SiHy DD materials 
are very similar. 
6.1.5 Keywords 






Contact lenses (CL) are a very convenient and common device to correct vision and are 
available in a wide variety of materials.186, 469 Most wearers use soft lenses, which are typically 
replaced after time periods between 1 day and 4 weeks.396 Although CLs are effective at 
correcting vision, they remain plagued by issues associated with end of day dryness and 
discomfort,175, 197, 198, 216 which may lead to cessation of CL wear or “contact lens dropout”.197, 
198, 201, 470, 471  
One way to improve the performance of CLs (and potentially reduce dropouts) is to increase 
the replacement frequency of CLs.275 The ultimate for this concept is to replace lenses every 
day, and daily disposable (DD) CLs were introduced in the mid-1990’s 424, 425, 429, 430 and 
continue to increase in popularity.396, 447, 472 Their use has been associated with a decrease in 
CL-related inflammation,437 microbial keratitis,434 improved overall comfort and visual 
acuity,473 and reduced tear film (TF) deposits.325, 429, 452, 473, 474  
The pre-corneal TF coats the ocular surface to prevent dehydration, nourish the cornea, and 
provide a smooth layer for clear vision.98, 475, 476 To carry out all of these functions, the integrity 
and stability of the TF is important and if the stability of the TF over the lens surface is poor, 
then CL-related complications may arise.79, 105, 215, 477 The TF is a complex structure composed 
of a wide variety of mucins, proteins, lipids, and salts that are organized in a certain order.175 
When CLs are placed onto the ocular surface they disrupt the TF by splitting it into a pre- and 
post-lens TF 175 and by accumulating TF proteins 237, 239 and lipids.62, 63, 257, 268, 275 These 
 
101 
processes result in decreased TF stability compared with that seen without a lens in place.98, 
215, 477 
TF stability is commonly measured through the determination of the tear break-up time 
(TBUT), which measures the thinning/instability of the TF layer 98, 478 and can be tested 
invasively or non-invasively.98, 385 To measure the stability invasively, a small amount of 
sodium fluorescein is added to the TF on the ocular surface to permit the visualization of the 
TF.478 However, this method changes the physiological TF integrity and leads to a reduced 
TBUT compared with measures that do not disturb the TF.479, 480 By projecting various grids 
or patterns onto the TF overlying the cornea, it is possible to measure TBUT non-invasively 
(NIBUT).481, 482 Most methods to determine NIBUT utilize a topographer that projects uniform 
placido ring mires onto the patients’ ocular surface and any changes in the structure of these 
mires depict a break-up of the TF.98, 481, 482 Average BUTs in normal eyes are often >20 seconds 
(s), where <10 s is considered abnormal and ≤ 5 s is often associated with dry eye symptoms,479, 
483 whereas during CL wear BUTs generally lie between 3 to 10 s.98, 175, 238, 453, 484-487 
To-date, very little data exists on the NIBUTs associated with DD lens materials. Given 
their increasing popularity this study sought to develop a novel in vitro model to determine 
pre-lens NIBUTs and to subsequently use this method to compare NIBUTs between various 
contemporary DD CLs.  
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6.3 Material & Methods 
6.3.1 Contact lenses and pre-treatment 
Three silicone hydrogel (SiHy) lenses [delefilcon A (Alcon), somofilcon A (CooperVision), 
narafilcon A (Johnson & Johnson)], and two commercially available conventional hydrogel 
(CH) DD CLs [etafilcon A (Johnson & Johnson), nesofilcon A (Bausch+Lomb)] were 
evaluated in this study. All lenses had a dioptric power of -3.00 and base curve of 8.5 or 8.6 
mm and were obtained from the manufacturer in the original commercial packaging. Table 6-1 
details the properties of the CLs examined. 
Table 6-1. Properties of the contact lenses used in the study. 











United States adopted 
name (USAN) delefilcon A somofilcon A narafilcon A etafilcon A 
nesolfilcon 
A 





Water content (%) 33% (surface >80%) 56% 46% 58% 78% 
FDA group V V V IV II 
Centre thickness (mm) 0.09 0.07 0.09 0.08 0.05 
Oxygen permeability 
(x10-11) 140 60 100 28 42 
Oxygen transmissibility 
(x10-9) 156 86 118 25.5 42 









USAN: United States Adopted Names FDA: Food and Drug Administration HEMA, hydroxyethyl 
methacrylate; MA, methacrylic acid; PVP, polyvinyl pyrrolidone; NVP, N-vinylpyrrolidone; DMA, N,N-




6.3.2 Artificial Tear Solution  
The composition of the artificial tear solution (ATS) used has been previously reported.61 
In short, the solution contains various lipids (oleic acid methyl ester, cholesterol, triolein, 
phosphatidylcholine, cholesteryl oleate, and oleic acid), various salts, urea, glucose, proteins 
(lysozyme and hen egg albumin), and mucin, the concentrations of which were based on those 
in normal human tears.61 
6.3.3 Model Blink Cell 
A model blink cell (MBC) was utilized to incubate the CLs in the ATS. The MBC used in 
this study is an updated version to that which has been previously described by our group,266 
which enables us to incubate up to 48 CLs at a time. Specifically, it is composed of a 
polytetrafluoroethylene (PTFE/Teflon™) trough that is divided into 4 chambers that can each 
be filled with 250 mL of the ATS test solution. Each CL is placed on a Teflon button (Figure 
6-1A) that is positioned on a Teflon plate, which is attached to a motor that raises and lowers 
the plate in and out of the test solution. In order to further secure the CLs and prevent them 
from floating off the Teflon buttons, each lens is held in place with a clip. A gap of 100 µm 
between the button and clip-on allows the CLs to float freely and prevents the mounted CLs 
from getting damaged. Furthermore, the mechanics are set up within an environmental 




    
Figure 6-1. Teflon button for holding lenses (A) and Model Blink cell controlled environmental 
chamber (B).  
6.3.4 Topographer 
To measure the NIBUTs, we utilized a corneal topographer (CA-100, Topcon Canada) to 
illuminate the upper CL surfaces and project a uniform Placido ring structure onto them (Figure 
6-2 & Figure 6-3). An additional video camera (Canon-XA10; Figure 6-2) was used to capture 
the changes of the Placido ring appearance by recording the LCD on the topographer.  
 









Figure 6-3. Placido ring image over a “fresh” contact lens (A) and a dried-up lens surface (B). The 
smooth rings in A compared with the irregular rings in B indicate the difference between a confluent 
and a broken tear layer. 
6.3.5 Experimental Outline 
At the start of the experiment, four lenses of each type were taken out of the blister pack, 
placed onto a Teflon button in the MBC, and the initial (T0) NIBUT was measured. Thereafter, 
the CLs were submerged in the ATS for 3 s and exposed to air for 10 s, to mimic intermittent 
air exposure. The environment in the MBC chamber was set at a humidity of 50±5% and a 
temperature of 34±4°C. After 2, 6, 12, and 16 h of incubation each lens was raised into focus 
of the topographer and the BUTs were determined. After each measurement was taken, the 
lenses continued to cycle in and out of the ATS until the 16 h time-point. 
6.3.6 Data Analysis 
NIBUTs were determined by analysing the recorded videos manually by comparing the 
video sequences frame by frame until a significant change in the structure of the mires 
occurred. To achieve this, we focused on the innermost 6 to 8 concentric rings reflected from 
a CL, compared the initial Placido ring structure, once it came out of solution, and measured 




who recorded the first disruption in the mires was masked as to the lens material and time of 
ATS exposure during this process.  
  
Figure 6-4. In vitro placido ring images retrieved from the experiment; T0 (A) and first break-up 
(13 sec) over lens material (B) 
After assessing the NIBUTs of every lens material, data analysis was conducted using 
repeated measures-analysis of variance (RM-ANOVA) and univariate analysis to test for any 
significance within each time-point and lens material, using SPSS Statistics 23. An alpha level 
of P < 0.05 was considered significant. Individual differences were analyzed using a Tukey 
post-hoc analysis.  
6.4 Results 
The results of the study are reported in Table 6-2, Table 6-3, and Figure 6-5. Table 6-2 
illustrates that the NIBUT measurements depended significantly on the duration of incubation, 
the type of CL material, as well as the interaction between these factors (P < 0.001). When a 
general comparison was made between all tested CL types (all time-points pooled), CH lens 
materials showed significantly greater NIBUTs than SiHy lenses (P ≤ 0.001), but no significant 




(P ≥ 0.912). Nesofilcon A had the longest average NIBUT of all tested CLs, with this 
difference being significant (P ≤ 0.001) over the SiHy materials only. 
Table 6-2. Repeated-measures analysis of variance statistical results for NIBUTs over various DD 
contact lens materials 
 
Table 6-3. NIBUT over contact lenses in seconds (mean ± SD) 
USAN: United States Adopted Names 
 
As shown in Table 6-3, at T0, the two CH lenses revealed significantly longer NIBUTs (P 
≤ 0.001) than all three SiHy materials, but no significant difference was found between the two 
CH lens materials (P = 0.262) or the SiHys (P ≥ 0.984). After 2 h of lens incubation, delefilcon 
A showed the shortest NIBUT (P ≤ 0.037) in comparison to all other CLs and etafilcon A 
presented the longest NIBUT; however, this was only statistically significant compared with 
delefilcon A (P ≤ 0.001). After 6 h, the NIBUT of etafilcon A was significantly longer than all 
other examined CLs (P ≤ 0.001). After 12 h of incubation, the CH nesofilcon A showed a 
Repeated-measures analysis of variance statistical results for NIBUTs across time 




square F P 
Duration of incubation 2608.09 4 651.02 343.94 <0.001 
CL material 351.11 4 87.78 34.44 <0.001 
Incubation time 
* CL material 665.99 16 41.62 21.99 <0.001 
Error 113.57 60 1.89   
USAN Delefilcon A Somofilcon A Narafilcon B Etafilcon A Nesofilcon A 
T0 11.44 ± 1.76 11.81 ± 0.61 10.79 ± 0.64 26.20 ± 5.79 22.00 ± 1.32 
2 h 8.66 ± 0.22 11.30 ± 1.08 12.85 ± 1.03 13.81 ± 0.60 13.48 ± 2.00 
6 h 7.86 ± 0.18 8.54 ± 0.52 7.33 ± 0.18 13.29 ± 1.78 8.60 ± 0.48 
12 h 4.76 ± 0.20 3.64 ± 0.26 3.74 ± 0.15 3.03 ± 0.67 6.13 ± 0.36 
16 h 3.60 ± 0.26 2.77 ± 0.31 1.23 ± 0.13 1.84 ± 0.37 2.70 ± 0.31 
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statistically superior NIBUT over all other tested CLs (P ≤ 0.001). With a NIBUT of 3.6 ± 0.26 
s, delefilcon A had the longest BUT after 16 h of incubation and this difference was significant 
(P ≤ 0.001). 
Statistically significant (P ≤ 0.05) changes of NIBUT within the lens materials varied 
between time-points. Overall, NIBUT decreased significantly (P ≤ 0.002) between T0 and 2 h 
for all CLs, except for somofilcon A (P = 0.728) - which showed no relevant change - and 
narafilcon B, which marginally increased. NIBUT between T0 and 6, 12, and 16 h was 
significantly lower for all CLs (P ≤ 0.001). For delefilcon A, the reduction in NIBUTs was 
statistically significant (P ≤ 0.001) among most of the time-points, except between 2h-6h and 
12h-16h (P = 0.638 and P = 0.299, respectively). For somofilcon A lenses, we found 
statistically significant difference in NIBUT decrease amongst all time-points (P ≤ 0.002), 
except between T0-2h and 12h-16h (P = 0.782 and P = 0.328, respectively). As mentioned 
above, narafilcon B revealed an increase of NIBUT after 2h of incubation, whereas, all other 
time-points showed a continuous decrease in NIBUT. All differences between the time-points 
within narafilcon B were statistically significant (P ≤ 0.001). For etafilcon A, statistically 
significant differences (P ≤ 0.045) in NIBUT were found between all time-points. Nesofilcon 
A showed significant reduction differences (P ≤ 0.001) amongst some time-points, except 















Figure 6-5. Histogram representing the NIBUTs for the five daily disposable materials for up to 16 





6.5 Discussion  
The purpose of this study was to develop an in vitro model which could be used to determine 
pre-lens NIBUT values and to subsequently use this concept to compare the NIBUT of 
contemporary CH and SiHy DD materials over a period of 16 hours. The in vitro model used 
a methodology in which lenses were incubated in an ATS that mimicked the composition of 
the TF and during their incubation were intermittently exposed to the air, in an attempt to better 
mimic in vivo CL wear. In general, we found that the NIBUTs for CH were longer than those 
for SiHy materials, particularly when immediately removed from the blister pack, and that the 
NIBUTs for all materials reduced gradually over time. 
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Close inspection of Figure 6-5 shows graphically how the NIBUTs reduced with increasing 
exposure to the ATS over time. Of interest, is that the NIBUT reduced for all materials, such 
that after 16 h the differences in NIBUT were relatively small, as compared with the T0 times, 
in which the CH materials had clearly longer NIBUT. It would appear that over time, exposure 
to the ATS and the MBC doping procedure was a great “leveler”, with this process reducing 
any major differences in NIBUT between all 5 materials.  
The most likely reason for this reduction in NIBUT relates to deposition of the lenses with 
components of the ATS. Previous work has shown that, on average, CH materials tend to 
preferentially deposit proteins (particularly group IV materials such as etafilcon A, which has 
a strong attraction for lysozyme)160, 225, 229, 235, 239, 332, 390, 488 and SiHy materials tend to 
preferentially deposit lipids.58, 62, 160, 187, 257, 260, 268 This deposition holds true even for those 
materials replaced on a DD basis such as those examined in this study.229, 254, 260, 325, 332, 489 It is 
likely that the progressive accumulation of deposition over the course of the day, regardless of 
its type, resulted in a gradual reduction in surface wettability, measured by a reduction in 
NIBUT. To-date, there are no studies that have attempted to directly link levels of increasing 
deposition with reducing NIBUT, and thus our suggestion that increasing deposition led to the 
reduction in NIBUT remains a hypothesis only. However, several studies have shown that 
deposition is cumulative,63, 229, 234, 235, 237, 254, 325, 332, 388, 489-496 that pre-lens NIBUT is often lower 
after a period of wear 255, 486 (although not always)497 and that comfort reduces both over the 
day and across the replacement period.275  
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It is of interest to compare these in vitro results with previously published in vivo values for 
T0 NIBUTs. The results of this study for the SiHy materials are nearly two times longer than 
previously published results, with Varikooty et al 453 and Kojima et al 487 reporting in eye pre-
lens NIBUT values of 5 to 8 s. For the CH CLs, the same relative difference is observed, with 
T0 NIBUTs in this study being over 20 s, whereas in vivo data reported for CH materials are 
typically half this or lower.406 These differences may exist for a variety of reasons. One 
difference between our in vitro setup and the in-eye situation relates to the large amount of 
ATS the lenses were exposed to (250mL), compared to the physiological levels of tears that 
are available at any given time (3mL/24h).457, 458, 498 This may impact the data in two ways. 
Firstly, the volume of tears sorbed to the lenses in the in vitro test may result in reduced 
dehydration during the time that the lenses are exposed to the air, as excess fluid may 
accumulate on the lens surface. Previous work by our group has shown that deposition is 
influenced by the degree to which lenses dehydrate.266 Thus, different levels of deposition 
between the lenses in this in vitro analysis may occur compared with that seen in eye, which 
could impact the subsequent NIBUT determined. Secondly, the excess amount of ATS would 
provide greater amounts of protein and lipid to be available to deposit on the lens materials 
than that seen in eye, again potentially impacting the NIBUT recorded. Previous work by us 
has shown that greater amounts of available lipid results in more lipid deposition63 and that the 
amounts of proteins and lipids (and their relative concentrations) can impact lens deposition, 
particularly on SiHy materials.62, 331 The deposition of lipid or denatured protein on lens 
materials may increase the hydrophobic nature of the lens surfaces, reducing the NIBUT. 
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Another aspect to consider that may help to explain these differences relate to the mounting of 
the lenses during the deposition process. The CLs in this experiment are mounted horizontally 
within the MBC rather than vertically, as they are when worn. This exerts a different force on 
the tear spreading over the lens surface, which may affect the observed NIBUTs and drying 
patterns. In addition, the MBC does not take the mechanical contribution of the blink of the 
eyelids into account. The eyelids, and the lid margins in particular, are thought to play a major 
role in the spread of the TF.499, 500 The lids help to redistribute and re-establish the formation 
of the TF layers as the lids open. The meibum lipids that are expressed and secreted by the lids 
as we blink play a crucial role in stabilizing the TF and preventing TF evaporation, which 
affects the measured BUTs.54, 70, 98, 477, 498 In our MBC model, the lipids are fully incorporated 
and solubilized in the ATS, creating a homogeneous mixture, and will therefore not form an 
outermost layer that could retard the dehydration of the TF, which may lead to faster NIBUTs 
than in vivo data shows. 238, 484, 485 
To our knowledge, this is the only study to present kinetic data over a day that investigates 
NIBUT over CH and SiHy materials so we are unable to determine how these values compare 
with previous data using other methods. One previous study examined pre-lens NIBUT over 
two CH materials after 5 hours 486 and found that the NIBUT only reduced for wearers who 
were symptomatic, with asymptomatic wearers showing no such reduction in wettability. 
Varikooty et al 453 tested tear breakup after 8h of SiHy CL wear and recorded times between 
5.8 s (delefilcon A) and 4 s (narafilcon B) over the CLs. Our NIBUT measurements after 6-
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12h are in line with these results, suggesting that our in vitro method for these time periods are 
comparable to in vivo studies.  
One limitation of our methodology is that we determined the pre-lens NIBUTs manually, 
which could result in subjective bias when determining the first break in the projected placido 
pattern occurred. However, the observers were masked and thus any observations would be 
biased equally across all lenses equally. Ideally, all videos would be examined using automated 
software that would recognize such a distortion and this process is being undertaken.501 
In conclusion, we have developed a system to measure pre-lens NIBUTs over CLs in vitro 
that exposes the lens materials to an ATS that mimics the composition of the TF and 
incorporates the lens surface drying that occurs during the inter-blink period. Using this 
system, we were able to obtain in vitro data that, after 6 hours of TF exposure, is comparable 
to in vivo data. While NIBUT of CH materials are longer than that obtained with SiHy 
materials immediately out of the blister pack, it appears that after TF exposure the NIBUTs 
obtained between CH and SiHy DD materials are very similar. Further work is warranted in 
which the pre-lens NIBUT is determined over the course of the day to determine if a 
progressive reduction does occur and, if so, whether such a difference is mitigated by the 













In this final chapter, different commercially available assays for oxidative stress will be 
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Tear film (TF) lipids create a protective layer to prevent tear evaporation. Oxidation 
degrades lipids and can lead to tissue damage, which can cause alterations in the tear lipid layer 
resulting in symptoms of dry eye (DE). The purpose of this project was to optimize and develop 
a method to determine and quantify lipid peroxidation by-products that will indicate oxidative 
stress in tears, such as malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), and oxidized 
low-density lipoproteins (OxLDL). 
7.1.2 Methods 
Tear samples were collected from 10 volunteers, using calibrated disposable capillary tubes 
(Drummond Scientific Company). A volume of 5 µL/eye was collected and transferred into a 
0.1 mL sterilized plastic vial, capped, spun down with a centrifuge, and lyophilized to dryness 
for long-term storage (-80°C) until further analysis. Various assays that quantify lipid 
peroxidation by-products were compared against each other: thiobarbituric acid reactive 
substances (TBARS) assay, MDA-, 4-HNE-, and OxLDL-ELISA (enzyme-linked 
immunosorbent) assays. Pooled and individual tear samples were diluted in a wide range (10 
μL to 0.5 μL and 2 µL to 0.5 µL, respectively) to determine the lowest volume of tears that 
could be used with the assays. Subsequently, the samples’ fluorescence was measured with a 
fluorescence spectrophotometer at 530 nm (excitation) and 590 nm (emission), and absorbance 




The concordance correlation coefficient of all assays showed high linearity (R2≥0.989) and 
thus were judged as reliable techniques to measure oxidized lipids. For TBARS, the detected 
MDA of individual tear samples were below the limit of detection (LOD) of the assay. 
However, after tear samples were pooled and concentrated, 0.056±0.004 µM MDA could be 
measured. For the OxLDL ELISA, in pooled and diluted tears between 71.39 ± 3.78 ng/mL to 
28.81 ± 2.29 ng/mL were detected. When testing with individual tear samples (2.5µL), OxLDL 
ranged between 45.59 ± 2.95 ng/mL and 28.24 ± 4.66 ng/mL. All measurements using the 
MDA- and 4-HNE-Adduct ELISA assay were below the LOD. 
7.1.4 Conclusion 
Assays for oxidative stress were optimized for the use of tear samples and showed that 
oxidative stress is detectible in small quantities of tears (2.5 µL). Thus, these techniques could 
be employed to determine oxidative stress in TF lipids, which could potentially help to identify 
patients with dry eye and contact lens discomfort. 
7.1.5 Keywords 




The pre-corneal tear film (TF) is a protective and functional layer that serves to shield the 
cornea from the air and also provides some nutritional benefits.75 It is composed of a wide 
array of elements but can be simplified into a mucin, an aqueous, and a lipid layer.2, 68 The 
interactions between the outermost lipid layer and the underlying aqueous phase are of 
especially high value to prevent TF evaporation and dry eyes (DE).442 The lipid layer provides 
a protective film to avert TF evaporation 442 and consists of two main lipid groups and layers: 
an outermost layer that mainly consists of non-polar lipids that help stabilize the TF layer, and 
polar lipids that link the hydrophobic non-polar lipid phase with the hydrophilic aqueous 
phase.48, 54, 502 The innermost polar phase consists of amphiphilic lipids (phospholipids, 
sphingomyelin, ceramides, and long chain (O-acyl)-ω-hydroxy fatty acid (OAHFA)) 2, 33, 37, 42, 
68, 503, 504 that contain both hydrophilic and hydrophobic functional groups, allowing them to 
interact with water and lipids at the same time and, thus, function as mediators.48, 54, 502  
Lipids are thus major TF components that stabilize the tear film, protect the cornea, and 
prevent the evaporation of the aqueous layer.75 Among normal individuals, the lipid 
composition is fairly similar but the quality of the lipids change in people with DE symptoms 
and/or meibomian gland dysfunction (MGD).45, 349, 356 Structurally, most lipids are typically 
composed of long carbon chains (or cyclic groups in the case of sterols), which are defined by 
their degree of saturation. Unsaturated lipids contain one or more double carbon bonds, with 
each additional double bond increasing the degree of unsaturation of the molecule.56 The 
amphiphilic lipids of the polar phase may contain unsaturated fatty acids that are affected by 
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oxidation or phospholipids may undergo enzymatic lipolysis (through secretory phospholipase 
A2), which degrades lipids, and might cause deterioration of the native lipid structure, loss of 
functionality, and, may subsequently cause tissue or cell damage due to the formation of toxic 
species.56, 97, 125, 126, 128, 129, 132-134 Some of the external stress factors that cause lipid oxidation 
are wind, extreme temperatures, UV radiation, pollutants, irritants, and smoke.108, 132, 135-137 
Lipid peroxidation is known to be influential in the development of Alzheimer’s disease, 
Parkinson’s,138, 139 and cancer,135 and in the eye specifically, lipid oxidation is associated with 
age-related macular degeneration,140, 141 DE,137, 142, 143 uveitis,144 cataract,145-148 and keratitis.135, 
149 
To determine oxidative stress in blood and serum samples of humans, studies have shown 
that a thiobarbituric acid reactive substances (TBARS) assay or MDA/4-HNE ELISA kits are 
efficient procedures to obtain the amount of oxidative stress.128, 133, 142, 152, 153, 361, 362 These 
colorimetric methods measure the amount of the by-products malondialdehyde (MDA), 4-
hydroxynonenal (4-HNE), and oxidized low-density lipoproteins (Ox-LDL) that occur during 
the lipid peroxidation process.128, 133, 142, 150, 152, 153, 161, 361-364 Because these methods are 
primarily used to measure the oxidative stress in blood or serum, which are available in higher 
volumes than that possible in the collection of tears, the commercially available kits need to 
be optimized in order to examine human tears. To our knowledge, to-date only a few studies 
have investigated the amount of lipid peroxidation by-products in tears of DE patients and 
contact lens (CL) wearers. 106, 125, 142, 156, 159, 162, 163, 365 These studies found increased quantities 
of oxidative stress inhibitors in intolerant CL wearers,125 CLs,156, 365 the elderly,106 and DE 
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patients.142, 159, 162 Because a high rate of oxidative stress in human cells has been shown to be 
associated with diseases that are caused by cell death due to lipid oxidation,133 oxidative stress 
in the TF might be a possible cause for DE. 
To be able to assess lipid oxidation in tears, the objective of this project was to establish a 
sensitive method to detect natural by-products of lipid peroxidation and determine the amount 
of oxidative stress in the TF. The results from this project might provide previously unavailable 
information about the pathophysiology of DE by providing an insight into the cause of DE 
disease. 
7.3 Materials and Methods 
7.3.1 Tear Samples & Collection 
Tear samples were collected from volunteer participants using calibrated disposable 
capillary tubes (Drummond Scientific Company, Broomall). A maximum amount of 5 µL/eye 
was collected and transferred into a 0.1 mL sterilized plastic vial, capped, spun down with a 
centrifuge, and lyophilized to dryness for long-term storage (-80°C) until further analysis.  
7.3.2 Test Assays  




7.3.2.1 Thiobarbituric Acid Reactive Substances Assay 
The Thiobarbituric Acid Reactive Substances (TBARS; Cayman Chemicals Company, Ann 
Arbot, MI)505 kit is a standardized assay to measure lipid peroxidation in cells by measuring 
the amount of MDA present in a sample (Figure 7-1). After TF collections, samples were 
diluted (ranging from 6 µL to 0.75 µL) to determine the lowest volume of tears that could be 
used with the TBARS assay. In addition, to assess the sensitivity of the assay kit, 200 µL of 
tears  and artificial tear solution (ATS)61 were pooled, dried using a centrifugal evaporator, and 
re-suspended with 15 µL of de-ionized water to prepare a 13x concentrated “tear pool”. 
Subsequently, samples were measured fluorometrically using a SpectraMax M5 UV-Vis 
Spectrophotometer (Molecular Devices, Sunnyvale, CA) at an excitation of 530nm and an 
emission of 590nm. 
 




7.3.2.2 ELISA Kits 
TF samples were also assessed using various enzyme-linked immunosorbent assays 
(ELISA) that detect the oxidization by-products MDA (Cell Biolabs Inc., San Diego, CA)506 
and 4-HNE (Cell Biolabs Inc., San Diego, CA)507 bound to TF proteins and low-density 
lipoproteins (OxLDL; Cell Biolabs Inc., San Diego, CA).508 
7.3.2.3 OxLDL ELISA 
This ELISA assay508 detects OxLDL, which is a carrier of cholesterol and other fatty acids 
such as phospholipids that are essential for TF stability. To determine the amount of oxidative 
stress, individual tears and pooled tear samples were diluted in a wide range (2 µL to 0.5 µL 
and 10 μL to 0.5 μL, respectively) to determine the lowest volume of tears that could be used 
with this ELISA assay. Furthermore, a spike-and-recovery (SAR) test was performed to 
determine the accuracy of the ELISA when using it with tear samples. Therefore, tear and 
blood plasma samples were spiked with known amounts of MDA (7.81 ng/mL, 31.25 ng/mL, 
and 125 ng/mL) and compared to an un-spiked sample to determine the rate of recovery 
(RR%). A RR between 80-120% is considered an acceptable range and everything outside this 
range means that something in the analyte interferes with the assay.509 
7.3.2.4 MDA- and 4-HNE-Adduct Elisa 
In preparation for the MDA- and 4-HNE-Adduct ELISA assays,506, 507 two different 
collection methods were examined: regular tear collection using capillary tubes and a flush 
method.329, 330, 510 To perform the flush method, 50 µL of 0.9% sodium chloride was instilled 
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onto the superior conjunctiva. Thereafter, participants were asked to roll their eyes to ensure a 
complete wash of the anterior surface before the diluted (~10x) tears were collected with 
calibrated glass capillary tubes within 1 minute. This tear collection method was applied to 
rinse out all possible oxidation markers from the surface of the eye. For comparison, the tear 
samples from the traditional collection method were processed without further dilution. After 
sample preparations were completed, the absorbance was measured using the SpectraMax M5 
UV-Vis Spectrophotometer at 450 nm for all ELISA assay kits. 
Furthermore, we used surplus samples of tears from symptomatic and asymptomatic lens 
wearers from a previously conducted study in the CCLR to determine the amount of lipid 
peroxidation by-products. The tear samples were pooled to reach a quantity of 50 µL each, 
diluted, prepared, and tested according to the assay protocols. 
In a further attempt to test if the MDA and 4-HNE-ELISA kits could be used to determine 
lipid oxidation, four volunteers were asked to wear four different CLs: lotrafilcon B (Air Optix 
Aqua, Alcon Inc.); balafilcon A (PureVision2, Bausch+Lomb); narafilcon B (TrueEye 1day, 
Johnson & Johnson); and etafilcon A (Acuvue2, Johnson & Johnson)] for 4 hours a day. 
Thereafter, a 6 mm disc was punched out of the lens material, placed into a well of both ELISA 
test plates, and assays were prepared and performed according to the test protocols. 
7.3.3 Analysis 
Calibration curves were generated for each assay to determine the coefficient of 
determination (COD), limit of detection (LOD), and quantification (LOQ).511 The linearity 
equations of the calibration curves were used to interpolate the amount of detected oxidation 
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by-product. The LOD and LOQ were calculated based on the slope and the standard error of 
the predicted y-value for each x in the regression of the calibration curves and determined on 
a 3:1 and 10:1 ratio, respectively. All values are tabulated in Table 7-1. 
Table 7-1. Linearity equations of calibration curves, LOD, LOQ, and coefficient of 
determination values of tested lipid oxidation assays. 
Oxidation 
Assay Biomarker COD Equations LOD LOQ R
2 
TBARS MDA y = 3.617x – 0.2605 0.31µM 1.04 µM 0.989 
ELISA 
OxLDL y = 0.011x – 0.0306 36.49 ng/mL 121.63 ng/mL 0.994 
MDA y = 0.064x + 0.0075 6.76pmol/mg 22.53pmol/mg 0.991 
4-HNE y = 0.765x + 0.0029 0.51µg/mL 1.69µg/mL 0.992 
 
7.4 Results and Discussion 
7.4.1 Thiobarbituric Acid Reactive Substances Assay 
Figure 7-2 and Table 7-1 show the generated calibration curve and the linearity equation of 
the TBARS assay. The amount of detected MDA for tear dilution were similar, below the 
assays LOD, and depicted graphically in Figure 7-2: 0.039 ± 0.187 µM in 6 µL, 0.162 ± 0.063 
µM in 3 µL, 0.113 ± 0.034 µM in 1.5 µL, and 0.089 ± 0.077 µM in 0.75 µL. When tears were 
pooled and concentrated (13x; Figure 7-3), the amount of MDA found in tears was 0.721 ± 
0.058 µM, which would equate to 0.056 ± 0.004 µM in a normal concentration (1x) in tears. 
In the 13x concentrated ATS, we found 0.922 ± 0.047 µM of MDA, which suggests that the 





Figure 7-2. Generated calibration curve for TBARS assay and detected amount of MDA in diluted 
tear samples. Fluorescence was read at 530 nm (excitation) and 590 nm (emission). 
 
Figure 7-3. Generated calibration curve for TBARS assay and detected amount of MDA in 
concentrated tear pool and ATS. Fluorescence was read at 530 nm (excitation) and 590 nm (emission).  
 
126 
Using the TBARS assay, this study was not able to detect MDA within individual tear 
samples. To detect oxidative stress in tears, a pooling step of multiple tear samples (200 µL) 
from several subjects and creating a high concentrated solution (13x) of those samples was 
required. Similar to this study, other published work that used the TBARS assay to determine 
oxidative stress in tears reported that a pooling step was required. 142, 365 Following that, 
Augustin et al.142 found an increase of MDA in tears of patients with DE symptoms, whereas 
for Mahomed and colleagues,365 the detected quantity of the oxidative stress biomarker was 
below the assays LOD, similar to the results of this study. A more recent publication by Schuett 
et al. 163 oxidized various PUFAs in vitro to study the effects of varying degrees of oxidation 
on CL depositions. To test their oxidized lipid mixture for presence of MDA, 25 µL of the 
mixture were added to the TBARS assay. All of those studies have been able to detect MDA 
in artificial and tear samples, but the reported amounts of samples necessary to achieve that 
exceed the amount of tears that would be available on a patient’s eye. 
A different tear collection method employed by Benlloch-Navarro et al. 106 was the 
Schirmer’s strip, presumably to maximize the amount of tear components within a sample. 
However, this method is more invasive than capillary tubes, which leads to reflex tearing, and 
in turn, may result in further tear dilution, oxidation, and decreased amounts of detected MDA. 
Also, extra steps are required to extract the tear samples from Schirmer’s strips which 
potentially dilutes the samples further and may increase the amount of oxidation, depending 
on the methods that are applied.  
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It would appear that it is possible to measure MDA in tears of patient groups/categories 
through the TBARS method; however, the specificity of it is still in debate as thiobarbituric 
acid (TBA) has shown to react with other chemical species that might be present in the TF and 
may lead to misinterpretations of the results.133, 366, 367 Further examination and optimization 
of the TBARS assay is therefore required to increase its sensitivity for testing individual tear 
samples at low volumes. A promising approach to further enhance the accuracy and account 
for any other TBA reactions in samples is to include a separation step of the test solution before 
measuring the MDA absorbance by including a high-pressure-liquid-chromatography (HPLC) 
106, 133 step or by using liquid chromatography mass-spectrometry (LCMS). Incorporating such 
methods into the measuring procedure has shown to lower the amount of required tear samples 
and was successfully applied to determine increased amounts of oxidative stress in elderly.106 
As mentioned previously, using small sample amounts is especially important to investigate 
oxidative stress in individual tears from patients with DE or contact lens discomfort (CLD). 
Those patients usually present with very small amounts of tear fluid readily available to collect, 
and in order to provide them with a tailored treatment plan, a more specific and sensitive 




7.4.2 ELISA Kits 
7.4.2.1 OxLDL ELISA 
Due to the small amount of collectable tears from the subjects and to determine the smallest 
amount of tears necessary, we first created a tear pool of all subject samples and tested for the 
presence of OxLDL in 10 µL, 5 µL, 2.5 µL, 1.25 µL, and 0.63 µL. The results are shown in 
Figure 7-4 and OxLDL in pooled tears was: 71.39 ± 3.78 ng/mL, 50.01 ± 8.06 ng/mL, 41.86.86 
± 3.50 ng/mL, 33.86 ± 1.27 ng/mL, and 28.81 ± 2.29 ng/mL, respectively. Based on those 
results, it appears that the ELISA could be used with tear samples a small as 2.5 µL, which 
showed OxLDL above the assays LOD (36.49 ng/mL; see Table 7-1). Subsequently, we 
measured OxLDL in 2.5 µL of four individual tear samples and detected between 45.59 ± 2.95 
ng/mL and 28.24 ± 4.66 ng/mL of OxLDL (Figure 7-5), where two tear samples presented 
OxLDL above the LOD and two others below it. Therefore, this ELISA assay might be feasible 
to be used to measure OxLDL in tears, but to determine if we can accurately measure oxidative 












Figure 7-4. Generated calibration curve for OxLDL ELISA assay and detected amount of oxidation 
in pooled tear samples. Absorbance was read at 450 nm. 
 
 
Figure 7-5. Amount of OxLDL detected in 2.5 µL of individual tear samples. 
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One of the first hurdles we had to overcome using this ELISA assay was a required chemical 
precipitation step to separate out proteins from test samples. When first using the assay with 
tear samples, no precipitation occurred. The ELISA kit is usually used for blood and serum 
samples that consist of significantly larger amounts of protein (65-85 mg/mL)512 within a 
sample compared to tears (6.5-9 mg/mL),513 which might be a reason why the separation step 
was not successful. To support the precipitation of proteins, 52 µg/µL lysozyme was added to 
the tear samples as a carrier protein; however, still no precipitation occurred. An additional 
approach of pooling and concentrating the tear samples also did not work in our favour to 
precipitate out enough protein to be measured with the assay. In a further step, an ammonium 
sulfate (NH4)2SO4 solution of 75% concentration was created and 2 µL solution were added 
per 1 µL of the previously created lysozyme-tear mixture. After allowing the mixture to 
equilibrate for 15 minutes and centrifuging it for an additional 15 min at 2500g, the protein 
precipitation was successful and a pellet formed (Figure 7-6). After the precipitate and 





Figure 7-6. Precipitation of 
tear samples after addition of 
lysozyme and ammonium 





The results of the SAR test revealed a recovery rate (RR) for the spiked plasma samples of 
81%, 84%, and 111% and are therefore within the normal range 80-120% compared to the un-
spiked plasma sample, which confirms that this OxLDL assay is an accurate technique to use 
with such sample types. For the tear samples, however, the recovery values were ≥156% and, 
therefore, out of the normal range. Furthermore, the high RR values show that the samples are 
interfering with the assay. A probable cause for the out of range RR could be the additionally 
added lysozyme and (NH4)2SO4, but further analysis is necessary to determine the actual cause 
before this ELISA assay can be used confidently for the examination of tears.  
7.4.2.2 MDA-, and 4-HNE-Adduct ELISA Kits 
Figure 7-7 and Figure 7-8 show the calibration curves and Table 7-1 the linearity equations 
of the MDA- and 4-HNE Adduct ELISAs. No differences were found between the two tested 
collection methods (flushed vs. normal capillary collection). In addition, the received tear 
samples of symptomatic and asymptomatic DE patients showed similar MDA (Figure 7-7) and 
4-HNE (Figure 7-8) amounts. All of the measured values are below the assays LOD and are 
tabulated in Table 7-2 and Table 7-3. 
A recent study by Choi et al. 162 examined tears of non-Sjögren’s Syndrome (SS) DE and 
non-DE patients and found increased amounts of both MDA and 4-HNE in non-SS DEs, using 
similar ELISA assays. However, comparing the results of non-DE patients,162 the amount of 
detected MDA in our study was significantly smaller (3.80 ± 1.05 pmol/mg), whereas, the 
amount of 4-HNE (0.02 ± 0.03 µg/mL) was similar. These differences in oxidative stress 
biomarkers to the results presented by Choi et al. 162 might be a consequence of the amount of 
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tear samples (30 µL vs. 5 µL) that were used in both studies. Furthermore, we did not find 
significant amounts of oxidation biomarkers when examining samples from symptomatic and 
asymptomatic DE patients, which might be related to the age and long term storage of the 




Figure 7-7. Generated calibration curve for the MDA ELISA assay and detected amount of 









Figure 7-8. Generated calibration curve for the 4-HNE ELISA assay and detected amount 
of oxidation in symptomatic and asymptomatic tear samples. 
  
   Px 002 Px 004 Px 006 Px 007 
Flushed Tear 




0.563 ± 0.074 0.573 ± 0.056 0.604 ± 0.013 0.712 ± 0.019 
Lotrafilcon B 1.336 ± 0.084 2.290 ± 2.019 3.676 ± 1.686 1.569 ± 0.396 
Balafilcon A 2.009 ± 0.627 1.225 ± 0.094 1.644 ± 0.143 4.633 ± 3.867 
Narafilcon B 1.205 ± 0.145 1.038 ± 0.196 0.846 ± 0.031 1.769 ± 0.968 
Etafilcon A 0.901 ± 0.113 2.914 ± 2.171 2.588 ± 0.953 1.600 ± 1.054 
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Table 7-3. Amount of 4-HNE (µg/mL) measured in tears and on various contact lens 
materials. 
  Px 002 Px 004 Px 006 Px 007 
Flushed Tear 
Collection 0.206 ± 0.212 0.080 ± 0.031 0.056 ± 0.003 0.056 ± 0.001 
Traditional 
Tear Collection 0.063 ± 0.008 0.082 ± 0.016 0.063 ± 0.002 0.052 ± 0.011 
Lotrafilcon B 0.075 ± 0.120 0.195 ± 0.096 0.000 ± 0.207 0.412 ± 0.219 
Balafilcon A 0.503 ± 0.059 0.428 ± 0.053 0.291 ± 0.023 0.372 ± 0.028 
Narafilcon B 0.050 ± 0.051 0.510 ± 0.376 0.000 ± 0.021 0.231 ± 0.009 
Etafilcon A 0.000 ± 0.018 0.074 ± 0.035 0.000 ± 0.099 0.301 ± 0.158 
 
As a final test and preliminary study for future projects, we tested the amount of MDA and 
4-HNE on contact lenses that were worn for 4 hours. The results are listed in Table 7-2 and 
Table 7-3 depict amounts below the assays LOD with ≤ 4.63 ± 3.87 pmol/mg of MDA and ≤ 
0.50 ± 0.06 µg/mL of 4-HNE. However, the results show that amounts of measured MDA and 
4-HNE on CLs varied greatly between patients and lens materials. Despite the low detected 
quantities, CLs seem to be a carrier for oxidative stress markers. Once lipids deposit on CLs, 
they become immobilized and are exposed to UV radiation and oxygen for far longer and are 
therefore more susceptible to oxidation,132 which may explain why the amount of detected 
biomarkers on CLs in this study was greater than the detection in tears. Nevertheless, the 
degree of oxidation has been shown to affect the amount of total lipids depositing on CLs,163 
and once deposited, oxidation by-products can be sequestered from CLs materials.163, 365 This 




Oxidative stress may very well occur in the TF, but the impact on DE and contact lens 
discomfort (CLD) is still in debate.132, 135, 137 The amount of occurring lipid oxidation by-
products, however, depends on individual lipid composition, the turnover rates of the TF,132 or 
the presence of lipid degrading enzymes in tears of DE patients or CL wearers.97, 125, 126, 134 We 
believe that occurring lipid peroxidation may have a destructive effect on TF lipids and their 
stability, however, it is more difficult for oxidative stress by-products to accumulate over time 
because of the frequent TF renewal every time we blink. In general, researchers have been able 
to show that increased lipid oxidation causes health issues by testing blood or serum samples, 
but in contrast to tears, those samples are extracted from an enclosed system where oxidative 
stress can build up and cause more damage over time. Although, this study only found 
biomarkers of oxidative stress below the assay’s LOD, some of the tested CLs showed greater 
amounts of detected biomarkers compared to tears, which supports the idea to use CLs as a 
medium to collect markers of oxidative stress that occur on the eye and build up over time in 
future studies. 
Unfortunately, no current data exists that determined the amount of oxidative stress by-
products in normal tears, which makes it difficult to compare the measured values of this or 
other studies. Therefore, future studies should focus on developing a more sensitive and 
specific method to determine lipid peroxidation in tears, to help create a database for oxidative 
stress in tears of normal patients, DE patients, and CL wearers. The development of a sensitive 
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test assay and such a database will directly benefit DE patients and practitioners to determine 
the most perfect and efficient treatment of DE or CLD. 
The objective of this study was to develop a sensitive method to determine oxidative stress 
of individual tear samples. The results show that markers of oxidative stress can be detected 
using the examined assays, however, only in very small quantities. Specifically, the TBARS 
kit was optimized for the use of tear samples and showed that small quantities of MDA are 
detectible, when samples were pooled and concentrated. The OxLDL ELISA kit was optimized 
for the use of tear samples as low as 2.5µL. Both techniques could be employed to determine 
the oxidative stress in TF lipids collected from patients with DE and CL-related DE. However, 
further work is needed to increase the sensitivity of all presented assays to be used to determine 
the lipid peroxidation in small tear sample volumes from patients with DE or CLD. To further 
lower the amount of required tear volume needed to test for oxidative stress markers, the 
presented assays could be used in combination with an HPLC or LCMS. 
7.6 Acknowledgment 





Chapter 8  
Conclusions and Future Outlook  
Despite the constant growth in the popularity of CL 396, 472 and the many improvements in 
CL materials over the past few decades, the CL market still reports high numbers of patients 
ceasing CL wear, mainly due to CLD.197, 198, 454 The introduction of SiHy lens materials 
contributed immensely to the recent success of CLs,396 which can mainly be attributed to the 
increased oxygen transmissibility that these lens materials provide.177, 439, 440 However, SiHy 
materials are relatively more hydrophobic than conventional hydrogels, which may affect 
wettability,404, 405, 441 and may lead to increased lipid deposition.58, 62, 63, 227, 257, 258, 260, 262, 263, 267, 
268, 398, 449 It is widely believed that lipid deposition on CLs has a detrimental effect on material 
properties and lens performance on the eye, and may contribute to CLD and dryness.261, 271, 272 
However, an extensive literature search was unable to show a strong correlation between 
reduced CL comfort and increased lipid deposition on CLs.275 
A CL immediately interacts with the ocular surface after lens insertion and research has 
shown that TF deposition occurs instantaneously and continuously throughout its use.62, 63, 160, 
227, 238, 239, 255, 257, 267, 268, 332, 371, 514 Despite the modification of surfaces 188, 189, 441, 515 to reduce 
the affinity of lipids for SiHy lenses, they are still prone to deposit in greater quantities on these 
lens materials.58, 62, 63, 227, 258, 263, 268, 449   Common strategies among practitioners to minimize 
lipid deposition and to improve end of day comfort with CLs includes the use of cleaning 
solutions to remove deposits or to reduce the replacement frequency and switch patients to a 
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DD lens wear modality. However, valuable information is still missing on whether such 
strategies might be helpful to improve CL comfort. 
To first answer the question of whether existing cleaning procedures and solutions are 
capable of efficiently reducing or fully removing accumulated TF lipids from CLs, Chapter 3 
examined various contemporary lens materials exposed to different MPSs. Through the use of 
radiolabelled cholesterol, this chapter assessed the lipid uptake onto five SiHy lenses after an 
incubation period of 16 h a day over a time period of 7 days. Additionally, CLs were either 
stored in a saline solution or cleaned (using a rub & rinse procedure) with one of five MPSs 
between the incubation times. After extracting the accumulated TF lipids from the CLs, it was 
found that balafilcon A and senofilcon A lens materials were the highest depositors of 
cholesterol, which was consistent with other studies.58, 60-63, 263, 266, 268 Only one of the 
contemporary MPSs showed a significant effect in the reduction of deposited cholesterol, and 
only on the two highest-depositing CL materials. Overall, this study showed that the efficiency 
of current MPSs to reduce and/or remove accumulated TF lipids from CLs is highly dependent 
on the material/solution combination. In cases where lipid deposition remains an issue, 
changing the lens material or increasing the replacement frequency of CLs would be 
appropriate. 
The majority of patients wearing SiHy DD lens materials report excellent comfort.451, 452 
Information about the affinity of TF lipids depositing onto DD CLs, however, is lacking. In 
Chapter 4, the in vitro quantities and hierarchy of cholesterol deposition onto various DD lens 
materials are described. In this chapter, three contemporary SiHy and four CH DD CLs were 
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incubated in a lipid-containing ATS over a time period of 16 h and the degree of lipid uptake 
was assessed over time, using a radiochemical methodology. It was found that SiHy 
accumulate significantly more lipid than CH lens materials even after only one day of 
exposure. Furthermore, the quantities of extracted lipids from the DDs were far less than 
reported values on DW CLs that also evaluated lipid deposition after one day.58, 63, 449 This in 
vitro study was the first to investigate lipid uptake onto various DD lens materials and provides 
valuable information for manufacturers and practitioners alike.  
An important question that remained unanswered to-date concerns the location of lipid 
deposition on SiHy CLs and whether it was largely surface-located or was within the bulk of 
the lens material. The differences in lipid uptake and penetration in DD lens materials was, 
therefore, assessed in Chapter 5. Furthermore, this chapter investigated a novel in vitro 
approach to evaluate deposition and penetration of TF lipids. Three SiHy and four CH DD CLs 
were incubated for 4 and 12h in an ATS using two different incubation methods: the traditional 
“in-vial” method and a novel in vitro platform. In contrast to using the traditional “in-vial” 
method, where CLs were statically incubated in 3.5 mL of ATS, CLs were mounted on a novel 
in vitro eye-blink platform that simulated physiological tear flow, tear volume, air exposure 
and blinking. Through the use of NBD-cholesterol and LSCM, it was found that SiHy lenses 
depicted higher fluorescence intensities than CH lenses and that fluorescence intensities varied 
between incubation methods and CL materials. Specifically, when CLs were incubated using 
the “in-vial” method, the fluorescence intensities of NBD-cholesterol were relatively higher 
than using the novel in vitro platform. This experiment supported the theory that the traditional 
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“in-vial” incubation method is rudimentary and that more advanced in vitro models that 
simulate important ocular factors such as intermittent air exposure, physiological tear volumes, 
and tear flow may provide better insight to elucidate the interactions between CLs and TF 
components. Additionally, the localization of lipid deposits on CLs may play a significant role 
in determining CLD and provide valuable information to optimize the efficiency of MPSs in 
removing lipid deposits from CLs. 
To elucidate the impact of TF deposits on the wettability of DD SiHy lens materials, Chapter 
6 described the development of a novel in vitro model and used it to compare NIBUTs of five 
contemporary DD CLs. Three SiHy and two CH CLs were incubated for up to sixteen hours 
in a complex ATS by using a model blink cell that specifically mimics intermittent air 
exposure, which was previously shown to impact lipid deposition.266 To model the drying 
effect that occurs between blink intervals, lenses were continuously submerged in the ATS for 
three seconds and exposed to air for ten seconds. By using a corneal topographer, it was found 
that the initial NIBUT of CHs was longer than over SiHy CLs. However, after twelve hours 
the NIBUTs of SiHy CLs was longer but very similar to CHs. Overall, this method showed 
varying levels of deposition may affect the measured NIBUTs of CLs and that NIBUT values 
gradually decrease over time, which were comparable to in vivo data. 
The final chapter of this thesis, Chapter 7, assessed and optimized various assays that 
determine lipid peroxidation by-products in tears, which may play a role in DE and CLD.125, 
132 Tear samples were collected with micro-capillary tubes, diluted and processed to determine 
the smallest volume of tears that could be used to measure the presence of MDA, 4-HNE, and 
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OxLDL. Despite the small quantities of detected oxidative stress markers, the assays were 
optimized for the use of small tear volumes and could be employed to determine oxidative 
stress and potentially help to identify the cause for patients that suffer from DE or CLD. 
The work presented in this thesis has provided deeper knowledge about the ability of various 
cleaning solutions to remove lipids from CLs and added valuable information about the 
interactions of TF lipids with CLs, particularly about DD lens materials. Furthermore, the use 
of two novel in vitro methods provided constructive information about the location of lipid 
deposits and the impact of TF lipids on tear break up times. Together, all of these results may 
help better predict the performance of a CL, and thus provide further information for 
manufacturers during the design process and clinicians when deciding the best possible product 
on the market for their patients. 
Despite the tendency of SiHy CLs to accumulate significant amounts of TF lipids, there is 
an ongoing debate on whether lipid deposition is generally good or bad for the performance of 
a CL.160, 272 Future projects could, therefore, focus on the development of cleaning solutions 
that are capable of removing lipid contamination efficiently, or selectively removing lipid types 
that may result in poor lens performance. Moreover, further studies are required to determine 
if the levels of lipid deposits found on DD CLs may prove deleterious during wear and such 
studies should determine if a progressive reduction of pre-lens NIBUT does occur during CL 
wear.  
To develop “smart” lens materials and lens care products that will be capable of selectively 
depositing or removing lipid deposits, future studies are warranted to determine and 
 
142 
differentiate between “bad” and “good” TF lipids by evaluating their impact on CL 
performance and comfort. Such studies could employ loading or coating contemporary lens 
materials with a specific lipid or lipid combinations and subsequently compare comfort ratings 
and lens performance of those treated lenses to untreated CLs in vivo. However, these studies 
are not easy to conduct. They will be time consuming, costly, could potentially result in 
infections if the lens materials are not sterilized appropriately before wear and will thus require 
extensive testing and ethics clearance before they can be carried out. Nevertheless, lipids that 
might be beneficial to deposit onto CLs include cholesterol or amphiphilic lipids such as 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE). Although cholesterol has been 
shown to be one of the major TF lipids depositing on SiHy lens materials, small quantities of 
deposited cholesterol on CLs may provide an antibacterial treatment option.516 However, the 
exact amount of cholesterol on lenses that can exhibit an anti-bacterial effect is currently 
unknown and requires further investigation. PC and PE are lipids that are believed to support 
the spreading of the lipid phase by mediating between the TF lipids and the underlying aqueous 
phase.48, 54, 502 Incorporating or coating lens materials with these amphiphilic phospholipids 
might therefore be favourable, as they could occupy the hydrophobic chains within the SiHy 
lens materials to prevent excessive and continuous accumulation of other TF lipids and might 
simultaneously enhance the hydrophilicity and wettability of CL surfaces.262 
Further research is also necessary to determine the role of oxidized TF lipids and their by-
products in the development of DED and to assess in which way lipid peroxidation has an 
impact on CL deposition and discomfort. Even though phospholipids might be beneficial for 
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CL performance and comfort, 68, 517-519 these lipids consist of unsaturated and PUFAs that are 
prone to oxidation. To further our understanding of the role of oxidized lipids in relation to 
DED and CLD, future studies need to identify the exact fragmentation and conformational 
changes in TF lipids that oxidation may cause. Therefore, in addition to using traditional 
ELISA-based assays, upcoming projects should employ more sensitive analytical methods, 
such as mass-spectrometry, Raman-spectrometry, or HPLC technology to precisely determine 
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